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ABSTRACT 
 
STRUCTURAL AND BIOCHEMICAL STUDIES OF THE 
CARBOXYLTRANSFERASE DOMAIN FROM PYRUVATE CARBOXYLASE 
 
 
 
Adam D. Lietzan 
 
Marquette University, 2014 
 
 
 
Pyruvate carboxylase (PC; E.C. 6.4.1.1), a multifunctional biotin-dependent 
enzyme, catalyzes the bicarbonate- and MgATP-dependent carboxylation of pyruvate to 
oxaloacetate. To complete the overall reaction, the tethered biotin prosthetic group must 
first gain access to the biotin carboxylase domain and become carboxylated, and then 
translocate to the carboxyltransferase (CT) domain where the carboxyl group is 
transferred from biotin to pyruvate. Kinetic analyses of PC have suggested that the 
spatially distinct reactions, which occur in the active sites of the BC and CT domains, are 
well coordinated. To gain insights into the molecular events necessary for coordinating 
catalysis in the CT domain, structural and biochemical studies were performed.       
An in vitro enzyme assay was previously developed to measure the oxamate-
induced decarboxylation of oxaloacetate in the CT domain. While this reaction has been 
widely utilized, the mechanism has not been fully established. Structural data reveals that 
oxamate is positioned in the active site of the CT domain in an identical manner to the 
substrate, pyruvate, and kinetic data demonstrates that the mechanism proceeds through a 
simple ping-pong bi bi mechanism. These results establish this assay as an ideal method 
to dissect the role of biotin in the isolated CT domain reaction. 
To investigate the molecular events necessary for facilitating biotin binding into 
the CT domain active site, structural investigations of the CT domain in the presence and 
absence of the substrate, product and intermediate analogs were conducted. These studies 
revealed a substrate-induced conformational change that is essential for catalysis. Site-
directed mutations of two conformation-stabilizing residues result in a reduced rate of 
biotin-dependent reactions but have no effect on the rate of biotin-independent reactions, 
indicating that these residues are essential in facilitating biotin binding during catalysis. 
Furthermore, these structures reveal that CT domain ligands do not interact directly with 
the active site metal as previously hypothesized and that the substrate maintains its 
orientation throughout catalysis. Collectively, these studies reveal fundamental new 
insights into how substrate binding in the CT domain active site facilitates biotin binding 
during catalysis and contribute to a detailed description of how PC coordinates catalysis 
between two spatially distinct active sites.	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CHAPTER 1: INTRODUCTION 
 
 
 
By its simplest definition, metabolism is a cellular activity whereby a series of enzyme-
catalyzed reactions convert reactants into desired products in a carefully defined fashion. 
Cellular metabolism, which is divided into catabolic and anabolic reaction pathways, is 
essential for cellular homeostasis. Together these pathways are responsible for capturing 
potential energy from macromolecules such as carbohydrates, lipids and proteins and 
transforming it into chemical energy needed for the cell to complete chemical, 
mechanical and transport work. The energetic penalty associated with inefficiently 
transferring metabolites between biochemical pathways can be destructive and often 
times fatal to the cell (Jin, DiPaola, Mathew, & White, 2007). The cell eventually 
becomes disorganized and ultimately dies without adequate control of cellular 
metabolism. For this reason, these pathways and their associating enzymatic machinery 
must be well coordinated. In an attempt to increase metabolic efficiency, the cell takes 
advantage of numerous protein complexes and multifunctional enzymes. These systems 
serve to enhance the efficiency in transferring pathway or reaction intermediates and 
assist with regulating metabolism. 
To ensure that metabolites are effectively transferred between metabolic 
pathways, the enzymes required for the chemical conversions are often localized 
together. That is, the localization or compartmentalization of enzymes in defined areas of 
the cell such as the cytosol, mitochondrial matrix or cellular membrane greatly influences 
pathway activity and the transfer of metabolites. One such mechanism through which 
metabolic compartmentalization can take place is by forming multienzyme complexes. 
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These enzyme systems function sequentially by catalyzing consecutive reactions linked 
by common metabolic intermediates. In this way, intermediates produced from one 
enzyme are transferred to the next enzyme without mixing with the cellular contents. This 
mechanism is called substrate channeling.   
By definition, substrate channeling facilitates the direct transfer of an intermediate 
between two spatially distinct enzymes that catalyze sequential reactions (reviewed in 
Miles, Rhee, & Davies, 1999; Zhang, 2011). This process eliminates the free diffusion of 
intermediates into the bulk solvent, thus reducing the transit time of the intermediate 
while protecting it from decomposition by the aqueous external environment (X. Huang, 
Holden, & Raushel, 2001). Substrate channeling also prevents substrate competition 
between competing biosynthetic pathways. 
 The two forms of substrate channeling are tunnels/channels and swinging arm-
mediated catalysis. Tunneling occurs when a reaction intermediate travels through an 
enclosed tunnel to the subsequent active site. Tunneling can be either intra- or 
intermolecular in nature. For example, tryptophan synthase exists as an (αβ)2 complex in 
plants and bacteria. The reaction product, indole, of the α-subunit must traverse through a 
25 Å long hydrophobic intramolecular tunnel to the β-subunit where it and L-serine are 
condensed to form tryptophan (Hyde, Ahmed, Padlan, Miles, & Davies, 1988; Rhee, 
Parris, Ahmed, Miles, & Davies, 1996). Reaction intermediates can also be charged and, 
as is the case with dihydrofolate reductase-thymidylate synthase, have been shown to 
traverse along an oppositely charged ridge to the subsequent active site (Knighton et al., 
1994). This form of substrate channeling is referred to as electrostatic channeling.  
On the other hand, swinging arm-mediated catalysis allows for the direct transfer 
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of the reaction intermediate between active sites by way of a covalently tethered 
prosthetic group (reviewed in Perham, 2000). The first described swinging arm-mediated 
enzyme complexes were the 2-oxo acid dehydrogenase complexes, which utilize the 
lipoyl-lysine prosthetic group to transfer an acyl group from 2-keto acids such as 
pyruvate and α-ketoglutarate to coenzyme A (CoA) (Green & Oda, 1961; Nawa, Brady, 
Koike, & Reed, 1960). Since that initial discovery, additional enzyme complexes, which 
include a biotinyl-lysine or a phosphopantetheinyl-serine prosthetic group, have been 
shown to employ a swinging arm-mediated mechanism.  
While the swinging arm-mediated mechanism has been generally described for 
various enzyme complexes, the prospective molecular details required for coordinated 
catalysis between active sites remains vague. Limited studies have addressed or described 
the conformational changes required for catalysis in enzymes that employ a swinging 
arm-mediated mechanism. For example, it is recognized that the multifunctional biotin-
dependent enzyme pyruvate carboxylase (PC) must oscillate through various 
conformational states in order to complete catalysis, but a thorough description of those 
conformational states is currently lacking. The aim of this dissertation is, in part, to 
describe the conformational changes necessary to facilitate catalysis in PC with a special 
emphasis on the role of biotin in the carboxyltransfer reaction of PC. Insights gained into 
the role of biotin in this reaction may be applicable to other enzymes in the biotin-
dependent enzyme family and, more generally, to swinging arm multi-enzyme complexes 
as a whole.     
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1.1 Biotin-dependent Enzymes 
 
 
 
In order to fully appreciate the complexity and elegance associated with the biotin-
dependent enzyme family utilizing a swinging arm-mediated mechanism to complete 
catalysis between spatially distinct active sites, one must be familiar with the chemistry 
associated with the biotin prosthetic group. Furthermore, it is imperative to recognize that 
the biotin-dependent enzymes all utilize a swinging-arm mediated mechanism, but do so 
to accommodate various cellular metabolic needs. This section aims to address the 
importance of biotin in catalysis and provides a brief overview of the classes that form 
the biotin-dependent enzyme family.   
In 1933, Burk and colleagues described an accessory growth factor isolated from 
egg yolk that was essential for the growth of the nitrogen-fixing bacterium, Rhizobium  
(Allison, Hoover, & Burk, 1933). Three years later, Kögl and Tonnis isolated a 
crystalline ‘Bios’ factor from duck egg yolks that they called biotin (Kögl & Tonnis, 
1936). Shortly thereafter, biotin was recognized as the essential growth factor common to 
bacteria, yeast and mammals (reviewed in Lanska, 2012). Subsequently, the structure of 
biotin was chemically deduced (Figure 1-1; (du Vigneaud, 1942)) and it was shown to be 
involved in carboxylation reactions, providing a clue into its role in cellular physiology  
(Lardy & Peanasky, 1953). Eventually, biotin was found to be covalently tethered to and 
necessary for catalysis in acetyl CoA carboxylase (Wakil, Titchener, & Gibson, 1958). 
This critical observation established a biological role for biotin in CO2 fixation and 
resulted in the discovery of a family of enzymes known today as the biotin-dependent 
enzymes. 
	   5	  
 
 
Figure 1-1. Chemical structure of biotin and N-carboxybiotin. 
 
1) Biotin, also known as vitamin H, vitamin B7 or coenzyme R, is composed of a valerate side 
chain tethered to a bicyclic ring. The bicyclic ring consists of an ureido ring fused to a 
tetrahydrothiophene ring. 2) N-carboxybiotin is the reaction intermediate for all biotin-dependent 
enzymes. Biotin is carboxylated at the 1’-N position.   
 
 
 
The biotin-dependent enzymes are present across all three domains of life 
(Archaea, Bacteria and Eukaryota), and phylogenetic analyses of the individual domains 
suggest an ancient evolutionary origin (Lombard & Moreira, 2011). These enzymes all 
contain an active site that is responsible for carboxylating biotin and, in all cases except 
for the Class II decarboxylases, a second active site for transferring the carboxyl moiety 
to an accepting substrate. In this way, each biotin-dependent enzyme contains two 
distinct half-reactions with the first always being the carboxylation of biotin. 
Furthermore, because this family of enzymes requires multiple domains to accomplish 
catalysis, each member of the family is considered to be a multifunctional enzyme and 
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the mechanism by which the carboxyl group is transferred between active sites via a 
biotin carrier is known as a swinging-arm mediated mechanism (Perham, 2000). 
Biotin serves as a conduit for carboxyl transfer and is carboxylated at the 1’-N 
position during the first partial reaction (Figure 1-1; (Fry, Fox, Lane, & Mildvan, 1985)). 
The resulting carboxybiotin product is relatively stable with a half-life exceeding 100 
minutes at pH 8 (Knowles, 1989). The stability afforded by covalently tethering a high-
energy carboxyl group to biotin is critical since energy is expended in carboxylating 
biotin and because carboxybiotin must physically translocate to a second active site prior 
to transferring the carboxyl moiety to an acceptor substrate.  
Furthermore, biotin is covalently tethered to the ε-amino group of a conserved 
lysine via an amide linkage in the biotin carboxyl carrier protein (BCCP) domain (Rylatt, 
Keech, & Wallace, 1977). The BCCP domain serves as a flexible carrier that moves 
between functional domains in order to present biotin to each active site for catalysis. The 
structural architecture for the C-terminal portion of the BCCP domain is conserved for all 
enzymes within the family suggesting a common ancestor. The conserved lysine that is 
biotinylated is located at the C-terminal portion of all BCCP domains and is biotinylated 
by the enzyme biotin protein ligase (Chapman-Smith & Cronan, 1999). In most cases, the 
modified lysine residue is bracketed within a conserved sequence consisting of Ala-Met-
Lys-Met. In PC and transcarboxylase (TC), the identity extends to Ala-Met-Lys-Met-
Glu-Thr, indicating that these enzymes have diverged more recently compared to other 
members of the family.  
The classification of the biotin-dependent enzymes is primarily based on the 
identity of the substrate that is either carboxylated or decarboxylated during catalysis. 
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This designation is determined by the carboxyltransferase (CT) component of the enzyme 
(Figure 1-2). For example, the CT domain of PC catalyzes the carboxylation of pyruvate 
thus deriving the name pyruvate carboxylase for the full-length enzyme. The exception to 
this nomenclature is the enzyme transcarboxylase, which utilizes two separate CT 
domains for catalysis. Additionally, the various components that comprise the 
multifunctional enzyme may exist as separate subunits or may be physically fused 
together into a large, multidomain single polypeptide chain (Figure 1-2). Many members 
of the biotin-dependent enzyme family require an oligomeric state greater than one to be 
functional and often exhibit cooperativity during catalysis. However, urea carboxylase 
exists as a monomer in solution and therefore is not arranged in a higher oligomeric state  
(C. Fan, Chou, Tong, & Xiang, 2012). 
As previously stated, all biotin-dependent enzymes utilize biotin in order to 
transfer a carboxyl moiety, however the mechanism by which the enzyme carboxylates 
biotin or transfers the carboxyl moiety serves to subdivide the family into three classes. 
These three classes of biotin-dependent enzymes are briefly described below. 
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Figure 1-2. Schematic diagram of the biotin-dependent enzyme family showing the 
arrangement of catalytic and biotin carrier domains. 
 
The biotin-dependent enzyme family is subdivided into three classes. The Class I carboxylases 
include pyruvate carboxylase (PC), acetyl CoA carboxylase (ACC), propionyl CoA carboxylase 
(PCC), methylcrotonyl CoA carboxylase (MCC), urea carboxylase (UC) and geranyl CoA 
carboxylase (not shown). Within this class, both PC and ACC are further subdivided by their 
distinct structural arrangements. As described in section 1.2.2, the majority of PC enzymes are of 
the α4 form, with all domains arranged on a single polypeptide chain. A few PC enzymes are 
classified as “subunit type” and these are composed of separate α- and β- subunits. The ACC 
enzymes of prokaryotic origin are composed of individual subunits while eukaryotic ACC is a 
multifunctional enzyme with all domains originating from a single polypeptide chain. The Class 
II decarboxylases include the oxaloacetate decarboxylase complex (ODC), methylcrotonyl CoA 
decarboxylase (MDC), glutaconyl CoA decarboxylase (GDC) and malonate decarboxylase (not 
shown). The Class III transcarboxylase consists of a single enzyme, transcarboxylase from P. 
shermanii, described in Section 1.1.3. The domains are colored to highlight the homology among 
the individual domains. Complete abbreviations are as follows: ACC, acetyl CoA carboxylase; 
BCCP, biotin carboxyl carrier protein; GDC, glutaconyl CoA decarboxylase; MCC, 
methylcrotonyl CoA carboxylase; MDC, methylcrotonyl CoA decarboxylase; MgATP/HCO3-, 
biotin carboxylase domain; ODC, oxaloacetate decarboxylase complex; PC, pyruvate 
carboxylase; PCC, propionyl CoA carboxylase; UC, urea carboxylase. 
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1.1.1 Class I – Carboxylases 
 
 
 
Class I enzymes are unique within the biotin-dependent family in catalyzing carbon 
fixation. On the basis of chemical reactivity, enzymes involved in oxidizing carbon 
dioxide for carbon fixation would be predicted to favor nucleophilic attack on the 
electrophilic carbon of carbon dioxide. However, at physiological pH and temperature, 
the concentration of dissolved carbon dioxide is twenty times less than bicarbonate ion 
(10 µM vs. 200 µM), making dissolved carbon dioxide availability low by comparison 
(Butler, 1982). While there are enzymes that utilize dissolved carbon dioxide as a 
substrate (ribulose-1,5-biphosphate carboxylase oxygenase, or RuBisCO, is a well-known 
example), these enzymes often suffer from low catalytic activity. Biotin-dependent 
carboxylases have evolved to effectively utilize the more abundant bicarbonate ion for 
carbon fixation (Cooper, Tchen, Wood, & Benedict, 1968; Kaziro, Hass, Boyer, & 
Ochoa, 1962).   
The biotin-dependent carboxylases include acetyl CoA carboxylase (EC 6.4.1.2), 
3-methylcrotonyl CoA carboxylase (EC 6.4.1.4), propionyl CoA carboxylase (EC 
6.4.1.3), urea carboxylase (UC; EC 6.3.4.6), and pyruvate carboxylase (EC 6.4.1.1; 
Figure 1-2). All enzymes within this class use a common mechanism to carboxylate 
biotin in the structurally conserved biotin carboxylase (BC) domain. In the presence of 
two metal ions, typically Mg2+, ATP is cleaved to activate bicarbonate for the subsequent 
carboxylation of biotin (Figure 1-3.1). The carboxyl moiety is then transferred from the 
carboxybiotin intermediate to an acceptor substrate located in a completely separate 
active site in the CT domain. Many of these Class I enzymes use a common mechanism  
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Figure 1-3. Reaction schemes for the various classes of enzymes within the biotin-dependent 
enzyme family. 
  
The general reaction scheme for each biotin-dependent enzyme class is represented. The classes 
are as follows: 1. Class I – carboxylases; 2. Class II – decarboxylases; 3. Class III – 
transcarboxylase.  
 
 
 
and a conserved CT domain to act on a variety of thioester substrates (Waldrop, Holden, 
& St. Maurice, 2013), but a subset within this class, namely PC and UC, do not act on 
thioester substrates and their CT domains differ substantially in structure and mechanism 
from each other and from the other enzymes in this class. 
1.1.2 Decarboxylases 
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Class II enzymes facilitate sodium transport from the cytoplasm to the periplasm in some 
archaea and anaerobic bacteria (Figure 1-3.2). The enzymes included in this class are the 
oxaloacetate decarboxylase complex (ODC; EC 4.1.1.3), methylmalonyl CoA 
decarboxylase (EC 4.1.1.41), and glutaconyl CoA decarboxylase (EC 4.1.1.70; Figure 1-
2). A biotin-dependent malonate decarboxylase (EC 4.1.1.89) has also been described 
that proceeds through the formation of a malonyl-thioester with a specific acyl carrier 
protein (ACP) (Berg, Hilbi, & Dimroth, 1997; Dimroth & Hilbi, 1997). Decarboxylating 
the β-keto acid of oxaloacetate or the thioester of methylmalonyl CoA or glutaconyl 
CoA, affords the necessary free energy to pump sodium ions across the lipid bilayer  
(Buckel, 2001; Buckel & Semmler, 1983; Dimroth, Jockel, & Schmid, 2001; Hilpert & 
Dimroth, 1982). The resulting sodium gradient drives the synthesis of ATP, solute 
transport and motility in these organisms (Mulkidjanian, Dibrov, & Galperin, 2008). This 
class of biotin-dependent enzymes does not transfer a carboxyl moiety to an acceptor 
substrate. Instead, carboxybiotin transits to the membrane-bound β-subunit where it is 
decarboxylated to biotin and CO2 in a reaction that consumes a periplasmic proton and is 
coupled to Na+ translocation from the cytoplasm to the periplasm. 
1.1.3 Class III – Transcarboxylase 
 
 
 
The only enzyme currently described in Class III is transcarboxylase (EC 2.1.3.1) from 
the bacterium Propionibacterium shermanii (Figure 1-2). Transcarboxylase transfers a 
carboxyl moiety from methylmalonyl CoA to pyruvate, thus resulting in the formation of 
propionyl CoA and oxaloacetate (Wood, Allen, Stjernholm, & Jacobson, 1963). 
Transcarboxylase is unique among the biotin-dependent enzymes in that it catalyzes 
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carboxyl transfer between two organic molecules. The enzyme utilizes two separate CT 
domains to accomplish this transfer (Figure 1-3.3). 
1.2 Pyruvate Carboxylase 
 
 
 
Woronick and Johnson (1960) first identified an ATP-dependent CO2-fixing system in 
cell-free extracts from Aspergillus niger (Woronick & Johnson, 1960). This novel CO2-
fixing reaction was postulated to result in the production of the dicarboxylic acid, 
oxaloacetate, from pyruvate, ATP and CO2. These initial observations swiftly lead to the 
discovery of an enzyme in avian and bovine liver tissue, which catalyzed the production 
of oxaloacetate in an ATP-, CO2-, pyruvate-, Mg2+-, and biotin-dependent manner (Utter 
& Keech, 1960). This novel enzyme was therefore designated pyruvate carboxylase (PC). 
 Briefly, PC catalyzes the MgATP-dependent carboxylation of pyruvate by 
bicarbonate through a nonclassical, two-site Bi Bi Uni Uni ping-pong system. That is, the 
overall reaction is the result of two partial reactions catalyzed at spatially distinct active 
sites (Figure 1-4). In the first partial reaction (Figure 1-4.1), the bicarbonate-dependent 
cleavage of MgATP is coupled to the carboxylation of the tethered prosthetic group 
biotin in the BC domain. This is followed by the second partial reaction (Figure 1-4.2), 
where the carboxybiotin intermediate physically translocates to the spatially distinct CT 
domain and transfers the carboxyl moiety from biotin to pyruvate, thus forming 
oxaloacetate. 
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Figure 1-4. Reaction scheme depicting the two half reactions that collectively form the 
overall pyruvate carboxylation reaction for pyruvate carboxylase. 
  
1) Biotin carboxylase domain catalyzed MgATP- and bicarbonate-dependent carboxylation of 
biotin. 2) Carboxyltransferase domain catalyzed carboxylation of pyruvate by carboxybiotin to 
form oxaloacetate. 
 
 
 
Since the first reported primary sequence (Lim, Morris, Occhiodoro, & Wallace, 
1988), phylogenetic analyses have brought insights into the origins of PC. It is 
hypothesized that the cenancestor of PC possessed a set of protein domains capable of 
carboxylating pyruvate. These domains were likely fused together into a single gene in 
bacteria and subsequently transferred to eukaryotes via horizontal gene transfer  
(Lombard & Moreira, 2011). To date, PC enzymes have been identified across a wide 
range of organisms including bacteria, fungi, monocot/dicot plants, invertebrates, and 
vertebrates (Wallace & Easterbrook-Smith, 1985; Wurtele & Nikolau, 1990). With such a 
broad distribution across organisms, it is not surprising that PC greatly influences cellular 
metabolism. The aim of this section is to describe the metabolic pathways influenced by 
PC, the enzyme architecture of the catalytic domains and the reaction mechanism features 
for each spatially separate active site. 
1.2.1 Metabolic Pathways and Health Implications 
 
 
 
Pyruvate, the simplest α-keto acid, is a central precursor metabolite and is located at the 
cross roads between several catabolic and anabolic pathways. Pyruvate is the end product 
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of glycolysis, an intermediate in the metabolism of the glucogenic amino acids (alanine, 
cysteine, glycine, serine and threonine) and the result of oxidizing lactate. Furthermore, 
pyruvate is essential for gluconeogenesis and lipogenesis, two metabolic pathways 
important in mammalian health. Not surprisingly, regulating pyruvate flux through the 
various mentioned metabolic pathways is vital for maintaining cellular health with PC 
being a necessary component in executing this task. For this reason, the role of PC in 
metabolism has been extensively studied.  
In general, PC plays a significant role in supplying oxaloacetate to the 
tricarboxylic acid (TCA) cycle for the replenishment of intermediates removed during 
periods of increased biosynthetic activity (Owen, Kalhan, & Hanson, 2002). The TCA 
cycle is regarded as one of the most vital biochemical pathways in aerobic organisms. 
Altering PC activity directly influences the availability of metabolites required for fatty 
acid, amino acid and glucose synthetic pathways. Genetically disrupting PC activity 
results in PC deficiency, which is a rare (incidence of 1:250,000; (B. H. Robinson, 
2006)), autosomal recessive metabolic disorder that presents with three distinct clinical 
phenotypes (Types A, B and C; (Marin-Valencia, Roe, & Pascual, 2010)). The most 
severe form of PC deficiency is Type B, whereby the afflicted individual does not have 
detectable levels of PC protein or mRNA transcript (R. H. Robinson, 2001). Without a 
functional PC enzyme, the individual exhibits severe lactic acidemia, improper 
psychomotor development and mental retardation (Marin-Valencia et al., 2010). Death 
occurs within the first few months of life. These severe neuropathic phenotypes can, in 
part, be attributed to a lack of γ-aminobutyric acid and glutamate production, essential 
neurotransmitters needed for neuronal development (Murin, Cesar, Kowtharapu, 
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Verleysdonk, & Hamprecht, 2009). Conversely, the mildest form of PC deficiency is 
Type C. These individuals suffer from acute episodes of lactic acidosis and ketoacidosis 
during elevated metabolic activity with no other recognizable phenotypes (De Meirleir, 
2013; Marin-Valencia et al., 2010).  
Additionally, aberrant PC activities in both the pancreas and liver have been 
directly correlated with the development of Type II diabetes, obesity and metabolic 
syndrome (Del Prato, 2009; Jitrapakdee, Wutthisathapornchai, Wallace, & MacDonald, 
2010; Kahn, Hull, & Utzschneider, 2006). Furthermore, tumor development also exhibits 
aberrant PC activities and/or protein levels making the need to understand the 
fundamental catalytic and regulatory mechanisms of this enzyme incredibility important  
(T. W. Fan et al., 2009; Han & Liu, 2010; MacDonald, Tang, & Polonsky, 1996; 
MacDonald et al., 2009). The following subsections focus primarily on the role of PC in 
two prominent metabolic pathways and on the impact of PC in higher eukaryote health. 
The goal of introducing these select biochemical pathways is to convey the importance 
and impact PC activity has on cellular metabolism; however, it should be noted that the 
biochemical pathways described here only represent a small portion of pathways 
influenced by PC activity.  
1.2.1.1 Gluconeogenesis 
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In mammals, brain tissue and red blood cells rely almost exclusively on glucose as an 
energy source. For this reason, eukaryotic cells take advantage of a biochemical pathway 
for the de novo synthesis of glucose (purple; Figure 1-5). Gluconeogenesis occurs in 
hepatocytes and, to a lesser extent, the renal cortex and small intestines when circulating 
glucose levels are low (Hagopian, Ramsey, & Weindruch, 2003). Within the cell, the 
enzyme-catalyzed pathway required for glucose synthesis begins with the carboxylation 
of pyruvate to oxaloacetate by PC. For the exception of fungi, this reaction occurs in the 
mitochondrial matrix. Once formed, phosphoenolpyruvate carboxykinase decarboxylates 
and phosphorylates oxaloacetate to phosphoenolpyruvate (PEP; (Hanson & Patel, 1994)). 
PEP is subsequently transported through the TCA anion carrier system to the cytosol 
where it can be converted to glucose via the reverse pathway of glycolysis, fructose 1,6-
bisphosphate, and glucose 6-phosphatase. During periods of starvation, PC protein levels 
and activity increase for the replenishment of circulating glucose (Large & Beylot, 1999; 
Salto, Sola, Oliver, & Vargas, 1996).    
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Figure 1-5. The role of pyruvate carboxylase in gluconeogenesis (purple), the 
pyruvate/citrate shuttle (green) and the pyruvate/malate shuttle (blue). 
  
Both the pyruvate/citrate and pyruvate/malate shuttles increase the ratio of NADPH/NADP+, 
which triggers distal signals involved in insulin exocytosis. Abbreviations are as follows: MDH, 
malate dehydrogenase; MDH (OAA-decarb), malate dehydrogenase (oxaloacetate-
decarboxylating); PC, pyruvate carboxylase (red); PEP, phosphoenolpyruvate; PEPCK, 
phosphoenolpyruvate carboxykinase; TCA cycle, tricarboxylic acid cycle. 
 
 
 
1.2.1.2 Pyruvate Shuttling 
 
 
 
Elevated plasma glucose levels stimulate insulin secretion from pancreatic β-cells. Type 
II diabetes is a chronic metabolic condition characterized by a decrease in insulin 
sensitivity and/or the inability for β-cells to produce insulin (Eisenbarth, Polonsky, & 
Buse, 2011; Inzucchi & Sherwin, 2011). PC is highly expressed in pancreatic β-cells and 
during periods of increased circulating glucose levels, PC mRNA and protein expression 
are upregulated (MacDonald, 1995b). Further, it is estimated that 40 - 60% of pyruvate 
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derived from glucose is carboxylated to oxaloacetate in rat β-cells, suggesting that PC is 
a major contributor to pyruvate metabolism in this cell type  (Jitrapakdee, Vidal-Puig, & 
Wallace, 2006). The signal cascade responsible for insulin secretion into circulation is the 
result of elevated ATP/ADP and NADPH/NADP+ ratios in the pancreatic β-cell cytosol 
(Maechler and Wollheim, 2001; Lang, 1999).  
One mechanism to increase NADPH levels in the cell is through the pyruvate 
shuttling pathways (blue and green; Figure 1-5). To initiate these processes, PC catalyzes 
the carboxylation of pyruvate to oxaloacetate in the mitochondrial matrix. Once formed, 
oxaloacetate can be: 1) converted to citrate by citrate synthase and acetyl CoA or 2) 
converted to malate by malate dehydrogenase and NADH. Unlike oxaloacetate, both 
citrate and malate take advantage of transporters to assist with their direct translocation 
out of the mitochondrial matrix (Farfari, Schulz, Corkey, & Prentki, 2000; MacDonald, 
1995a). Inhibition of PC activity by the pharmacological inhibitor, phenylacetic acid, 
results in a reduction of malate and citrate being exported out of the mitochondria and a 
decrease in insulin secretion, further establishing a link between PC activity and insulin 
secretion (MacDonald, 1995b). Once in the cytosol, citrate is converted back to 
oxaloacetate by ATP citrate lyase. Oxaloacetate is then converted to malate by malate 
dehydrogenase and the resulting malate is oxidized to pyruvate by malate dehydrogenase 
(oxaloacetate-decarboxylating). In order to oxidize malate to pyruvate, malate 
dehydrogenase (oxaloacetate-decarboxylating) reduces NADP+, effectively increasing the 
concentration of NADPH in the cell. When malate is transported out of the mitochondrial 
matrix, it can be oxidized directly to pyruvate thus bypassing the added steps needed to 
oxidize citrate to form NADPH. These two processes are therefore termed 
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pyruvate/citrate or pyruvate/malate shuttling depending on the metabolite being 
transported out of the mitochondrial matrix. While much debate remains over whether the 
increase in NADPH ratios are due to the pyruvate/citrate or pyruvate/malate shuttle, it is 
certain that these two pathways depend heavily upon PC activity making PC an intriguing 
target for Type II diabetes (Farfari et al., 2000; MacDonald, 1995a).  
1.2.2 Quaternary Protein Structure 
 
 
 
The native active form of PC is a tetramer. However, two distinct variants of the tetramer 
exist depending on the source organism. For most PC enzymes, the functional domains 
are arranged on a single ~1200 amino acid polypeptide chain with a molecular weight of 
~120 – 130 kDa. Four identical polypeptide chains associate together to form a 
homotetramer of ~500 kDa that constitutes the α4 form (Figure 1-2). Early electron 
micrographs of various PC enzymes suggested that the α4 form possesses either a 
tetrahedral or rhombic geometry with the tetramer containing two pairs of subunits 
located orthogonally to one another on two different planes (Mayer, Wallace, & Keech, 
1980; Osmani, Mayer, Marston, Selmes, & Scrutton, 1984).  
The less common form is the α4β4 form, which is observed primarily in archaea  
(Mukhopadhyay, Stoddard, & Wolfe, 1998; Mukhopadhyay, Patel, & Wolfe, 2000) and 
bacterial species such as Pseudomonas citronellolis (Barden et al., 1975; Cohen, Duc, 
Beegen, & Utter, 1979) and Aquifex aeolicus (Kondo et al., 2004). This tetrameric form 
consists of two distinct polypeptide chains: 1) a ~ 55 kDa polypeptide (β) chain which 
possesses MgATP-dependent biotin carboxylation activity and 2) a ~ 70 kDa polypeptide 
(α) chain which includes an N-terminal CT domain and a C-terminal BCCP domain 
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(Figure 1-2). The α and β polypeptide chains associate together into a subunit with four 
complete subunits required for an active tetramer. To date, structural studies of the α4β4 
PC enzymes have been limited. However, the quaternary configuration of the α4β4 PC 
enzyme from P. citronellolis is proposed to be similar to α4 type PC enzymes (Cohen et 
al., 1979), but this hypothesis has yet to be confirmed with higher resolution techniques 
such as cryo-electron microscopy or X-ray crystallography. 
The recently reported X-ray crystal structures of the complete α4 type PC 
enzymes from Rhizobium etli (RePC) and Staphylococcus aureus (SaPC) have assisted in 
offering insights into the quaternary structure and molecular basis for catalysis (St. 
Maurice et al., 2007; Xiang & Tong, 2008). These structures display the subunits 
arranged in a rhombohedral geometry with the tetramer being stabilized at each corner 
through homodimer interactions between the BC and CT domains (Figure 1-6). The 
tetramer can therefore be divided into a top and bottom face with each face of the 
tetramer containing two monomers. The monomer pairs of each face run antiparallel to 
one another and perpendicular between the faces. Additionally, the monomer pairs of 
each face share minimal contacts with one another with the majority of the stabilizing 
interactions for the tetramer existing at the BC-BC and CT-CT dimer interface between 
the top and bottom faces. 
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Figure 1-6. Quaternary structure and intermolecular reaction mechanism of pyruvate 
carboxylase. 
  
The PC tetramer is arranged in two distinct layers, with the monomers running antiparallel on 
each face and perpendicularly between the layers. Both R. etli (pdb i.d. 2QF7) and S. aureus (pdb 
i.d. 3BG5) primarily associate at the dimer interface between the biotin carboxylase (blue) and 
carboxyltransferase (yellow) domains. S. aureus PC maintains contacts between the allosteric 
(green) domains from opposite layers of the tetramer. This interaction is not observed in RePC. 
For clarity and to enable comparison, the BCCP domain is omitted from the top illustrations of 
the R. etli and S. aureus tetramers. The bottom tetramer illustrates the translocation of the BCCP 
domain (red) between the biotin carboxylase and carboxyltransferase domain active sites on 
opposing monomers of the R. etli PC enzyme (based on pdb i.d. 3TW6). The distance between 
active sites of opposing monomers on the same face is ~ 60 Å. 
 
 
 
1.2.3 Intermolecular Transfer Mechanism Required for Catalysis 
 
 
 
The tetrameric arrangement of RePC provided evidence for an intermolecular transfer 
mechanism whereby the carboxyl transfer occurs between active sites on opposite 
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polypeptide chains as opposed to the same polypeptide chain (Figure 1-6). Upon review 
of the RePC crystal structure, it was discovered that the distance between the BC and CT 
domain active sites is closer between neighboring monomers than between active sites on 
the same polypeptide chain (St. Maurice et al., 2007). Mixed hybrid tetramer experiments 
with RePC indicated that the BCCP-biotin physically moves by ~ 50-70 Å from the BC 
domain on one polypeptide chain to the CT domain on a neighboring polypeptide chain 
and not between active sites located on the same polypeptide chain (Lietzan et al., 2011; 
St. Maurice et al., 2007). In addition to these results, cryo-EM studies of SaPC and the 
crystal structures of PC from Homo sapiens (HsPC; pdb i.d. 3BG3) and S. aureus (pdb 
i.d. 3BG5) display BCCP-biotin from one monomer extending into the CT domain active 
site from a neighboring monomer, thus supporting an intermolecular transfer mechanism 
for catalysis  (Lasso et al., 2010; Xiang & Tong, 2008). These data also explain why the 
enzyme is inactive for pyruvate carboxylation activity in its dimeric and monomeric 
forms (Attwood, Johannssen, Chapman-Smith, & Wallace, 1993; Attwood & Geeves, 
2002; Khew-Goodall, Johannssen, Attwood, Wallace, & Keech, 1991)  
 Elucidating the tetrameric architecture and the intermolecular transfer mechanism 
has aided greatly in understanding how PC catalyzes the carboxylation of pyruvate. This 
discovery, while exceptional, only represents a small portion of the many structural 
aspects involved in catalysis that remain unclear. For example, it is unknown if PC 
enzymes employ a communication mechanism to signal the translocation of the BCCP 
domain between opposing polypeptide chain active sites or if this translocation event is 
due merely to random sampling of the BCCP domain between active sites. Further, 
multiple X-ray crystal structures of the BC domain co-crystallized with several reaction 
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intermediates have demonstrated the various conformations the active site must 
experience during catalysis to promote biotin binding and ATP cleavage (Chou, Yu, & 
Tong, 2009; Thoden, Blanchard, Holden, & Waldrop, 2000; Waldrop, Rayment, & 
Holden, 1994), Such detailed structural studies are absent for the CT domain making its 
contributions to catalysis not well defined. It has, however, been demonstrated that 
substrates induce the translocation and subsequent decarboxylation of carboxybiotin in 
the CT domain (Goodall, Baldwin, Wallace, & Keech, 1981), but the structural 
mechanism underlying this phenomenon remains unclear. The following subsections 
summarize the current state of scientific knowledge with regard to the structural and 
catalytic aspects of the BC and CT domains required for the carboxylation of pyruvate in 
PC.   
1.2.4 Biotin Carboxylase (BC) Domain 
 
 
 
The biotin carboxylase domain, which is common to all biotin-dependent carboxylases, 
catalyzes the MgATP- and HCO3--dependent carboxylation of biotin, or the first partial 
reaction involved in PC catalysis (Figure 1-4.1). Due to its functional conservation, the 
structural architecture of the BC domain is similar for all members of the biotin-
dependent carboxylases. To date, structures of the BC domain from E. coli ACC  
(Broussard et al., 2013; Cheng et al., 2009; Chou et al., 2009; Chou & Tong, 2011; Miller 
et al., 2009; Mochalkin et al., 2009; Shen, Chou, Chang, & Tong, 2006; Thoden et al., 
2000; Waldrop et al., 1994) P. aeruginosa ACC (Mochalkin et al., 2009), S. aureus ACC 
(Mochalkin et al., 2009), S. cerevisiae ACC (Shen, Volrath, Weatherly, Elich, & Tong, 
2004), H. sapiens ACC (Cho et al., 2007), P. aeruginosa MCC (C. S. Huang, Ge, Zhou, 
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& Tong, 2011), R. pomeroyi (α) – R. denitrificans (β) PCC chimera (C. S. Huang et al., 
2010), B. thermodenitrificans PC (Kondo et al., 2007), A. aeolicus PC (Kondo et al., 
2004), SaPC (Xiang & Tong, 2008; Yu et al., 2009; Yu, Chou, Choi, & Tong, 2013) and 
RePC (Lietzan et al., 2011; St. Maurice et al., 2007) have been reported making this 
domain highly characterized. 
 In all cases, the BC domain is divided into three subdomains (A, B, and C-
subdomains, Figure 1-7; (Waldrop et al., 1994)). The A-subdomain contains a parallel β 
sheet surrounded by four α-helices (purple; Figure 1-7). The B-subdomain, which is 
connected to the A-subdomain by a helix-turn-helix motif, threads away from the core of 
the protein (light blue; Figure 1-7). Because the B-subdomain is glycine and serine-rich 
and has a high conformational flexibility, as evident by high B-values compared to 
subdomains A and C, it is sometimes unresolved in the X-ray crystal structures. The B-
value or temperature-factor is an indication of the static or dynamic mobility of an atom 
in an X-ray crystal structure; a higher B-value indicates a higher degree of disorder or a 
higher degree of uncertainty in the atom placement within the model (Rupp, 2010). The 
C-subdomain, which is the largest subdomain of the protein, is comprised of an eight-
stranded anti-parallel β sheet with a surrounding cluster of six α-helices (cyan; Figure 1-
7). The active site is primarily formed by the B- and C-subdomains with all three 
subdomains arranged together into an ATP-grasp fold.  
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Figure 1-7. The individual protein domains and their collective arrangement into an α4-type 
pyruvate carboxylase monomer.  
 
The biotin carboxylase domain is divided into three subdomains: the A (purple), B (light blue) 
and C-subdomains (cyan). Upon ATP binding, the B-subdomain translocates 8 Å in order to close 
the active site. The carboxyltransferase domain consists of a TIM barrel fold (yellow) with a C-
terminal capping funnel (grey). The biotin carboxyl carrier protein domain (red) and allosteric 
domain (green) are also depicted. The biotin carboxylase domain with and without ATP was 
generated with pdb i.d. 1DV2 and 1DV1, respectively. All other domains were extracted from 
pdb i.d. 2QF7. 
 
 
 
1.2.5 Proposed Reaction Mechanism for the Biotin Carboxylase Domain 
 
 
      
The role of the biotin carboxylase domain is to carboxylate biotin at the 1’-N position 
with HCO3- via ATP cleavage. To initiate the reaction, MgATP must bind in a cleft 
between the A and C-domains. The β- and γ-phosphates of ATP interact with a loop (T-
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loop) of the B-subdomain, causing the domain to translocate 8 Å inward towards the A- 
and C-subdomains effectively closing the active site (Thoden et al., 2000). For efficient 
catalysis, two Mg2+ ions must properly position ATP in the active site. Without these 
Mg2+ ions, the ATP molecule twists back upon itself making for a nonproductive binding 
pose (Mochalkin et al., 2008). Once MgATP, HCO3- and biotin are bound, the active site 
is tightly sealed and the reaction can proceed.  
 For catalysis, HCO3- must first be deprotonated by a general base to allow the 
concert nucleophilic attack by CO32- on the γ-phosphate of MgATP (Figure 1-8). The 
resulting high-energy trianionic carboxyphosphate intermediate may either 1) decompose 
into CO2 and phosphate followed by reaction of CO2 with biotin or 2) the carboxyl group 
is transferred directly from carboxyphosphate to biotin. While the exact route by which 
biotin is carboxylated by carboxyphosphate remains unknown, it is clear that the reaction 
must proceed through a carboxyphosphate intermediate. PC from sheep kidney and 
chicken liver are capable of using carbamoyl phosphate, an analog of carboxyphosphate, 
to catalyze the phosphorylation of ADP suggesting carboxyphosphate is an intermediate 
in the BC domain catalyzed reaction (Ashman & Keech, 1975; Attwood & Graneri, 
1991). If the carboxyphosphate intermediate decomposes to CO2 and phosphate, the 
phosphate ion is proposed to then migrate towards biotin where it deprotonates biotin at 
the 1’-N  position. The biotin enolate intermediate attacks the electrophilic CO2 making 
carboxybiotin. This newly formed carboxybiotin is excluded from the active site, but 
remains protected until pyruvate or an analog of pyruvate binds in the active site of the 
CT domain (Goodall et al., 1981; Lietzan et al., 2011; Zeczycki, Menefee, Adina-Zada et 
al., 2011).  
	   27	  
 
 
Figure 1-8. Proposed catalytic reaction mechanism for the biotin carboxylase domain.  
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The role of the BC domain and its contribution to catalysis has been thoroughly 
investigated in many of the enzymes within the biotin carboxylase family. This sentiment 
is no exception for PC, with minimal research being conducted on the CT domain by 
comparison. The research for this dissertation focuses primarily on the structural and 
catalytic contributions of the CT domain to PC and therefore minimal research will be 
presented concerning the BC domain. Consequently, further discussion of the BC domain 
is beyond the scope of this dissertation. For a detailed description of the structural 
architecture and proposed catalytic mechanism of the BC domain, please refer to 
(Waldrop et al., 2013). 
1.2.6 Carboxyltransferase (CT) Domain 
 
 
 
The CT domain of PC catalyzes the transfer of a carboxyl group from carboxybiotin to 
pyruvate to form oxaloacetate (Figure 1-4.2). Prior to X-ray crystallographic studies of 
the CT domain, three central mechanistic features were certain: 1) the carboxylation of 
pyruvate to oxaloaceate proceeds with retention of the stereochemical configuration of 
the carbon atom undergoing carboxylation (Cheung, Fung, & Walsh, 1975; Rose, 1970), 
2) the reaction proceeds by a stepwise mechanism (Attwood, Tipton, & Cleland, 1986; 
O'Keefe & Knowles, 1986), and 3) carboxybiotin does not translocate to the CT domain 
before pyruvate or a pyruvate analog binds in the active site (Goodall et al., 1981).  
While structural advances in recent years have improved the description of 
catalysis in the CT domain of PC, the mechanistic details have remained consistent with 
the earlier kinetic observations. Additionally, the 5S subunit of P. shermanii 
transcarboxylase (5S TC) and the α-subunit of the oxaloacetate decarboxylase complex 
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(α-ODC), which are structurally and catalytically homologous to the CT domain of PC, 
have also contributed to our understanding of the carboxyl transfer mechanism. The 5S 
TC catalyzes the carboxylation of pyruvate to oxaloacetate from carboxybiotin, while α-
ODC decarboxylates oxaloacetate to form pyruvate and carboxybiotin. Investigations of 
the 5S TC and α-ODC will therefore be surveyed with the PC literature where 
appropriate in this section. 
The structural core of the CT domain from PC, 5S TC and α-ODC is composed of 
the canonical triosephosphate isomerase (TIM) barrel, which is a common structural 
motif utilized by at least 15 different enzyme families (yellow; Figure 1-7; (Banner et al., 
1975; Wierenga, 2001). This conserved protein fold consists of eight α-helices and eight 
parallel β-strands that alternate along the peptide backbone. Each β-strand connects to the 
next adjacent strand in the barrel through a right-handed loop that includes one of the α-
helices. Therefore the α8β8 motif results in a solenoid that curves around to produce a 
donut shape, with the active site being located at the C-terminal end of the eight parallel 
β-strands of the barrel. This solenoid feature of the TIM-barrel results in a 2-fold 
symmetry, making this motif an excellent scaffold for an active site (Nagano, Orengo, & 
Thornton, 2002)  
 A C-terminal extension primarily comprised of α-helices creates a funnel leading 
into the active site located at the mouth of the TIM-barrel (grey; Figure 1-7). This 
capping funnel is also observed in the homologous biotin-dependent 5S TC (Hall et al., 
2003) and α-ODC (Studer et al., 2007), further suggesting a common ancestor for these 
three enzymes. 
1.2.6.1 Active Site Metal and Associating Amino Acid Residues 
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In addition to the 5S TC and α-ODC, the active site of the CT domain from PC is 
centered on a structurally conserved metal (Figure 1-9A). In PC enzymes, the identity of 
the tightly bound metal ion is species-specific. Vertebrates predominantly bind Mn2+, 
whereas yeast and bacteria prefer Zn2+ (Wallace & Easterbrook-Smith, 1985). On the 
other hand, the 5S TC primarily binds Co2+ in its active site (Hall et al., 2003), but there 
is also evidence for Zn2+ binding (Ahmad, Lygre, Jacobson, & Wood, 1972; Northrop & 
Wood, 1969). α-ODC purified from source binds Zn2+ exclusively, but can bind Co2+ 
when heterologously expressed in E. coli (Studer et al., 2007). Currently, it is unclear 
why PC enzymes from different source organisms prefer to bind different metal ions in 
the active site of the CT domain.  
 
 
 
 
 
Figure 1-9. The active site metal, pyruvate binding site and biotin binding site in the 
carboxyltransferase domain of pyruvate carboxylase.   
 
A. The active site metal is octahedrally coordinated by at least one water molecule, an aspartate, 
two histidines (HxH) and a lysine, which can be carbamylated. B. Pyruvate is positioned in the 
active site by two arginines, a lysine and a glutamine. A glutamine and an arginine are within 
hydrogen bonding distance to the carbonyl oxygen of pyruvate. The other arginine forms a 
bidentate interaction with the carboxyl moiety of pyruvate. C. Biotin is stabilized by multiple 
interactions in the active site. The ureido oxygen of biotin is within hydrogen bonding distance of 
the side chain of a glutamine and a serine and the amide backbone of a lysine. This triad (orange) 
is predicted to stabilize the biotin enolate intermediate during catalysis. The threonine (grey) 
serves as both an acid and base during catalysis. Panel A of this figure was generated from pdb 
i.d. 2QF7 while panels B and C were from pdb i.d. 3BG3.  
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It is clear that the metal ion in the CT domain plays an important functional role 
in all three enzymes. At least one water molecule, a conserved aspartate, two conserved 
histidines (HxH) and a conserved lysine octahedrally coordinate the metal ion in all cases 
(Figure 1-9A). Mutating the metal chelating aspartate in PC from B. thermodenitrificans 
results in a 22-fold reduction in pyruvate carboxylation activity and a 54-fold increase in 
KM for pyruvate (Yong-Biao, Islam, Sueda, & Kondo, 2004). In α-ODC from V. 
cholerae, mutations in either the conserved aspartate or the two hisidines (HxH) 
obliterates enzyme activity, further supporting an essential role for the metal ion in 
catalysis (Studer et al., 2007). Moreover, removal of the bound metal with 1,10-
phenanthroline causes the dissociation of the PC tetramer, suggesting the metal ion 
assists in stabilizing the active tetrameric form (Carver, Baldwin, Keech, Bais, & 
Wallace, 1988). Similarly, physical removal of the tightly bound metal in 5S TC (Ahmad 
et al., 1972) and α-ODC (Dimroth & Thomer, 1992) causes aggregation and enzyme 
dissociation.  
Mutating the conserved metal chelating lysine in 5S TC, α-ODC and PC 
universally reduces, but does not eliminate enzyme activity (Hall et al., 2003; St. Maurice 
et al., 2007; Studer et al., 2007; Yong-Biao et al., 2004; Zeczycki et al., 2009). In the CT 
domain from RePC and HsPC, but not SaPC, the lysine is carbamylated (Lietzan et al., 
2011; St. Maurice et al., 2007; Xiang & Tong, 2008; Yu et al., 2009; Yu et al., 2013). 
The lysine residue is always observed interacting with the metal ion regardless of its 
carbamylation state in all PC enzyme structures. However, the active site lysine in the 
apo structure of the 5S TC is carbamylated, but not in the apo structure of α-ODC (Hall 
et al., 2003; Studer et al., 2007). When the 5S TC is crystallized with oxaloacetate, the 
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lysine is not carbamylated. While it seems likely that the primary purpose of the lysine is 
to coordinate and stabilize the metal ion, it is plausible that the liberated CO2 combines 
with the lysine during catalysis to prevent CO2 from leaving the active site (Hall et al., 
2003; Studer et al., 2007). This proposed mechanism for trapping CO2 during catalysis is 
incomplete since residual enzyme activity is retained when the lysine residue is mutated. 
These results suggest that the residue is not absolutely essential for catalysis. 
While the metal ion is proposed to stabilize the developing charge by forming a 
bidentate interaction with the pyruvate enolate intermediate, no such interaction has ever 
been observed. Therefore it is still unknown if the metal is participating directly in the 
reaction or solely serving to maintain active site integrity as has been previously 
hypothesized (Carver et al., 1988). 
1.2.6.2 Pyruvate Binding Site  
 
 
 
Prior to crystallographic evidence, it was known that the pyruvate binding site is near the 
metal ion and that pyruvate is an outer-sphere ligand  (Fung, Mildvan, Allerhand, 
Komoroski, & Scrutton, 1973; Mildvan, Scrutton, & Utter, 1966; Reed & Scrutton, 
1974). The X-ray crystal structures of the 5S TC, SaPC and HsPC co-crystallized with 
pyruvate confirmed that the pyruvate binding site lies near the active site metal ion and 
made it possible to identify the associating residues (Figure 1-9B; (Hall et al., 2003; 
Xiang & Tong, 2008)). In all cases, the carbonyl oxygen of pyruvate is observed within 
hydrogen bonding distance of both a conserved arginine and glutamine. These hydrogen 
bonding interactions are proposed to stabilize the pyruvate enolate intermediate formed 
during catalysis. Mutating these residues in RePC results in complete elimination of 
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pyruvate carboxylation and partial reduction of oxaloacetate decarboxylation activity 
(Duangpan et al., 2010). Pyruvate carboxylation activity can be partially recovered with 
an arginine to lysine mutation in RePC, suggesting that the positive charge is most likely 
contributing to catalysis (Duangpan et al., 2010). Mutating the neighboring aspartate 
responsible for stabilizing the arginine positioning in the active site leads to a significant 
decrease in enzyme activity and tetramer stability, further suggesting a charge stabilizing 
role for the arginine during catalysis (Yong-Biao et al., 2004). Furthermore, mutating the 
analogous arginine and glutamine residues in α-ODC completely eliminates enzyme 
activity (Studer et al., 2007). The structures of SaPC and HsPC with pyruvate bound also 
identified another conserved active site arginine responsible for forming a bidentate salt 
bridge interaction with the carboxyl group of pyruvate (Xiang & Tong, 2008). Not 
surprisingly, mutating this residue destroys pyruvate carboxylation activity in SaPC (Yu 
et al., 2009). 
1.2.6.3 Amino Acid Triad For Biotin Stabilization 
 
 
 
During catalysis, the decarboxylation of carboxybiotin in the active site is proposed to 
generate a biotin enolate intermediate prior to protonation (Attwood & Wallace, 2002). 
The X-ray crystal structures of HsPC and SaPC co-crystallized with pyruvate resulted in 
a catalytic pose whereby biotin is bound with pyruvate in the active site (Xiang & Tong, 
2008). This snapshot of catalysis identified a highly conserved triad of residues 
specifically interacting with biotin in the active site (Figure 1-9C). It was hypothesized 
that these residues are tasked with facilitating the decarboxylation of carboxybiotin by 
promoting the formation of the anionic biotin intermediate (Zeczycki et al., 2009). The 
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residues that constitute this conserved triad are a glutamine, a serine and the backbone 
amide of a lysine. According to the structures, the triad stabilizes the developing negative 
charge at the ureido oxygen via hydrogen bonds at tetrahedral angles (Zeczycki et al., 
2009). When mutated, these residues reduce the rate of biotin-dependent oxaloacetate 
decarboxylation thus providing evidence for a role in biotin stabilization (Zeczycki et al., 
2009). 
1.2.6.4 The Catalytic Acid/Base Threonine 
 
 
 
One of the most exciting observations from the structural studies of PC is a conserved 
threonine directly situated between pyruvate and biotin (Figure 1-9C; (Xiang & Tong, 
2008)). Its interaction with both pyruvate and the 1’-N position of biotin strongly 
suggests a proton shuttling mechanism between pyruvate and biotin (Yu et al., 2009; 
Zeczycki et al., 2009). Mutational studies of this threonine suggest it serves as both a 
general acid and general base in the reaction mechanism. It is hypothesized that, in a 
concerted fashion, the threonine donates a proton to the biotin enolate intermediate while 
simultaneously abstracting a proton from pyruvate to form the reactive pyruvate enolate 
intermediate (Zeczycki et al., 2009). Utilizing a concerted proton transfer mechanism 
avoids the production of an unstable and highly reactive threonine alkoxide intermediate.  
1.2.6.5 Disease Causing Mutations 
 
 
 
It is noteworthy that nine disease-causing single nucleotide substitutions have been 
identified in human PC (Monnot et al., 2009). Of these, four (R583L, A610T, R631Q and 
M743I – HsPC numbering) have been mapped to the CT domain and the residues are 
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conserved in PC, 5S TC and α-ODC. The A610T mutation is located at the opening of 
the active site. The bulkier threonine partially precludes the binding of biotin in the active 
site, thus greatly reducing enzyme activity (Hall et al., 2003; Yu et al., 2009). The M743I 
mutation is located deep in the active site where it most likely disrupts pyruvate binding  
(Hall et al., 2003; Xiang & Tong, 2008). The R583L and R631Q mutations are located at 
the surface of the CT domain, distant from the active site. It has been proposed that these 
mutations may induce a conformational change that alters the interaction between 
domains and interferes with the transmission of the regulatory signal from acetyl CoA in 
PC (Monnot et al., 2009).  
1.2.7 Proposed Reaction Mechanism for the Carboxyltransferase Domain 
 
 
 
The transcarboxylation reaction for PC follows a step-wise mechanism (Figure 1-10). In 
the presence of pyruvate, carboxybiotin binds in the active site. Once bound, 
carboxybiotin decarboxylates and the resulting enolate intermediate is stabilized by the 
conserved active site triad. It is proposed that rotation of the carboxyl group out of plane 
with the urea ring of biotin may trigger decarboxylation, but the exact features of the 
active site that promote the decarboxylation of carboxybiotin during catalysis remain 
unknown (Thatcher, Poirier, & Kluger, 1986). Then through a concerted proton transfer, 
a conserved threonine protonates the 1’-N of the biotin enolate intermediate while 
simultaneously abstracting a proton from the methyl group of pyruvate. The chelation of 
pyruvate with the active site metal increases the acidity of the protons of the methyl 
group, allowing the threonine to act as a general base to abstract a proton from the methyl 
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group. This forms the reactive pyruvate enolate intermediate that can serve as a 
nucleophile to attack the liberated CO2 thus forming oxaloacetate. 
 
 
 
 
 
Figure 1-10. Proposed catalytic reaction mechanism for the carboxyltransferase domain.  
 
 
 
1.2.8 Biotin carboxyl carrier protein (BCCP) domain 
 
 
 
As previously mentioned, the BCCP domain is responsible for presenting biotin, which is 
covalently attached to a conserved lysine, to both the BC and CT domain active sites 
(red; Figure 1-7). In PC, this domain is either fused to the CT domain (some prokaryotes) 
or to the polypeptide chain containing both functional domains (eukaryotes).  
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Several NMR and X-ray crystal structures of the BCCP domain have assisted in 
providing structural insights into the architecture of this domain (Athappilly & 
Hendrickson, 1995; Bagautdinov, Matsuura, Bagautdinova, & Kunishima, 2008; Jank, 
Sadowsky, Peikert, & Berger, 2002; Yao, Wei, Soden, Summers, & Beckett, 1997). The 
BCCP domain consists of two sets of four antiparallel β-strands arranged around an 
approximate two-fold axis (red; Figure 1-7). The overall fold is primarily stabilized by 
hydrophobic interactions with the site of biotinylation being located on a hairpin turn that 
connects two of the β-strands at the C-terminal portion.      
1.2.9 Allosteric/ Pyruvate Carboxylase Tetramerization Domain 
 
 
 
Most α4 forms of PC are subject to allosteric regulation (reviewed in Adina-Zada, 
Zeczycki, & Attwood, 2012). Acetyl CoA, a non-essential allosteric activator, enhances 
pyruvate carboxylation activity and stabilizes the tetramer. Until recently, however, the 
binding site for acetyl CoA was unknown. The structure of RePC revealed the nucleotide 
portion of the non-hydrolyzable acetyl CoA analog, ethyl CoA, bound in a previously 
unrecognized pocket located between the BC and allosteric domain (St. Maurice et al., 
2007).  
 The allosteric domain consists of four anti-parallel β-strands (~ 60 amino acids) 
that concavely wraps a long, central α-helix (~30 amino acids; green; Figure 1-7). The 
central α-helix links the BC and CT domains. The nucleotide for CoA binds at a cleft 
created by the N-terminal portion of the α-helix and the BC domain. A group of 
conserved arginines, which originate from both the BC and allosteric domain and are 
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needed for allosteric activation, assist in coordinating the nucleotide portion (Adina-Zada 
et al., 2012; St. Maurice et al., 2007). 
A binding pocket for acetyl CoA exists on each monomer of the PC tetramer. 
Surprisingly, ethyl CoA was observed bound in only two binding pockets located on the 
same face of the tetramer. In the RePC structure, this binding event pushes the associating 
monomers closer together, effectively reducing the distance between active sites of 
opposing polypeptide chains on one face of the tetramer. The pair of monomers located 
on the other face of the tetramer, which are void of ethyl CoA, are located further away 
from one another. It was therefore hypothesized that the mode of allosteric activation by 
acetyl CoA is to reduce the distance between active sites (St. Maurice et al., 2007). 
However, the structures of SaPC with and without acetyl CoA displayed a symmetrical 
tetramer with acetyl CoA binding resulting in a slight rotation of the BC domain making 
this hypothesis incomplete  (Xiang & Tong, 2008; Yu et al., 2009). In the SaPC 
structures, the allosteric domains are observed interacting between different faces of the 
tetramer. These interactions, which are not observed in RePC, are essential for 
tetramerization and therefore the allosteric domain in SaPC is also known as the pyruvate 
carboxylase tetramerization (PT) domain (Xiang & Tong, 2008; Yu et al., 2009). 
1.3 Overview 
 
 
 
PC is a biotin-dependent enzyme that catalyzes the MgATP- and bicarbonate-dependent 
carboxylation of pyruvate to oxaloacetate, an important anaplerotic reaction in central 
metabolism. Since its discovery over fifty years ago, much research has been dedicated to 
understanding its role in central metabolism and various disease states. The vast body of 
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literature overwhelmingly indicates that PC plays a role in numerous disease states such 
as type II diabetes and tumor progression. However, many aspects of the molecular and 
chemical reaction mechanism for this enzyme remain unknown. For example, it is 
unclear how the binding of a substrate in the CT domain induces the translocation of 
carboxybiotin from the BC domain. This dissertation aims to elucidate the molecular 
mechanisms required for PC catalysis by focusing on the contributions to catalysis from 
the CT domain. 
More specifically, chapter 3 provides insights into the stimulatory role of 
oxamate, an isosteric and isoelectronic inhibitory analog of pyruvate, in the oxamate-
induced decarboxylation of oxaloacetate reaction, an in vitro coupled enzyme assay 
developed to study the CT domain reaction in isolation. This assay system is utilized for 
many studies conducted on PC in this dissertation and therefore understanding its 
mechanism assists in interpreting both previously published and current kinetic data. This 
chapter also elaborates on the role of the BCCP domain in the carboxyltransfer reaction 
and presents data supporting a biotin-independent oxaloacetate decarboxylation activity 
in PC. Chapter 4 describes a substrate-induced biotin binding pocket that is essential for 
catalysis in the CT domain. This work provides the first molecular insights into how PC 
may efficiently coordinate catalysis between two spatially distinct active sites. Chapter 5 
presents structural data of the CT domain with bound product and intermediate analogs. 
These structures of PC further assist in describing the chemistry involved in 
carboxylating pyruvate and present a unique mechanistic feature among enzymes that 
catalyze reactions proceeding through an enolpyruvate intermediate. Finally, chapter 6 
briefly discusses the discrepancy between the tetrameric symmetries observed for RePC 
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and SaPC. The role of differing quaternary conformational states of PC has been heavily 
debated and this chapter indicates that PC enzymes may adopt a wider array of structural 
conformations than previously recognized. Collectively the work presented here advances 
the molecular and catalytic description of PC, a necessity when considering the 
development of therapeutics for its regulation in various disease states. Given the 
conservation with CT domains in the oxaloacetate decarboxylase complex and 
transcarboxylase, the structure-based mechanisms described for PC within this 
dissertation may also be applicable to the larger family of biotin-dependent enzymes.	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CHAPTER 2: MATERIALS AND METHODS 
 
 
 
2.1 General 
 
 
 
IPTG, D-biotin, ampicillin, kanamycin, chloramphenicol, DL-dithiothreitol (DTT), Tris 
buffer, epoxysuccinyl-L-leucylamido(4-guanido) butane (E-64), and pepstatin A were 
purchased from Research Products International Corp. (Mount Prospect, IL). Malate 
dehydrogenase and lactate dehydrogenase were purchased from Roche Diagnostics 
(Indianapolis, IN). Acetyl CoA was purchased from Crystal Chem, Inc. (Downers Grove, 
IL). Granulated LB broth (Miller’s modification) was purchased from EMD Millipore 
Chemicals, Inc. All oligonucleotide primers reported here were synthesized by Integrated 
DNA Technologies (Coralville, IA) or Sigma-Aldrich. The correct gene sequence of all 
PC constructs was confirmed by complete sequencing of the gene at Functional 
Biosciences, Inc. (Madison, WI). All other materials were purchased from Sigma-
Aldrich. PC from Rhizobium etli (RePC) was previously subcloned into a modified pET-
17b vector(St. Maurice et al., 2007).   
2.2 Domain Truncations of RePC 
 
 
 
2.2.1 ΔBC RePC 
 
 
 
PC from R. etli (RePC) was previously subcloned into a modified pET-17b vector for 
expression in λ(DE3) lysogenized Escherichia coli (St. Maurice et al., 2007). For the BC 
domain truncation, it was determined that Gln465 represents the C-terminal end of the 
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BC domain, based on the X-ray crystal structure of RePC (pdb i.d. 2QF7). The ΔBC 
RePC construct, therefore, begins at Gln466. Construction of the ΔBC RePC domain 
deletion in the pET-28a expression plasmid was as follows: ∼ 2.1 kbp fragment was PCR 
amplified from the wild-type RePC pET-17b template using the primers 5’-CCG CAT 
GCA TCA GCA GGT CAA GCG C-3’ (forward) and 5’-GCA GCG GCT AGC TCA 
TCC GCC GTA A-3’ (reverse). The PCR amplified fragment was digested with 
NheI/NsiI and ligated into a Pst I/NheI digested modified pET-28a-(His)8-TEV 
expression vector. This modified pET-28a vector was generated by insertion of two 
additional N-terminal His residues and a TEV cleavage tag using the QuikChange 
mutagenesis protocol (Lietzan et al., 2011). The ΔBC RePC construct maintains the 
complete allosteric, carboxyl transferase (CT), and biotin carboxyl carrier protein 
(BCCP) domains of RePC.  
2.2.2 ΔBCΔBCCP RePC 
 
 
 
For the BCCP domain truncation, it was determined that Ala1067 represents the N-
terminal end of the BCCP domain based on the X-ray crystal structure of RePC (pdb i.d. 
2QF7). The BC and BCCP domain deletion construct (ΔBCΔBCCP RePC) was therefore 
generated via the QuikChange mutagenesis protocol by incorporating two stop codons 
after the codon for Ala1067 in an expression vector encoding the BC domain truncation 
of RePC (ΔBC RePC) using the oligonucleotide primers 5’-GCC CGA TCG GGC CTG 
ATG AGC GAC GGG AGC CGC-3’ (forward) and 5’-GCG GCT CCC GTC GCT CAT 
CAG GCC CGA TCG GGC-3’ (reverse). The resulting ΔBCΔBCCP RePC construct 
retains the complete allosteric and carboxyl transferase domains of RePC. 
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2.2.3 ReBCCP 
 
 
 
It was determined that Gly1069 represents the N-terminal end of the BCCP domain, 
based on the X-ray crystal structure of RePC (pdb i.d. 2QF7). However, when the BCCP 
domain from RePC is subcloned into the pET-28a expression vector with a N-terminal 
(His)8 tag and expressed in E. coli, it does not effectively bind the Ni2+-NTA resin during 
purification. Therefore, the BCCP domain construct from RePC (ReBCCP) was N-
terminally extended to begin at Gly1056. Construction of ReBCCP in the pET-28a 
expression plasmid was as follows: ~350 bp fragment was PCR amplified from the wild-
type RePC pET-17b template using the primers 5′-CCG CAT GCA TGG CCA GCC 
GCG CCG TAT C-3′ (forward) and 5′-GCA GCG GCT AGC TCA TCC GCC GTA A-3′ 
(reverse). The PCR amplified fragment was digested with NheI/NsiI and ligated into a 
PstI/NheI digested modified pET-28a-(His)8-TEV expression vector (Lietzan et al., 
2011).  
2.3 Site-Directed Mutagenesis of RePC 
 
 
 
All mutations were generated using the QuikChange site-directed mutagenesis protocol 
(Agilent Technologies; Santa Clara, CA). All oligonucleotide primers utilized for site-
directed mutagenesis of RePC are reported in Table 2-1. All forms of the RePC gene were 
cloned into an expression vector and those expression constructs are reported in Table 2-
2. 
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Table 2-1. Oligonucleotide Primer Sequences for the Various Mutations of RePC 
 
Mutation Oligonucleotide primer sequence 
D590A 5’-GCG CCA CCT TCG CCG TCT CGA 
TGC GC-3’ (forward) 
5’-GCG CAT CGA GAC GGC GAA GGT 
GGC GC-3’ (reverse) 
Y628A 5’-GGC GTC GGT GCG ACC AAC TAT-
3’ (forward) 
5’-GAT AGT TGG TCG CAC CGA CGC 
C-3’ (reverse) 
Y628F 5’-GCC AAT GGC GTC GGT TTC ACC 
AAC TAT CCC G-3’ (forward) 
5’-CGG GAT AGT TGG TGA AAC CGA 
CGC CAT TGG C-5’ (reverse) 
K1119Q 5’-CCA TCG AGG CCA TGC AGA TGG 
AAA CCG CG-3’ (forward) 
5’-CGC GGT TTC CAT CTG CAT GGC 
CTC GAT GG-3’ (reverse) 
 
 
 
Table 2-2. Various Forms of RePC and the Expression Vector in which Each Gene is 
Cloned 
 
Gene Expression Vector 
RePC wt (His)9 pET-17b 
Y628F RePC (His)9 pET-17b 
Y628A RePC (His)9 pET-17b 
Y628F RePC (His)9 pET-17b 
K1119Q RePC (His)9 pET-17b 
ΔBC RePC (His)8-TEV pET-28a 
K1119Q ΔBC RePC (His)8-TEV pET-28a 
ΔBCΔBCCP RePC (His)8-TEV pET-28a 
D590A ΔBCΔBCCP RePC (His)8-TEV pET-28a 
Y628A ΔBCΔBCCP RePC (His)8-TEV pET-28a 
Y628F ΔBCΔBCCP RePC (His)8-TEV pET-28a 
ReBCCP  (His)8-TEV pET-28a 
K1119Q ReBCCP (His)8-TEV pET-28a 
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2.4 Protein Production 
 
 
 
2.4.1 RePC wild-type and All Mutant Forms  
 
 
 
RePC and all mutant forms of the full-length enzyme were co-expressed with the 
pCY216 vector (Chapman-Smith, Turner, Cronan, Morris, & Wallace, 1994) encoding E. 
coli biotin protein ligase (BirA) in E. coli BL21Star(DE3) cells from a modified pET-
17b-(His)9 vector. Cells were cultured in M9 minimal media containing 200 mg/L 
ampicillin and 30 mg/L chloramphenicol at 37°C. At an optical density (600 nm) of 0.8 – 
0.9 and prior to induction with 1 mM IPTG and 20 mM L-arabinose, D-biotin and MnCl2 
were supplemented into the growth media to 3 mg/L and 0.1 mM, respectively. For the 
K1119Q mutant form, BirA was not co-expressed and D-biotin was not supplemented 
into the media during induction. Cultures were induced for 16 – 20 hours at 16°C. 
2.4.2 ΔBC RePC, K1119Q ΔBC RePC, ΔBCΔBCCP RePC, D590A ΔBCΔBCCP RePC, 
Y628A ΔBCΔBCCP RePC, and Y628F ΔBCΔBCCP RePC 
 
 
 
ΔBC RePC, K1119Q ΔBC RePC, ΔBCΔBCCP RePC, D590A ΔBCΔBCCP RePC, 
Y628A ΔBCΔBCCP RePC, and Y628F ΔBCΔBCCP RePC were expressed in E. coli 
BL21Star(DE3) cells from a modified pET28a-(His)8-TEV vector. The pCY216 vector 
encoding BirA was co-expressed with ΔBC RePC, but not with all forms of ΔBCΔBCCP 
RePC or the K1119Q mutant of ΔBC RePC. Cells were cultured in M9 minimal media 
containing 40 mg/L kanamycin and 30 mg/L chloramphenicol when expressing BirA. 
When the culture reached an optical density (600 nm) of 0.8 – 1.0, MnCl2 was 
supplemented in the growth media to 0.1 mM followed by induction with 1 mM IPTG for 
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16 – 20 hours at 16°C. When BirA was co-expressed, D-biotin and L-arabinose were 
supplemented into the media during induction to a final concentration of 2 – 4 mg/L and 
25 mM, respectively.  
2.4.3 ReBCCP and K1119Q ReBCCP 
 
 
 
ReBCCP and the K1119Q mutant form of ReBCCP were expressed and purified in a 
similar manner. ReBCCP in a pET-28a-(His)8-TEV plasmid was co-expressed in E. coli 
BL21Star(DE3) with E. coli biotin protein ligase A (BirA) on vector pCY216 (Chapman-
Smith et al., 1994). The K1119Q form of ReBCCP was not co-expressed with BirA. Both 
K1119Q and wild-type ReBCCP were expressed in LB broth (Miller’s modification) 
containing 50 mg/L kanamycin and 30 mg/L chloramphenicol (when co-expressing 
BirA). Cultures were grown at 37°C to an optical density (600 nm) of 0.4 – 0.5, 
supplemented with D-biotin to a final concentration of 4 mg/L, and induced with IPTG 
and L-arabinose to 1 mM and 25 mM, respectively. Following induction, cultures were 
grown at 30°C for 17 – 19 hours prior to harvesting. 
2.5 Protein Purification 
 
 
 
2.5.1 RePC wild-type, Y628F RePC, Y628A RePC, Y628F RePC, K1119Q RePC, ΔBC 
RePC, K1119Q ΔBC RePC, ΔBCΔBCCP RePC, D590A ΔBCΔBCCP RePC, Y628A 
ΔBCΔBCCP RePC, and Y628F ΔBCΔBCCP RePC  
 
 
 
All forms of RePC were purified using Ni2+-affinity and anion exchange chromatography. 
Harvested cells were re-suspended in “Buffer A” containing 20 mM Tris-HCl (pH 7.8), 5 
mM imidazole, 200 mM NaCl, 0.5 mM EGTA, 6 mM 2-mercaptoethanol, 1 mM 
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phenylmethane-sulfonyl fluoride (PMSF), 1 µM pepstatin A, and 5 µM E-64. MgCl2 was 
deliberately excluded from all buffers during purification of wild-type and mutant forms 
of ΔBC RePC and ΔBCΔBCCP RePC.  Cells were disrupted by sonication and the cell 
lysate was cleared by centrifugation at 10°C prior to loading onto a 10 mL Ni2+-NTA 
Profinity resin column (Bio-Rad Life Science; Hercules, CA). The enzyme was 
subsequently washed with ~ 300 mL of Buffer A and eluted from the column in Buffer 
A, with a gradient from 20 mM to 250 mM imidazole. Purified protein was pooled and 
dialyzed overnight against Buffer A at 4°C. For all forms of ΔBC RePC and ΔBCΔBCCP 
RePC, the Ni2+-NTA purified preparation was incubated in Buffer A with His-tagged 
recombinant TEV (rTEV) protease at 4°C (40:1 molar ratio of ΔBC RePC or 
ΔBCΔBCCP RePC to rTEV protease) to remove the N-terminal (His)8 tag. After (His)8 
tag cleavage, the protein sample was reapplied to a Ni2+-affinity column to remove the 
cleaved (His)8 tag and His-tagged-rTEV protease. The (His)8 tag cleavage and rTEV 
protease removal was > 95% efficient as estimated by SDS-PAGE. Cleaving the N-
terminal (His)9 tag of the full-length RePC with rTEV protease was unsuccessful, 
suggesting that the recognition sequence is inaccessible to the rTEV protease in the full-
length enzyme. Therefore all full-length forms of RePC retained the recombinant N-
terminal (His)9 tag.  
All purified protein samples were pooled and dialyzed in “Buffer B” containing 
20 mM triethanolamine (pH 8.0), 50 mM NaCl, 1 mM EGTA, and 2 mM DTT at 4°C in 
preparation for anion exchange chromatography. Protein was loaded on a 10 mL column 
volume of Q-Sepharose Fast Flow resin (GE Healthcare), washed with 60 mL of Buffer 
B and was sequentially eluted from the resin in Buffer B using a linear gradient from 50 
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mM to 1 M NaCl. Fractions were pooled and dialyzed against a storage buffer consisting 
of 10 mM Tris-HCl (pH 7.8), 50 mM NaCl, 10 mM MgCl2, 5% (v/v) glycerol and 2 mM 
DTT. An Amicon stirred cell with a 30 000 Da molecular weight cutoff filter was used to 
concentrate protein preparations to a range of 3 - 12 mg/mL. Concentrated protein was 
flash frozen in liquid nitrogen prior to storage at -80 °C. Full-length RePC, ΔBC RePC 
and ΔBCΔBCCP RePC enzyme concentrations were determined spectrophotometrically 
using the calculated molar extinction coefficient of 118 000 M-1 cm-1, 76 780 M-1 cm-1, 
and 75 290 M-1cm-1, respectively, at 280 nm (Gasteiger et al., 2005). 
2.5.2 ReBCCP and K1119Q ReBCCP 
 
 
  
The ReBCCP proteins were purified to homogeneity using Ni2+-affinity and anion 
exchange chromatography. Harvested cells were re-suspended in “Buffer A” containing 
50 mM Tris-HCl (pH 7.8), 5 mM imidazole, 200 mM NaCl, 0.5 mM EGTA, 5 mM 2-
mercaptoethanol, 1 mM PMSF, 1 µM pepstatin A, and 5 µM E-64. Cells were disrupted 
by sonication and the cell lysate was cleared by centrifugation at 10°C prior to loading 
onto a 10 mL Ni2+-NTA Profinity resin column (Bio-Rad Life Sciences; Hercules, CA). 
The protein was subsequently washed with 160 mL of Buffer A and eluted from the 
column in Buffer A, with a gradient from 20 mM to 250 mM imidazole. Purified protein 
was pooled and dialyzed against Buffer A with His-tagged recombinant TEV (rTEV) 
protease at 4°C (40:1 molar ratio of ReBCCP to rTEV protease). After (His)8 tag 
cleavage, the ReBCCP sample was reapplied to a Ni2+-affinity column to remove the 
cleaved (His)8 tag and His-tagged-rTEV protease. Purified protein samples were pooled 
and dialyzed overnight in “Buffer B” containing 20 mM triethanolamine (pH 8.0), 50 
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mM NaCl, 1 mM EGTA, and 2 mM DTT at 4°C. Protein was flowed over a 10 mL 
column volume of Q-sepharose Fast Flow resin (GE Healthcare). Due to the high 
prevalence of positively charged residues at the N-terminal portion (theoretical pI for 
ReBCCP is 8.33), ReBCCP flows through the column while remaining impurities bind 
the resin. The flow through was pooled and dialyzed against a storage buffer consisting 
of 30 mM Tris-HCl (pH 7.8), 50 mM NaCl, and 2 mM DTT. An Amicon stirred cell with 
a 3 500 Da molecular weight cutoff filter was used to concentrate the ReBCCP 
preparations to a range of 2 – 3 mg/mL. Concentrated protein was flash frozen in liquid 
nitrogen and stored at -80°C. ReBCCP protein concentration was determined 
spectrophotometrically using the calculated molar extinction coefficient of 1 490 M-1cm-1 
at 280 nm (Gasteiger et al., 2005).  
2.6 Protein Crystallization 
 
 
 
2.6.1 ΔBCΔBCCP RePC and Y628A ΔBCΔBCCP RePC 
 
 
 
Wild-type and the Y628A mutant form of ΔBCΔBCCP RePC were crystallized under 
similar conditions using the batch crystallization method under oil. Crystallization 
conditions for all X-ray crystal structures were nearly identical. For the ΔBCΔBCCP 
RePC structure co-crystallized with pyruvate, a protein solution consisting of 10 mg/mL 
ΔBCΔBCCP RePC and 30 mM pyruvate was mixed at a 1:1 ratio with a precipitant 
solution comprised of 12 – 14% (w/v) PEG 8000, 100 mM BisTris (pH 6.0), 300 – 400 
mM tetramethylammonium chloride (TMACl) and 2% (v/v) glycerol. The Y628A mutant 
was co-crystallized with 50 mM pyruvate. A seed stock was created using the seed bead 
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kit from Hampton Research (Aliso Viejo, CA). Briefly, a single apoprotein ΔBCΔBCCP 
RePC crystal was pulverized in 500 µL of precipitant solution and 0.5 µL of the seed 
solution was added to the crystallization drop immediately following mixing. The drop 
was covered with paraffin oil and diamond shaped crystals (250 µm × 200 µm × 150 µm) 
formed within 2-3 days. After 5-7 days, the crystals were serially transferred in 5% (v/v) 
glycerol increments from a synthetic mother liquor solution consisting of 10% (w/v) PEG 
8000, 65 mM BisTris (pH 6.0), 200 mM TMACl, 5% (v/v) glycerol, and 25 mM NaCl to 
a cryoprotectant solution consisting of 11.5% (w/v) PEG 8000, 90 mM BisTris (pH 6.0), 
350 mM TMACl, 20% (v/v) glycerol, and 25 mM NaCl and flash cooled in liquid 
nitrogen. 
2.6.2 ΔBCΔBCCP RePC with Oxamate and Biotin or Pyruvate and Biocytin 
 
 
 
ΔBCΔBCCP RePC was crystallized using the batch crystallization method under oil. 
Crystallization conditions were nearly identical for all crystals. For the ΔBCΔBCCP 
RePC structure containing pyruvate and biocytin, a protein solution consisting of 10 
mg/mL ΔBCΔBCCP RePC and 40 mM pyruvate was mixed at a 1:1 ratio with a 
precipitant solution comprised of 11% (w/v) PEG 8000, 100 mM BisTris (pH 6.0), and 
345 mM TMACl. For the ΔBCΔBCCP RePC structure containing oxamate and biotin, a 
protein solution consisting of 10 mg/mL ΔBCΔBCCP RePC, 50 mM oxamate, and 10 
mM 1’N-acetyl-d-biotin (Guchhait et al., 1974) was mixed at a 1:1 ratio with a 
precipitant solution comprised of 14% (w/v) PEG 8000, 110 mM 3-morpholinopropane-
1-sulfonic acid (MOPS; pH 6.0), 165 mM TMACl, 2% (v/v) glycerol, and 85 mM 1’N-
acetyl-d-biotin. A seed stock was created using the seed bead kit from Hampton Research 
	   51	  
(Aliso Viejo, CA). Briefly, a single apoprotein ΔBCΔBCCP RePC crystal was pulverized 
in 500 µL of precipitant solution and 0.5 µL of this pulverized seed solution was added to 
the crystallization drop immediately following the mixing of the protein and precipitant 
solutions. The drop was covered with paraffin oil and diamond shaped crystals formed 
with 2-3 days. After 5-7 days, the crystals grew to dimensions of ~300 µm × 200 µm × 
150 µm and were harvested. Crystals were then serially transferred in 5% (v/v) glycerol 
increments from the synthetic mother liquor solution to a cryoprotectant solution 
consisting of 11% (w/v) PEG 8000, 90 mM BisTris (pH 6.0), 200 mM TMACl, 20 mM 
pyruvate, 80 mM biocytin, and 20% (v/v) glycerol and flash cooled in liquid nitrogen. 
Crystals of ΔBCΔBCCP RePC co-crystallized with oxamate and biotin were transferred 
in an identical manner, excepting that 50 mM oxamate and 50 mM 1’N-acetyl-d-biotin 
replaced the 80 mM biocytin and 20 mM pyruvate. The cryo-protected crystals were 
immediately flash cooled in liquid nitrogen. 
2.6.3 ΔBCΔBCCP RePC with Oxalate 
 
 
 
ΔBCΔBCCP RePC was crystallized using the batch crystallization method under oil. For 
the ΔBCΔBCCP RePC structure containing oxalate, the protein solution consisting of 10 
mg/mL ΔBCΔBCCP RePC and 25 mM oxalate was mixed at a 1:1 ratio with the 
precipitant solution comprised of 11.3% (w/v) PEG 8000, 99 mM BisTris (pH 6.0), and 
346 mM TMACl. A seed stock was generated using the seed bead kit from Hampton 
Research (Aliso Viejo, CA). Briefly, a single apoprotein ΔBCΔBCCP RePC crystal was 
pulverized in 500 µL of precipitant solution and 0.5 µL of the seed solution was added to 
the crystallization drop immediately following mixing. The drop was covered with 
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paraffin oil and diamond shaped crystals formed with 2-3 days. After 5-7 days, the 
crystals were serially transferred in 5% (v/v) glycerol increments from a synthetic mother 
liquor solution consisting of 11% (w/v) PEG 8000, 70 mM BisTris (pH 6.0), 275 mM 
TMACl, 5% (v/v) glycerol, and 25 mM oxalate to a cryoprotectant solution consisting of 
11.5% (w/v) PEG 8000, 90 mM BisTris (pH 6.0), 300 mM TMACl, 20% (v/v) glycerol, 
and 25 mM oxalate and flash cooled in liquid nitrogen. 
2.6.4 ΔBCΔBCCP RePC with 3-hydroxypyruvate or 3-bromopyruvate 
 
 
 
Ligand soaking was required to obtain the structures of ΔBCΔBCCP RePC with 3-
bromopyruvate or 3-hydroxypyruvate. The protein solution consisting of 12.2 mg/mL 
ΔBCΔBCCP RePC, was mixed at a 1:1 ratio with the precipitant solution comprised of 
11.3% (w/v) PEG 8000, 99 mM BisTris (pH 6.0), and 346 mM TMACl. The 
crystallization drop was seeded and covered with paraffin oil as described above. Apo 
crystals of ΔBCΔBCCP RePC were transferred and soaked in a mother liquor solution 
containing 10% (w/v) PEG 8000, 80 mM BisTris (pH 6.0), 200 mM TMACl, and 80 mM 
3-bromopyruvate for 16 hours at room temperature. Similarly, apo crystals of 
ΔBCΔBCCP RePC with 3-hydroxypyruvate were transferred and soaked in an identical 
mother liquor solution for 24 hours with 130 mM 3-hydroxypyruvate in place of 3-
bromopyruvate. Crystals were then serially transferred in 5% (v/v) glycerol increments 
from the synthetic mother liquor solution to a cryoprotectant solution consisting of 11% 
(w/v) PEG 8000, 90 mM BisTris (pH 6.0), 200 mM TMACl, 80 mM 3-bromopyruvate or 
130 mM 3-hydroxypyruvate, and 20% (v/v) glycerol and flash cooled in liquid nitrogen. 
2.7 Data Collection and Structure Determination 
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X-ray diffraction data were collected at the Advanced Photon Source (APS), beamline 
LS-CAT 21-ID on Rayonix MarMosaic 225 CCD and 300 CCD detectors (Tables 2-3, 2-
4, 2-5). Diffraction images were processed with the HKL2000 suite (Otwinowski & 
Minor, 1997). In all cases, the diffraction data were anisotropic, with diffraction falling 
off in the b* direction relative to the a* and c* directions. This contributed to the modest 
resolution limits and to the elevated Wilson B-value. Anisotropic data truncation using 
the diffraction anisotropy server (http://services.mbi.ucla.edu/anisoscale/) did not 
improve the electron density maps or the refinement statistics and was, therefore, not 
used for data processing. The structures were solved by molecular replacement using the 
CT+allosteric domains of the wild-type RePC enzyme (pdb i.d. 2QF7) as the search 
model with the program Phaser (McCoy et al., 2007). Following molecular replacement, 
translation/liberation/screw (TLS) refinements were performed using REFMAC 
(Murshudov, Vagin, & Dodson, 1997; Winn, Isupov, & Murshudov, 2001; Winn, 
Murshudov, & Papiz, 2003). Initial B factors were set at a constant value of 20.0 Å2 prior 
to the start of refinement. Each monomer was treated as a rigid TLS group. TLS 
refinement improved the 2Fo-Fc maps and lowered the final R and Rfree for each model by 
1.5% and 3.0%, respectively, consistent with what is expected from using a single TLS-
group model (Zucker, Champ, & Merritt, 2010). All four monomers in the asymmetric 
unit were restrained using non-crystallographic symmetry for all models during the entire 
refinement process. The models were extended by several rounds of manual model 
building with COOT (Emsley & Cowtan, 2004) and successive refinements with 
REFMAC. Water molecules were added to the model in COOT with subsequent manual 
verification. In all cases, monomers A and B are packed more tightly in the asymmetric 
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unit than monomers C and D. As a result, monomers A and B exhibit lower B-factors and 
are better defined by the electron density maps. All figures were generated from 
monomer A of the structure. Data collection and processing statistics are summarized in 
Tables 2-3, 2-4, and 2-5. The atomic coordinates have been deposited in the Protein Data 
Bank (Tables 2-3, 2-4, 2-5). 
 
 
 
Table 2-3: Data Collection and Refinement Statistics 
 
 ΔBCΔBCCP RePC ΔBCΔBCCP RePC + pyruvate 
Y628A ΔBCΔBCCP 
RePC + pyruvate 
PDB ID code 4JX4 4JX5 4JX6 
APS Beamline 21-ID-F 21-ID-G 21-ID-G 
Wavelength, Å 0.979 0.979 0.979 
Detector MarMosaic 225 MarMosaic 300 MarMosaic 300 
Space Group P212121 P212121 P212121 
Cell Dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
85, 157, 245 
90, 90, 90 
 
85, 157, 245 
90, 90, 90 
 
85, 157, 246 
90, 90, 90 
Resolution 
range, Å 
50.0–2.98  
(3.03–2.98)a 
50.0–2.55  
(2.59–2.55)a 
50.0–2.78  
(2.83–2.78)a 
Redundancy 7.3 (7.0) 7.2 (7.1) 7.2 (7.0) 
Completeness 
(%) 99.7 (97.9) 99.8 (99.9) 99.9 (99.6) 
Unique 
Reflections 70179 107658 83911 
Rmerge (%) 8.9 (40.0) 8.5 (44.4) 7.4 (42.6) 
I / σI 20.6 (4.5) 24.0 (4.4) 26.3 (4.3) 
Refinement:    
Resolution 
range, Å 
50.0–2.98  
(3.06–2.98) 
50.0–2.55  
(2.61–2.55) 
50.0–2.78  
(2.85–2.78) 
Rcryst 0.213 (0.329) 0.187 (0.271) 0.208 (0.320) 
Rfree 0.247 (0.368) 0.233 (0.300) 0.258 (0.342) 
No. protein 
atoms 17166 17941 17344 
No. water 
molecules - 207 60 
Wilson B-value 
(Å2) 77.8 54.8 60.6 
Average total B-
factors 
(BTLS+Bresidual) 
(Å2) 
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Protein 92.2 71.6 76.7 
  Chain A   67.7   50.2    52.8 
  Chain B   94.6   67.4   78.3 
  Chain C   95.0   86.4   87.0 
  Chain D  113.3   83.4   90.1 
Ligands - 54.6 49.8 
Metal 76.2 59.2 73.0 
Solvent - 48.8 45.9 
Ramachandran 
(%)    
Most favored 91.0 89.9 90.2 
Additionally 
allowed 8.4 9.5 9.3 
Generously 
allowed 0.5 0.5 0.4 
Disallowed 0.1 0.0 0.0 
r.m.s. deviations    
Bond lengths (Å)  0.012 0.012 0.010 
Bond angles (°) 1.492 1.497 1.403 
a Values in parentheses are for the highest resolution bin. 
 
 
 
Table 2-4: Data Collection and Refinement Statistics 
 
 ΔBCΔBCCP RePC + oxalate 
ΔBCΔBCCP RePC + 
3-hydroxypyruvate 
ΔBCΔBCCP RePC + 
3-bromopyruvate 
PDB ID code 4MFD 4MFE 4MIM 
APS Beamline 21-ID-G 21-ID-F 21-ID-F 
Wavelength, Å 0.979 0.979 0.979 
Detector MarMosaic 300 MarMosaic 225 MarMosaic 225 
Space Group P212121 P212121 P212121 
Cell Dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
86, 157, 245 
90, 90, 90 
 
84, 158, 243 
90, 90, 90 
 
86, 157, 243 
90, 90, 90 
Resolution 
range, Å 
50.0–2.55  
(2.59–2.55)a 
50.0–2.60  
(2.64–2.60)a 
50.0–2.65  
(2.70–2.65)a 
Redundancy 7.3 (7.1) 5.5 (5.5) 7.1 (6.6) 
Completeness 
(%) 99.8 (99.3) 96.0 (93.2) 99.9 (99.7) 
Unique 
Reflections 108 188 91 812 95 052 
Rmerge (%) 8.6 (43.7) 6.6 (43.4) 8.2 (44.3) 
I / σI 21.1 (4.4) 22.8 (3.3) 24.5 (3.6) 
Refinement:    
Resolution 
range, Å 
48.26–2.55  
(2.61–2.55) 
49.37–2.61  
(2.67–2.61) 
48.3–2.65  
(2.72–2.65) 
Rcryst 0.193 (0.262) 0.177 (0.238)  0.186 (0.279) 
Rfree 0.240 (0.296) 0.225 (0.298)  0.235 (0.334) 
No. protein 17814 17488 17532 
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atoms 
No. water 
molecules 190 169 136 
Wilson B-value 
(Å2) 51.2 59.9 53.8 
Average total B-
factors 
(BTLS+Bresidual) 
(Å2) 
   
Protein 78.8 78.5 76.9 
  Chain A 53.2 58.4 56.0 
  Chain B 69.1 91.2 90.6 
  Chain C 101.1 74.5 73.4 
  Chain D 93.5 91.2 88.7 
Ligands 62.2 66.6 60.5 
Solvent 49.3 56.4 54.9 
Ramachandran 
(%)    
Most favored 90.9 90.4 90.8 
Additionally 
allowed 8.3 8.9 8.7 
Generously 
allowed 0.7 0.7 0.5 
Disallowed 0.0 0.0 0.0 
r.m.s. deviations    
Bond lengths (Å)  0.0157 0.0156 0.0140 
Bond angles (°) 1.638 1.727 1.612 
a Values in parentheses are for the highest resolution bin. 
 
 
 
Table 2-5: Data Collection and Refinement Statistics 
 
 ΔBCΔBCCP RePC + oxamate + biotin 
ΔBCΔBCCP RePC + 
pyruvate + biocytin 
PDB ID code 4LOC 4M6V 
APS Beamline 21-ID-F 21-ID-D 
Wavelength, Å 0.979 1.127 
Detector MarMosaic 225 MarMosaic 300 
Space Group P212121 P212121 
Cell Dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
 
84, 157, 245 
90, 90, 90 
 
 
85, 158, 245 
90, 90, 90 
Resolution 
range, Å 50.0–2.26 (2.30–2.26)
a 50.0–2.40 (2.44–2.40)a 
Redundancy 7.1 (6.8) 7.2 (7.1) 
Completeness 
(%) 98.3 (94.7) 99.8 (99.8) 
Unique 145868 128103 
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Reflections 
Rmerge (%) 8.4 (44.4) 6.9 (40.5) 
I / σI 20.6 (3.4) 25.7 (5.2) 
Refinement:   
Resolution 
range, Å 
43.75–2.26  
(2.32–2.26) 
50.0–2.40  
(2.46–2.40) 
Rcryst 0.176 (0.227) 0.188 (0.256) 
Rfree 0.216 (0.293) 0.227 (0.309) 
No. protein 
atoms 17924 17894 
No. water 
molecules 535 361 
Wilson B-value 
(Å2) 34.4 45.4 
Average total B-
factors 
(BTLS+Bresidual) 
(Å2) 
  
Protein 52.8 67.9 
Ligands 57.4 59.0 
Solvent 41.5 46.7 
Ramachandran 
(%)   
Most favored 92.2 92.4 
Additionally 
allowed 7.3 7.1 
Generously 
allowed 0.5 0.5 
Disallowed 0.0 0.0 
r.m.s. deviations   
Bond lengths (Å)  0.018 0.012 
Bond angles (°) 1.836 1.503 
a Values in parentheses are for the highest resolution bin. 
 
 
 
2.8 Enzyme Assays 
 
 
 
2.8.1 Pyruvate Carboxylation Assay 
 
 
  
Pyruvate carboxylation activity was determined spectrophotometrically by measuring the 
conversion of oxaloacetate to malate using malate dehydrogenase, as previously 
described (Duangpan et al., 2010). Reaction assays were initiated by the addition of RePC 
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(3 – 150 µg) in a 1 mL reaction volume at 25°C. All enzyme substrates were maintained 
at saturation except for pyruvate, which was varied from 0 to 50 mM where specified. 
Otherwise, each reaction was performed in 0.1 M Tris-HCl (pH 7.8), 25 mM NaHCO3, 
2.5 mM MgATP, 7 mM MgCl2, 12 mM pyruvate, 0.25 mM acetyl CoA, 0.24 mM 
NADH, and malate dehydrogenase (10 U). 
Pyruvate carboxylation activity was also measured for ΔBCΔBCCP RePC. 
Briefly, reaction assays were initiated by the addition of ΔBCΔBCCP RePC (975 µg) in a 
1 mL reaction volume at 30°C. Each reaction was performed in 50 mM NaHCO3, 25 mM 
pyruvate, 0.24 mM NADH, and malate dehydrogenase (30 U). Reactions were conducted 
in both 0.1 M Tris-HCl (pH 7.8) and 0.1 M Tricine-NaOH (pH 7.8) to evaluate the effects 
of various buffer systems on catalysis. For each velocity measurement, a non-enzymatic 
reaction rate was measured in parallel. No non-enzymatic rate was observed. 
2.8.2 Phosphorylation of MgADP Using Carbamoyl Phosphate. 
 
 
  
The phosphorylation of MgADP in the presence of carbamoyl phosphate was measured 
by following the production of ATP using a hexokinase/glucose-6-phosphate 
dehydrogenase coupled assay (Attwood & Graneri, 1991; Duangpan et al., 2010; 
Zeczycki et al., 2009). Specific activities were determined at 25°C in 3 mL reaction 
mixtures containing 0.1 M Tris-HCl (pH 7.8), 7 mM MgCl2, 3.5 mM MgADP, 0.25 mM 
acetyl CoA, 20 mM carbamoyl phosphate, 0.4 mM glucose, 0.36 mM NADP, glucose-6-
phosphate dehydrogenase (5U) and hexokinase (2U). The reaction was initiated by the 
addition of RePC (200 µg).   
2.8.3 Oxaloacetate Decarboxylation in the Presence and Absence of Oxamate. 
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The PC-catalyzed rate of oxaloacetate decarboxylation was determined by measuring the 
reduction of pyruvate to lactate using lactate dehydrogenase (Attwood & Cleland, 1986b; 
Duangpan et al., 2010; Zeczycki et al., 2009). Reactions were performed in 0.1 M Tris-
HCl (pH 7.8), 0.25 mM acetyl CoA, 0.24 mM NADH and lactate dehydrogenase (10 U). 
For reactions catalyzed by ΔBCΔBCCP RePC, 1 mM oxaloacetate was added prior to 
initiation of the reaction with enzyme (400 – 900 µg). The half-life for the spontaneous 
decarboxylation of oxaloacetate is 2 – 6 hours at room temperature (Wolfenden, Lewis, 
& Yuan, 2011). Therefore, oxaloacetate solutions were prepared fresh, kept on ice for the 
duration of the kinetic experiments and added immediately prior to initiation of the 
reaction. The enzyme-catalyzed rate was obtained by subtracting the slow rate of non-
enzymatic oxaloacetate decarboxylation from the rate measured in the presence of the 
enzyme. The rate of non-enzymatic oxaloacetate decarboxylation was measured using 
identical reaction components, but with the reaction being initiated by the addition of the 
final storage buffer that the protein was dialyzed against instead of the protein 
preparation. Oxaloacetate was fixed at 1 mM for all oxaloacetate decarboxylation 
reactions performed in the presence of 5 mM biotin, 5 mM biocytin or 1000× molar 
excess ReBCCP. Reactions exhibited substrate inhibition in the presence of oxamate (0.5 
mM) and, therefore, rates were determined at both 0.2 mM and 1 mM oxaloacetate unless 
specified. All reactions were conducted in a 1 mL reaction volume at 30°C. 
Data for the double reciprocal plot of velocity versus oxaloacetate concentrations 
for ΔBC RePC at fixed concentrations of oxamate were fit to the reciprocal of eq 1 using 
least-squares nonlinear regression, where A is the concentration of oxaloacetate, B is the 
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concentration of oxamate, KMA is the Michaelis constant for oxaloacetate, KMB is the 
Michaelis constant for oxamate, Ki1 is the kinetic inhibition constant for oxamate, and Ki2 
is the kinetic inhibition constant for oxaloacetate. This equation is derived from a ping-
pong kinetic scheme with double competitive substrate inhibition, as outlined in scheme 
3-1. Each data set was individually fit to the reciprocal of eq 1 using the least-squares 
error method with KaleidaGraph 4.1 (Synergy Software, Reading, PA). 
! 
v = Vmax[A][B]
KMA[B] 1+ [B]Ki1
" 
# 
$ 
% 
& 
' +KMB[A] 1+ [A]Ki2
" 
# 
$ 
% 
& 
' + [A][B]   [eq 1] 
 
2.9 Analysis of RePC Oligomeric State 
 
 
 
Size exclusion chromatography was performed on an A ̈KTA FPLC system using a 
Superose 6 10/300 GL size exclusion column from Amersham Pharmacia Biotech 
(Piscataway, NJ). Between 0.5 and 1 mg of ΔBC RePC and wild-type RePC was loaded 
and eluted at a flow rate of 0.3 mL min-1 in a buffer containing 10 mM Tris-HCl (pH 
7.4), 150 mM NaCl, 5% (v/v) glycerol, and 2 mM DTT. The eluent also included 250 µM 
acetyl CoA when assessing the oligomeric state of ΔBC RePC in the presence of acetyl 
CoA. Eluted samples were monitored at 280 nm, and the apparent molecular weights 
were estimated from a calibration curve. The Superose 6 10/300 GL size exclusion 
column was calibrated using the following set of proteins: carbonic anhydrase (29 kDa), 
ovalbumin (45 kDa), bovin serum albumin (66 kDa), alcohol dehydrogenase (150 kDa), 
β-amylase (200 kDa), apoferritin (443 kDa), and thyroglobulin (669 kDa). The size 
exclusion column was calibrated by fitting the partition coefficient (Kav) against the log 
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molecular weight of each standard protein. Kav is defined as (Ve − Vo)/(Vt − Vo) where Ve 
is the elution volume, Vo is the void volume, and Vt is the geometric column volume. 
2.10 Avidin Gel Shift Assay 
 
 
 
Biotinylation of each PC enzyme was assessed via the avidin gel shift assay. After 
protein purification, PC enzyme was diluted to a concentration of 1 mg/mL in a buffer 
containing 50 mM HEPES pH 7.5 and 200 mM KCl. 10 µL of the diluted protein mixture 
was combined with 20 µL of Laemmli sample buffer (Bio-Rad Life Science; Hercules, 
CA) and incubated at ~ 100°C for 3 minutes. Lyophilized avidin (Sigma-Aldrich) was re-
suspended in 50 mM HEPES pH 7.5 and 200 mM KCl to a concentration that is 10× 
molar excess of the diluted protein solution. Heated protein samples were allowed to cool 
to room temperature followed by the addition of 10× molar excess avidin solution (10 
µL). Solutions incubated for 15 – 20 minutes at room temperature and analyzed via SDS-
PAGE to assess the level of biotinylation for each PC enzyme preparation. 
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CHAPTER 3: THE ROLE OF BIOTIN AND OXAMATE IN THE 
CARBOXYLTRANSFERASE REACTION OF PYRUVATE CARBOXYLASE 
 
 
 
3.1 Introduction  
 
 
 
As described in chapter 1, the first partial reaction of PC consists of the N-terminal biotin 
carboxylase (BC) domain catalyzing the MgATP- and bicarbonate-dependent 
carboxylation of biotin (Figure 1-4.1). Carboxybiotin then physically translocates to the 
carboxyltransferase (CT) domain where the carboxyl moiety is transferred from biotin to 
pyruvate, thus forming oxaloacetate (Figure 1-4.2). Recent X-ray crystal structures of PC 
from Staphylococcus aureus and Homo sapiens have revealed detailed interactions 
between the biotin carboxyl carrier protein (BCCP) and CT domains (Xiang & Tong, 
2008), including a structural perturbation in α-helix 10 of the CT domain (residues 868 – 
890 in Homo sapiens PC), which accompanies the BCCP-CT domain interaction. Helix 
10 comprises a portion of a funnel leading into the active site and rotates to accommodate 
the interaction with BCCP but it is not known whether this structural rearrangement 
directly contributes to the enzymatic reaction in the CT domain active site.  
Furthermore, kinetic isotope effect studies suggest that pyruvate carboxylation in 
the CT domain occurs in a stepwise manner (Figure 1-10) (Attwood et al., 1986; O'Keefe 
& Knowles, 1986). Carboxybiotin, tethered to BCCP, enters the active site after pyruvate 
binds (Chapter 4) and is decarboxylated to generate a biotin enolate intermediate 
(Zeczycki et al., 2009). A proton is subsequently shuttled from pyruvate to the biotin 
enolate via a conserved threonine residue, forming an enolpyruvate intermediate. Finally, 
the liberated CO2 is transferred to pyruvate, generating oxaloacetate (Zeczycki et al., 
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2009). Conversely, oxaloacetate can decarboxylate in the CT domain concurrent with the 
carboxylation of biotin. There are mixed reports in the literature concerning whether 
oxaloacetate can decarboxylate in the absence of biotin  (Adina-Zada et al., 2008; 
Attwood & Cleland, 1986a; Duangpan et al., 2010; Islam, Sueda, & Kondo, 2005). These 
inconsistencies are due, in part, to the complexity of multi-domain catalysis in PC and to 
the variety of assay methods used for its study.  
While wild type PC can catalyze the decarboxylation of oxaloacetate, the rate is 
significantly enhanced in the presence of oxamate (Attwood et al., 1986; Attwood & 
Cleland, 1986b; Zeczycki et al., 2009). Oxamate is a structural analogue of pyruvate that 
was originally characterized as both a non-competitive (Scrutton, Olmsted, & Utter, 
1969) and uncompetitive inhibitor (Mildvan et al., 1966) of the overall pyruvate 
carboxylation reaction, with respect to pyruvate. The oxamate-induced oxaloacetate 
decarboxylation reaction has been widely used to study the carboxyltransferase activity in 
the CT domain of PC (Duangpan et al., 2010; Zeczycki et al., 2009) but the mechanistic 
features associated with oxamate stimulation have only recently been described. 
Recently, Marlier et al  (Marlier, Cleland, & Zeczycki, 2013) reported 13C NMR evidence 
for the carboxyl transfer from oxaloacetate to oxamate in Rhizobium etli PC and 
concluded that oxamate serves as an alternate substrate, thus accelerating the enzymatic 
decarboxylation of carboxybiotin. Interestingly, initial velocity patterns were inconsistent 
with a simple ping-pong mechanism, leaving several aspects of the oxamate stimulation 
mechanism unresolved.    
In this chapter, I report kinetic and structural data on several truncated constructs 
of Rhizobium etli PC, including the isolated CT domain. The goal of these studies is to 
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further clarify the stimulatory role of oxamate in the oxaloacetate decarboxylation 
reaction. Moreover, the initial velocity patterns for the oxamate-induced decarboxylation 
of oxaloacetate in the wild-type RePC enzyme exhibited sigmoidicity, suggesting 
cooperativity. Therefore an added objective is to develop a system to study the CT 
domain in isolation without this added complexity. The data presented here further clarify 
the stimulatory role of oxamate in the oxaloacetate decarboxylation reaction. I report that 
oxamate is positioned in the pyruvate binding site, in agreement with the Marlier et al 
(Marlier et al., 2013) report that oxamate serves as a carboxyl group acceptor in this 
reaction. My kinetic data further suggest that, in the absence of a BC domain, the 
oxamate-stimulated decarboxylation of oxaloacetate proceeds through a simple ping-
pong bi bi mechanism with double substrate inhibition. Additionally, I present kinetic 
data indicating that the BCCP domain devoid of biotin does not contribute directly to the 
enzymatic reaction. 
3.2 Results 
 
 
 
3.2.1 Effects of Biotin, Biocytin and BCCP on Oxaloacetate Decarboxylation 
 
 
 
The role of biotin in the biotin-dependent carboxylases has largely been studied for the 
biotin carboxylation reaction of the BC domain (Blanchard, Lee, Frantom, & Waldrop, 
1999; Chou et al., 2009; Levert, Lloyd, & Waldrop, 2000; Waldrop et al., 1994; Zeczycki 
et al., 2011). The role of biotin in the carboxyl transfer reactions of various biotin-
dependent carboxylases, however, has not been extensively characterized outside of the 
carboxyltransferase subunit of Escherichia coli acetyl CoA carboxylase (Blanchard & 
	   65	  
Waldrop, 1998; Blanchard, Chapman-Smith, Wallace, & Waldrop, 1999; Guchhait et al., 
1974). Complete X-ray crystal structures of PC have been reported in recent years  
(Lietzan et al., 2011; St. Maurice et al., 2007; Xiang & Tong, 2008; Yu et al., 2009), 
permitting a precise structural and kinetic characterization of the isolated CT domain. In 
addition, structural studies of S. aureus PC reveal that the BCCP domain physically 
interacts with the CT domain in order to facilitate biotin binding in the CT domain active 
site (Xiang & Tong, 2008; Yu et al., 2009). Whereas it is clear that free biotin is unable to 
rescue the overall pyruvate carboxylation activity in PC mutants lacking a covalently 
tethered biotin cofactor (Zeczycki et al., 2009; Zeczycki, Menefee, Jitrapakdee et al., 
2011), it is not known whether the BCCP-CT domain interaction is required in order for 
biotin to participate in the carboxyltransferase reaction. To better study the contribution 
of BCCP-biotin and its individual components to the carboxytransferase activity in PC, 
structure-guided truncations of the RePC holoenzyme were generated to enable a 
thorough investigation of the role of biotin in the CT domain reaction (Figure 3-1). The 
rate of oxaloacetate decarboxylation was measured in the presence of free biotin, biocytin 
and ReBCCP-biotin for various truncated and full-length constructs of RePC. 
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Figure 3-1. Primary sequence of Rhizobium etli pyruvate carboxylase (RePC) and the 
truncated constructs utilized in this study.  
 
The amino acid numbers designate the boundaries for the various functional domains of RePC. 
The darkly shaded areas represents the allosteric domain.     
 
 
 
All of the RePC constructs examined in the present study maintain an intrinsic 
rate of oxaloacetate decarboxylation, irrespective of whether or not the enzyme is 
biotinylated (Table 3-1 and Figure 3-2). At 1 mM oxaloacetate, wild-type RePC catalyzes 
the decarboxylation of oxaloacetate to pyruvate ~2-fold faster than ΔBC RePC or 
ΔBCΔBCCP RePC. Mutating Lys1119, the site of biotinylation in RePC, slightly reduces 
oxaloacetate decarboxylation compared to the biotinylated forms but the same trend 
holds, with the full length K1119Q RePC catalyzing oxaloacetate decarboxylation ~2-  
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Table 3-1. Effects of Free Biotin, Biocytin and ReBCCP on the Decarboxylation of 
Oxaloacetate by Pyruvate Carboxylase and Pyruvate Carboxylase Variants.a 
  
 1 mM 
oxaloacetate, kcat 
(min-1) 
+ 5 mM biotin, 
kcat (min-1) 
+ 5 mM biocytin, 
kcat (min-1) 
+ 1000× molar 
excess ReBCCPb, 
kcat (min-1) 
RePC wt 1.23 ± 0.01 2.2 ± 0.1 4.0 ± 0.1 76.0 ± 0.4 
K1119Q RePC 1.05 ± 0.02 1.90 ± 0.02 3.95 ± 0.05 94.4 ± 4.5 
∆BC RePC 0.51 ± 0.02 0.87 ± 0.03 1.62 ± 0.04 39.1 ± 0.8 
K1119Q ∆BC 
RePC 
0.37 ± 0.01 0.75 ± 0.01 1.43 ± 0.03 35.3 ± 0.9 
∆BC∆BCCP 
RePC 
0.46 ± 0.01 0.88 ± 0.01 2.56 ± 0.01 50.9 ± 3.9 
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 30°C, 1 mM oxaloacetate, 0.25 mM acetyl-
CoA (RePC wt and K1119Q RePC only), 0.24 mM NADH. Specific activities were determined in 
triplicate and the reported errors are standard deviations of the means. 
bReBCCP was assayed as a substrate at 1000-fold molar excess over the enzyme concentration. 
This ranged from 60 to 70 µM, depending on the enzyme concentration  
 
 
 
 
Figure 3-2. Avidin-gel shift assay for protein biotinylation of RePC wild-type, K1119Q 
RePC, ΔBC RePC, K1119Q ΔBC RePC, ΔBCΔBCCP RePC, ReBCCP (BCCP RePC) and 
K1119Q ReBCCP.  
 
A. Purified RePC wild-type (calculated molecular weight: 127 000 Da) and K1119Q RePC were 
assayed for biotinylation via the avidin-gel shift assay and resolved on an 8% SDS-PAGE gel. B. 
Purified ΔBC RePC (calculated molecular weight: 75 000 Da), K1119Q ΔBC RePC and 
ΔBCΔBCCP RePC (calculated molecular weight: 67 000 Da) were assayed for biotinylation via 
the avidin-gel shift assay and resolved on an 8% SDS-PAGE gel. C. Purified ReBCCP (calculated 
molecular weight: 10 500 Da) and K1119Q ReBCCP were assayed for biotinylation via the 
avidin-gel shift assay and resolved on a 14% SDS-PAGE gel. All preparations represented in the 
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avidin-gel shift assays were utilized for kinetic characterization. The (+) denotes the presence of 
avidin in the preparation, whereas the (-) is devoid of avidin.  
 
 
 
fold faster than the ΔBC K1119Q RePC. For each of the constructs examined in the 
present study, the addition of 5 mM free biotin or biocytin enhances the rate 2-fold and 4-
fold, respectively, over the intrinsic rate of oxaloacetate decarboxylation. Biocytin is the 
product of biotin being covalently tethered to the ε-amino group of a free lysine. Addition 
of a 1000-fold molar excess of biotinylated-ReBCCP greatly enhances the rate of 
oxaloacetate decarboxylation, up to 110-fold in the case of ΔBCΔBCCP RePC. None of 
the RePC variants exhibit a rate enhancement for oxaloacetate decarboxylation in the 
presence of the non-biotinylated K1119Q ReBCCP (Figure 3-3). Further, addition of 
biocytin to the reaction mixture containing non-biotinylated K1119Q ReBCCP does not 
enhance the rate of oxaloacetate decarboxyation (Figure 3-3). Finally, when an essential 
arginine residue (Arg621) in the CT domain active site is mutated (R621A ΔBCΔBCCP 
RePC), the enzyme-catalyzed biotin-independent oxaloacetate decarboxylation activity is 
completely eliminated (Table 3-2), demonstrating that the enzyme activity is specific and 
originates in the CT domain active site.  
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Figure 3-3.  Representative raw traces of ΔBCΔBCCP RePC catalyzed decarboxylation of 
oxaloacetate.  
 
Oxaloacetate decarboxylation was measured for ΔBCΔBCCP RePC (green), ΔBCΔBCCP RePC + 
70 µM K1119Q ReBCCP (red), ΔBCΔBCCP RePC + 5 mM biocytin (black), ΔBCΔBCCP RePC 
+ 5 mM biocytin + 70 µM K1119Q ReBCCP (cyan), and ΔBCΔBCCP RePC + 70 µM ReBCCP 
(blue). Reactions were performed as described in section 2.8.3 of chapter 2. Each reaction was 
initiated by the addition of 270 µg ΔBCΔBCCP RePC. Data were normalized to an absorbance of 
1 for comparison purposes.  
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Table 3-2. MgATP-independent Pyruvate Carboxylationa and Oxaloacetate 
Decarboxylationb Activities for ΔBCΔBCCP RePC 
 
MgATP-independent pyruvate carboxylation kcat (min-1) 
ΔBCΔBCCP RePC + Tris-HCl 0.11 ± 0.03 
ΔBCΔBCCP RePC + Tricine-NaOH 0.14 ± 0.05 
 
oxaloacetate decarboxylation  
ΔBCΔBCCP RePC  0.57 ± 0.008 
ΔBCΔBCCP RePC + 1 mM EDTA 0.58 ± 0.01 
ΔBCΔBCCP RePC + 5 mM EDTA 0.53 ± 0.008 
R621A ΔBCΔBCCP RePCc 0.039 ± 0.006 
Bovine serum albumin 0.039 ± 0.009 
aMgATP-independent pyruvate carboxylation reaction conditions: 100 mM buffer as specified 
(pH 7.8), 30°C, 25 mM pyruvate, 50 mM NaHCO3, 0.24 mM NADH, and 350 – 700 µg 
ΔBCΔBCCP RePC. bOxaloacetate decarboxylation reaction conditions: 100 mM Tris-HCl (pH 
7.8), 30°C, 1 mM oxaloacetate, 0.24 mM NADH, and ~ 300 µg ΔBCΔBCCP RePC or BSA. 
Enzyme was incubated at room temperature for 10 minutes in EDTA prior to the addition of 
oxaloacetate. Specific activities were determined in triplicate and the reported errors are the 
standard deviations of the means. cThe specific activity measurement for the R621A mutant of 
ΔBCΔBCCP RePC was conducted by Yi Lin.   
 
 
 
 Given that ΔBCΔBCCP RePC decarboxylates oxaloacetate in the absence of 
biotin, it is expected that this construct can also catalyze the carboxylation of pyruvate. 
The pyruvate carboxylation activities for ΔBCΔBCCP RePC were 0.11 ± 0.03 min-1 and 
0.14 ± 0.05 min-1 in Tris-HCl and Tricine-NaOH, respectively, indicating that this is not a 
buffer-catalyzed reaction (Table 3-2). Pyruvate carboxylation was not observed when 
either the enzyme or pyruvate was omitted from the reaction mixture, demonstrating that 
the observed rates, while slow, are enzyme-catalyzed. Pyruvate carboxylation activity for 
ΔBCΔBCCP RePC was virtually unaffected by changes in pH from pH 6.5 to pH 8.5, 
suggesting that the rates are not simply a function of the dissolved CO2 concentration. 
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The MgATP-independent pyruvate carboxylation activity for wild-type RePC was 
determined to be 0.044 ± 0.001 min-1.  
3.2.2 Effects of Oxamate on the Oxaloacetate Decarboxylation Reaction 
 
 
 
Oxamate stimulates the PC-catalyzed rate of oxaloacetate decarboxylation (Attwood & 
Cleland, 1986a). Recently, Marlier and colleagues (Marlier et al., 2013) provided 13C-
NMR evidence demonstrating that oxamate accepts the carboxyl group from oxaloacetate 
and proposed that biotin facilitates the carboxyl group transfer between these substrates. 
However, the steady-state kinetics were inconsistent with a simple ping-pong mechanism, 
suggesting that biotin decarboxylation was occurring through two competing pathways at 
low concentrations of oxamate. Nevertheless, Marlier et al (Marlier et al., 2013) proposed 
that oxamate accelerates the oxaloacetate decarboxylation reaction by acting as a 
carboxyl group acceptor, thereby accelerating the decarboxylation of carboxybiotin. To 
clearly determine whether oxamate binds in the CT domain active site, ΔBCΔBCCP 
RePC was co-crystallized with oxamate. The structure reveals that the binding orientation 
for oxamate is identical to that observed for pyruvate (Figure 3-4). The carboxyl group of 
oxamate forms a salt bridge interaction with the guanidinium group of Arg621 while the 
carbonyl oxygen is within hydrogen bonding distance of the side chains of Arg548 and 
Gln552. The binding of oxamate in the active site promotes the interaction between 
Tyr628 and Asp590, which forms a biotin binding pocket in the active site (Chapter 4).   
To further investigate the reaction pathway for the oxamate-stimulated 
decarboxylation of oxaloacetate, the oxamate independent and dependent rates of 
oxaloacetate decarboxylation were measured for various engineered constructs of RePC 
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(Table 3-3). As observed previously (Marlier et al., 2013), the wild-type rate of 
oxaloacetate decarboxylation is enhanced 3-fold in the presence of 0.5 mM oxamate. A 
mutation at the site of biotinylation in RePC, K1119Q, eliminates the oxamate-dependent  
 
 
 
Figure 3-4. Representative simulated annealing omit maps for oxamate (A) and pyruvate 
(B) in the active site of ΔBCΔBCCP RePC. 
  
The electron density maps are contoured to 3.0 σ. Oxamate and pyruvate are colored green and 
yellow, respectively. 
 
 
 
Table 3-3. Oxaloacetate Decarboxylation Activities in the Presence and Absence of Oxamate 
for Pyruvate Carboxylase and Pyruvate Carboxylase Variants.a 
 
 0.2 mM oxaloacetate, kcat 
(min-1) 
+ 0.5 mM oxamate, kcat (min-1) 
RePC wt 1.29 ± 0.02 3.8 ± 0.2 
K1119Q RePC 0.83 ± 0.02 0.83 ± 0.03 
∆BC RePC 0.53 ± 0.01 10.2 ± 0.3 
K1119Q ∆BC RePC 0.33 ± 0.01 0.35 ± 0.03 
∆BC∆BCCP RePC 0.45 ± 0.01 0.38 ± 0.03   
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 30°C, 0.2 mM oxaloacetate, 0.25 mM acetyl-
CoA (RePC wt and K1119Q RePC only), 0.24 mM NADH. Specific activities were determined in 
triplicate and the reported errors are standard deviations of the means. Acetyl-CoA does not affect 
the catalytic rate of oxaloacetate decarboxylation when the BC domain is removed. 
	   73	  
rate enhancement for oxaloacetate decarboxylation. In the absence of the BC domain 
(ΔBC RePC), the decarboxylation of oxaloacetate is enhanced 20-fold in the presence of 
oxamate and there is no rate enhancement in the K1119Q mutation of ΔBC RePC. 
Truncating both the BC and BCCP domains also eliminates the oxamate-induced rate 
enhancement. These results are consistent with the proposal that oxamate binds in the CT 
domain and serves to accept the carboxyl group from carboxybiotin.  
Double reciprocal plots obtained at varying oxaloacetate concentrations and fixed 
concentrations of oxamate are consistent with a simple Ping Pong Bi Bi kinetic 
mechanism that is subject to double competitive substrate inhibition (Figure 3-5). Such a 
pattern is expected when both substrates form a dead-end complex with an inappropriate 
enzyme form (Segel, 1975).  
 
 
3.2.3 Biotin and Biocytin Binding in ΔBCΔBCCP RePC  
 
 
 
The ΔBCΔBCCP RePC was co-crystallized in the presence of pyruvate or oxamate and 
soaked with free 1’N-acetyl-d-biotin or biocytin prior to data collection. ΔBCΔBCCP 
RePC crystallizes in the space group P212121 with the four monomers of the asymmetric 
unit arranging as a tetramer (Chapter 4). Electron density corresponding to free biotin or 
biocytin was not observed in the active site of the CT domain. Instead, in both structures, 
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Figure 3-5. A double reciprocal plot of initial velocity versus substrate concentration for the 
ΔBC RePC catalyzed decarboxylation of oxaloacetate at fixed concentrations of oxamate 
(0.1 mM, circles; 0.3 mM, triangles; 1.0 mM, squares; 5.0 mM, diamonds).  
 
Solid lines are the calculated individual fits of the data to the reciprocal of [eq 1]. INSET: The 
initial velocity normalized for enzyme concentration (vi/[E]T) as a function of low concentrations 
of oxaloacetate. Unlike the full-length enzyme(Marlier et al., 2013), the curves do not display any 
sigmoidicity. The oxamate concentrations are designated in the same way as for the double 
reciprocal plot and the curve fits are calculated from eq 1. 
 
 
 
biotin or biocytin were both observed bound in the well characterized biotin exo-binding 
site, at the interface between the central spanning α-helix of the allosteric domain and the 
CT domain  (Jitrapakdee et al., 2008; Xiang & Tong, 2008). There is no evidence for 
acetylation at the 1’-N position of biotin in the electron density (Figure 3-6), suggesting 
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that the acetyl group was hydrolyzed. Consequently, the ligand in the exo binding site 
corresponds to the unmodified biotin. The observed electron density for the ureido ring of 
free biotin and biocytin is clearly defined in all four exo-binding sites of the asymmetric 
unit, with monomer A exhibiting the lowest B-values or temperature factors for both 
ligands (Figure 3-6).  
Electron density corresponding to biocytin is also observed in the funnel leading 
to the active site of the CT domain (Figures 3-7 and 3-8). However, the 1’-N of biocytin 
is displaced 15.9 Å away from the active site metal, ~7 Å from the biotin binding position 
observed in the active site of the Homo sapiens PC (pdb i.d. 3BG3) and S. aureus PC 
crystal structures (pdb i.d. 3BG5). Biocytin maintains contacts in a ridge leading to the 
entrance of the active site with its most significant interactions occurring with α-helix 10 
(Gly842 – Leu857) of the CT domain. Notably, the position of α-helix 10 has been 
shown to be perturbed when BCCP binds with the CT domain of PC (Xiang & Tong, 
2008). 
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Figure 3-6. Representative simulated annealing omit maps for biotin (A) and biocytin (B) in 
the exo-binding site of ΔBCΔBCCP RePC.  
 
The electron density maps are contoured to 3.0 σ. The allosteric and CT domains are colored 
magenta and cyan, respectively. 
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Figure 3-7. Free biocytin (magenta, CPK coloring), co-crystallized with pyruvate (orange, 
CPK coloring), is bound in the funnel of the carboxyltransferase (CT) domain (cyan) 
leading to the active site.  
 
The BCCP domain and biotin (green) are shown from a structural superposition of the CT domain 
of HsPC (pdb i.d. 3BG3). The interaction between the BCCP and CT domain results in the 
inward rotation of α-helix 10, which threads away from the active site (yellow). The binding of 
biocytin in the funnel does not induce this same rotation in α-helix 10. 
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Figure 3-8. Biocytin bound in the funnel leading to the active site of the carboxyltransferase 
domain.  
 
A. Representative simulated annealing omit map for biocytin contoured to 3.0 σ. B. Biocytin 
binds in a ridge outside the positively charged tunnel leading to the CT domain active site.  
 
 
 
3.3 Discussion  
 
 
 
3.3.1 Contribution of the BCCP Domain to the Biotin-catalyzed Carboxyl Transfer 
Reaction of PC  
 
 
 
All of the PC variants examined in the present study exhibited a clear rate enhancement 
for oxaloacetate decarboxylation in the presence of free biotin, biocytin and BCCP-
biotin. A similar biotin-dependent rate enhancement has been reported for Bacillus 
thermodenitrificans PC (Islam et al., 2005). The rate enhancement is dependent on the 
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degree to which the biotin side-chain mimics the biotinylated enzyme. Biotin, which has 
a valeric acid substituent extending from the tetrahydrothiophene ring, is least effective at 
enhancing the rate. From the crystal structures of BCCP-biotin bound in the CT domain 
active site of Homo sapiens PC (HsPC; pdb i.d. 3BG3) and Staphylococcus aureus PC 
(SaPC; pdb i.d. 3BG5) (Xiang & Tong, 2008), it is likely that the positioning of free 
biotin is impeded by a charge repulsion between the side chain of Asp590 (conserved in 
all PC enzymes) and the valeric acid carboxylate of biotin, making free biotin a less 
effective substrate compared to biocytin and ReBCCP-biotin. A similar trend has been 
observed in the E. coli carboxyltransferase subunit of acetyl CoA carboxylase, where 
biocytin results in a Vmax increase that is three orders of magnitude greater than biotin  
(Blanchard & Waldrop, 1998). In an apparently contradictory result, Adina-Zada et al 
(Adina-Zada et al., 2008) reported that free biotin did not enhance the rate of oxaloacetate 
decarboxylation in the K1112A mutant of Bacillus thermodenitrificans PC (equivalent to 
the K1119Q mutant in RePC). However, in those studies, oxaloacetate decarboxylation 
was assayed in the presence of oxamate, which proceeds through a chemical mechanism 
that requires a tethered biotin cofactor for activity (see below).  
The rate of oxaloacetate decarboxylation is enhanced 60- to 110-fold in the 
presence of the bona fide substrate, BCCP-biotin. In an earlier study, BCCP-biotin was 
also reported to be more effective than free biotin in enhancing the rate of oxaloacetate 
decarboxylation in PC from Bacillus thermodenitrificans (Islam et al., 2005). In E. coli 
carboxyltransferase, a 2000-fold increase over biotin was observed when the biotinylated 
C-terminal BCCP domain was used as a substrate in place of free biotin (Blanchard & 
Waldrop, 1998). The most likely interpretation of these data is that the BCCP-CT domain 
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interaction contributes significantly to the proper positioning of biotin in the active site. 
However, the crystal structures of HsPC (pdb i.d. 3BG3) and SaPC (pdb i.d. 3BG5) 
reveal a rotation in α-helix 10 of the CT domain that accompanies the BCCP-CT domain 
interaction (Xiang & Tong, 2008). The α-helix 10 extends into the CT active site, raising 
the possibility that the BCCP-CT domain interaction directly influences catalysis in the 
CT domain through alterations in α-helix 10. In the present study, the K1119Q BCCP 
domain, which lacks a tethered biotin, is unable to enhance oxaloacetate decarboxylation 
and addition of free biocytin does not rescue this activity. Together, these results indicate 
that the BCCP-CT domain interaction does not directly enhance catalysis and serves only 
to properly position the carboxybiotin cofactor in the active site.  
It is noteworthy that removing the BC domain from RePC reduces the rate of 
oxaloacetate decarboxylation to 40% that of full length RePC, irrespective of whether the 
enzyme is biotinylated (Table 3-3). In solution, RePC is a tetramer while ΔBC RePC is a 
dimer (Lietzan et al., 2011). The reduced activity observed in RePC enzymes lacking a 
BC domain suggests that either the BC domain itself or enzyme tetramerization 
influences the biotin-independent CT domain activity. The BC domain homodimer from 
E. coli acetyl CoA carboxylase has been shown to exhibit synergism amongst the dimer 
active sites (Mochalkin et al., 2008) but, to date, no direct evidence for communication 
between the BC and CT domains has been reported for any biotin-dependent enzyme. 
The current study reveals that the BC domain does influence the CT domain activity, 
even in the absence of a biotin cofactor. Therefore this study offers direct evidence for 
communication between the BC and CT domains in PC, even in the absence of a biotin 
cofactor.  
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3.3.2 Oxamate Induced Oxaloacetate Decarboxylation Proceeds Through a Simple Ping-
Pong Bi Bi Kinetic Mechanism  
 
 
 
Oxamate stimulates the rate of oxaloacetate decarboxylation in PC enzymes isolated from 
chicken liver and RePC. Recently, it was demonstrated that CO2 is transferred from 
oxaloacetate to oxamate, with biotin most likely serving as a conduit (Marlier et al., 
2013). However, the reported initial velocity kinetics displayed sigmoidicity, suggesting 
an alternate route of decarboxylation for carboxybiotin and leaving some aspects of the 
mechanism unresolved.  
 There are several lines of evidence that strongly support a ping-pong mechanism 
for the oxamate-induced oxaloacetate decarboxylation reaction. The structure of RePC 
co-crystallized with oxamate clearly shows oxamate bound in the pyruvate binding site 
(Figure 3-4). Furthermore, the active site is observed in a closed conformation that is 
correlated with ligand binding in the CT domain active site (Chapter 4). The structure, 
therefore, is consistent with oxamate serving as the terminal carboxyl group acceptor in a 
ping pong-like reaction mechanism, as proposed by Marlier et al (Marlier et al., 2013). 
Furthermore, the RePC constructs in the current study display kinetic features that are 
fully consistent with a biotin-dependent CO2 transfer from oxaloacetate to oxamate: in all 
constructs where the site of biotinylation is mutated (K1119Q) or the BCCP domain is 
absent, oxamate no longer accelerates the rate of oxaloacetate decarboxylation. Finally, in 
the presence of a tethered biotin cofactor, the steady-state kinetics are fully consistent 
with a ping-pong mechanism with double competitive substrate inhibition, indicating that 
both pyruvate and oxamate share the same binding site (Figure 3-5). 
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Marlier et al observed that carboxybiotin can decarboxylate through an alternate 
pathway in RePC (Marlier et al., 2013). The most likely alternative route for 
decarboxylation of carboxybiotin in the wild-type enzyme is through enzyme-mediated 
decarboxylation in the BC domain active site (Attwood & Wallace, 1986). In the current 
study, therefore, oxamate induced decarboxylation kinetics were measured in ΔBC RePC, 
where decarboxylation in the BC domain is not a possibility. The double reciprocal plot 
of velocity against oxaloacetate for ΔBC RePC, at fixed concentrations of oxamate, show 
a pattern that is consistent with a simple ping pong bi bi mechanism with double 
competitive substrate inhibition (Figure 3-5). Unlike with wild-type RePC, no 
sigmoidicity is observed in the velocity vs. [S] plots of ΔBC RePC, indicating that no 
alternate pathway for carboxybiotin decarboxylation is present in ΔBC RePC (Figure 3-
5). Based on these results, the two pathways suggested by Marlier et al (Marlier et al., 
2013) for carboxybiotin decarboxylation in the wild-type enzyme are clarified. Following 
CO2 transfer from oxaloacetate to biotin in the wild-type enzyme, carboxybiotin has two 
possible fates (Figure 3-9): (1) Pyruvate exits the active site, allowing oxamate to bind 
and accept CO2 from carboxybiotin or (2) carboxybiotin translocates to the BC domain 
where it decarboxylates without forming the carbamylated oxamate. This second pathway 
for carboxybiotin decarboxylation explains the sigmoidicity observed by Marlier et al in 
the wild-type RePC kinetics (Marlier et al., 2013). 
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Figure 3-9. Kinetic scheme for the interaction of oxamate with PC in the oxaloacetate 
decarboxylation reaction.   
 
Abreviations are as follows: E, free enzyme; Ox, oxamate; OAA, oxaloacetate; E-CO2, 
carboxylated enzyme; Pyr, pyruvate; kdecarbox, spontaneous enzyme decarboxylation; KiB, 
inhibition constant for oxamate; KiA inhibition constant for oxaloacetate.  
 
 
 
Marlier et al (Marlier et al., 2013) demonstrated directly that oxamate accepts the 
carboxyl group from oxaloacetate, whereas the present crystal structure demonstrates that 
oxamate occupies the same binding site as pyruvate and β-hydroxypyruvate (a mimic of 
oxalocatete (Chapter 5); there is no crystal structure of PC with OAA bound). 
Eliminating tethered biotin (K1119C ΔBC) or the carrier domain altogheter 
(ΔBCΔBCCP) results in a complete loss of the oxamate acceleration (Table 3-3) 
indicating that biotin is required to shuttle the carboxyl group between the two substrates, 
and the double reciprocal kinetic pattern (Figure 3-5) combine to provide very strong 
support for a ping-pong reaction mechanism. 
3.3.3 The Biotin Exo-binding Site and a Putative Path for Biotin Insertion into the CT 
Domain Active Site  
 
 
 
Both free biotin and biocytin enhance the rate of oxaloacetate decarboxylation in the CT 
domain of RePC, with biocytin enhancing the rate 2-fold compared to biotin. In order to 
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better describe the origins of these rate enhancements, ΔBCΔBCCP RePC was co-
crystallized with either pyruvate or oxamate and soaked with free biotin or biocytin prior 
to data collection. While biotin and biocytin were not observed in the active site, these 
structures provided some interesting observations.  
Electron density corresponding to both biotin and biocytin was observed in the 
exo-binding site. Several prior structures have revealed that the biotin cofactor, when 
tethered to the BCCP domain, binds at this exo site located at the interface of the 
allosteric and CT domains  (Jitrapakdee et al., 2008; Xiang & Tong, 2008). The 
functional role of the exo-binding site remains unclear and our kinetic data cannot rule 
out the possibility that free biotin and biocytin enhance the rate of oxaloacetate 
decarboxylation by binding in the exo-binding site. However, free biotin binds directly in 
the 5S subunit of transcarboxylase, which is homologous with the CT domain of PC  
(Bhat & Berger, 2008). It is, therefore, likely that free biotin and biocytin directly access 
the active site in solution, despite the fact that they are not observed in the CT domain 
active site in the crystal structures. It is notable that electron density corresponding to 
biotin was not observed in the exo-binding site when ΔBCΔBCCP RePC was crystallized 
in the absence of biotin or biocytin (Chapter 4). 
While the function of the exo-binding site is unknown, an intriguing hypothesis is 
that this site, which appears to be unique to bacterial PC enzymes (Xiang & Tong, 2008), 
serves to increase the local concentration of free biotin. The binding of free biotin in the 
exo-binding site may promote the biotinylation of the BCCP domain by biotin protein 
ligase, affording a degree of posttranslational control to the enzyme.     
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Electron density corresponding to biocytin was also observed in the funnel 
leading into the CT domain active site (Figure 3-8). The funnel exhibits a largely positive 
surface charge distribution. While I cannot rule out that this additional binding position is 
simply an artifact of crystallization, the apparent affinity of the cofactor for this site 
suggests that the funnel may assist in directing the negatively charged carboxybiotin into 
the active site. Therefore, this structure may represent a snapshot of the path traversed by 
carboxybiotin as it gains access to the active site. 
3.3.4 A Biotin-independent Mechanism for Oxaloacetate Decarboxylation  
 
 
 
This study clearly and unambiguously demonstrates that biotin is not required for 
oxaloacetate decarboxylation by PC. All of the engineered RePC variants that lack a 
tethered biotin (K1119Q RePC, K1119Q ΔBC RePC and ΔBCΔBCCP RePC) retained 
oxaloacetate decarboxylation activity (Table 3-1). At 1 mM oxaloacetate, the biotin-
independent rate of oxaloacetate decarboxylation is ~85% of the biotin-dependent rate, 
similar to previous reports (Attwood & Cleland, 1986a; Duangpan et al., 2010). 
 To this point, there have been mixed reports regarding the absolute requirement 
for biotin on the oxaloacetate decarboxylation reaction in PC. A biotin-independent 
oxaloacetate decarboxylation activity was first described for chicken liver PC following 
incubation with avidin (Scrutton & Mildvan, 1968). This finding was corroborated by the 
report of a concentration dependent biotin-independent rate of oxaloacetate 
decarboxylation for chicken liver PC incubated with avidin (Attwood & Cleland, 1986a) 
and has also been observed in B. thermodenitrificans PC in the absence of a BCCP 
domain (Islam et al., 2005). However, mutations at the site of biotinylation in both B. 
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thermodenitrificans PC and RePC completely eliminated the oxamate-induced 
oxaloacetate decarboxylation activity, leading to the contradictory claim that biotin is 
required for oxaloacetate decarboxylation in PC (Adina-Zada et al., 2008; Zeczycki et al., 
2009). To address this discrepancy, the oxamate independent rate of oxaloacetate 
decarboxylation by RePC was measured under assay conditions identical to those 
previously reported (Adina-Zada et al., 2008) (Figure 3-10). The results unequivocally 
show a biotin-independent oxaloacetate decarboxylation activity for the K1119Q and 
ΔBCΔBCCP RePC mutant in the absence of oxamate. The oxaloacetate decarboxylation 
activity of ΔBCΔBCCP RePC is completely eliminated by the R621A mutation (Table 3-
2). Further, it was demonstrated that incubating the CT domain in the presence of EDTA 
does not eliminate the enzyme-catalyzed oxaloacetate decarboxylation activity (Table 3-
2). These results collectively demonstrate that the reaction is catalyzed in the CT domain 
active site.  
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Figure 3-10. Representative raw traces for the K1119Q RePC catalyzed decarboxylation of 
oxaloacetate in the presence and absence of biotin and oxamate.  
 
The enzyme-independent rate of oxaloacetate decarboxylation was followed for 3 minutes prior 
to the addition of 340 µg K1119Q RePC. Reaction conditions were identical to those reported 
previously (Adina-Zada et al. (2008) Int. J. Biochem. Cell Biol. 40, 1743-1752). Data were 
normalized to an absorbance of 1 for comparison purposes. 
 
 
 
I attribute the inconsistent reports of biotin-independent oxaloacetate 
decarboxylation in PC to the inclusion of oxamate in certain studies. While oxamate 
accelerates the biotin-dependent rate of oxaloacetate decarboxylation by serving as the 
carboxyl group acceptor from carboxybiotin (Marlier et al., 2013), it does not participate 
in the biotin independent oxaloacetate decarboxylation. Oxamate occupies an identical 
binding site as pyruvate in the active site (Figure 3-4) and, at high concentrations, 
competes with oxaloacetate (Figure 3-5). Therefore, the addition of oxamate to biotin-
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deficient mutants (e.g. K1119Q) competes with oxaloacetate for the enzyme active site 
and reduces the reaction rate, leading investigators to report that PC is unable to catalyze 
oxaloacetate decarboxylation in the absence of biotin.  
The biotin-independent oxaloacetate decarboxylation is expected to proceed via a 
similar mechanism to that proposed for the biotin-dependent decarboxylation reaction, 
where a concerted proton transfer between oxaloacetate and biotin facilitates carboxyl 
transfer (Zeczycki et al., 2009). When biotin is not present, another substrate must serve 
as the proton donor and, subsequently, serve as the nucleophile to attack the liberated 
CO2. Two possible candidates may serve as proton donors in the absence of biotin: the 
reaction buffer or water. The buffer is an unlikely candidate considering that current and 
previous studies have observed a biotin-independent decarboxylation rate in a variety of 
buffers, including potassium phosphate (Scrutton & Mildvan, 1968), Tricine (Attwood & 
Cleland, 1986a), Tris-HCl (Duangpan et al., 2010; Islam et al., 2005) and 4-(2-
hydroxyethyl)-1-piperazinepropansulfonic acid (EPPS). Given that the biotin-
independent reaction proceeds in a variety of distinct buffer systems, the more likely 
proton donor is water (Figure 3-11).  
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Figure 3-11. Proposed chemical mechanism for the biotin-independent decarboxylation of 
oxaloacetate in the CT domain.  
 
 
 
The crystal structure of ΔBCΔBCCP RePC with pyruvate (pdb i.d. 4JX5) contains several 
ordered water molecules in the active site (Figure 3-12).  
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Figure 3-12. The active site of the CT domain from RePC contains multiple ordered water 
molecules, which may contribute to the biotin-independent decarboxylation of oxaloacetate 
reaction 
 
A. Stereo view of representative electron density for ΔBCΔBCCP RePC co-crystallized with 
pyruvate. The 2Fo-Fc electron density map is contoured to 1.0 σ and is represented as grey mesh. 
The modeled atoms correspond to the final submitted coordinates. B. Biotin (green) was modeled 
in the CT domain active site from the HsPC X-ray crystal structure (pdb i.d. 3BG3). The 
positioning of the N1 position of biotin is near equivalent to a H2O molecule. 
 
 
 
Of particular interest is a water molecule occupying a site 2.9 Å from Thr882, at a 
location near to that occupied by the 1’-N of tethered biotin in the crystal structure of 
HsPC and SaPC (Xiang & Tong, 2008). Similar to the ureido oxygen of biotin, this water 
molecule forms a hydrogen-bonding network with the side chain of Ser885 (3.0 Å), the 
backbone amide of Thr882 (2.9 Å) and a second water molecule (2.5 Å). The pKa of 
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water (15.7) is less than the pKa for the 1’-N of biotin (~17; Fry et al., 1985), making it an 
equivalent proton donor, provided that the hydrogen-bonding network in the active site 
can stabilize the hydroxide ion in a similar manner to the biotin enolate. The stabilized 
hydroxide will subsequently react with the liberated CO2 to form bicarbonate, completing 
the reaction cycle. A similar biotin-independent mechanism has been proposed for the 
non-homologous oxaloacetate decarboxylase PA4872 from Pseudomonas putida, where a 
water molecule is thought to serve as the acid that donates a proton to the pyruvate 
enolate (Narayanan et al., 2008). 
The biotin-independent mechanism proposed in Figure 3-11predicts that the 
isolated CT domain (ΔBCΔBCCP RePC) will catalyze the formation of oxaloacetate from 
pyruvate and bicarbonate. Indeed, ΔBCΔBCCP RePC catalyzes the carboxylation of 
pyruvate at a reduced rate (kcat ~ 0.1 min-1) in the absence of biotin and in the presence of 
bicarbonate and pyruvate. While this is 3-4 orders of magnitude slower than the pyruvate 
carboxylation reaction catalyzed by wild-type RePC in the presence of ATP and HCO3-, 
the activity is consistent with water serving as a proton donor in the biotin-independent 
oxaloacetate decarboxylation reaction and reveals that the CT domain active site of PC 
can independently fix CO2, albeit at a very slow rate.   
It is clear from this study that the rate enhancement observed for the biotin-
dependent decarboxylation of oxaloacetate results from oxamate serving as a carboxyl 
group acceptor and that, in the absence of biotin and oxamate, the CT domain retains 
oxaloacetate decarboxylation activity. This establishes oxaloacetate decarboxylation 
assays in the presence and absence of oxamate as an effective means to dissect the role of 
biotin in the PC-catalyzed reaction. Such assays will be useful in investigating specific 
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residues in substrate binding and enolate stabilization in the CT domain reaction of PC 
presented in the next chapter. It is anticipated that investigations of the homologous 
biotin-dependent enzymes, transcarboxylase and the oxaloacetate decarboxylase 
complex, will also substantially benefit from the application of these assays. 
Interestingly, the rate of oxaloacetate decarboxylation in the isolated α-subunit of the 
oxaloacetate decarboxylase complex is approximately 20-fold higher than it is in the 
equivalent ΔBC construct of RePC (Di Berardino & Dimroth, 1995). This suggests that, 
while all three homologous biotin-dependent enzymes are structured to stabilize the 
pyruvate and biotin enolate intermediates, the oxaloacetate decarboxylase complex is 
predisposed to catalyze the decarboxylation reaction. A description of the molecular basis 
for these distinct differences between homologous enzymes awaits further structural and 
kinetic studies. 
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CHAPTER 4: A SUBSTRATE-INDUCED BIOTIN BINDING POCKET IN THE 
CARBOXYLTRANSFERASE DOMAIN OF PYRUVATE CARBOXYLASE 
 
 
 
4.1 Introduction 
 
 
 
The recent X-ray crystal structures of RePC and SaPC have allowed for structure-guided 
studies that have considerably advanced the characterization of the chemical mechanism 
for the CT domain reaction (Zeczycki et al., 2009). For example, in the CT domain of 
Rhizobium etli PC (RePC), Thr882 acts to shuttle a proton from the biotin enolate to 
pyruvate (Zeczycki et al., 2009) while Arg548, Gln552 and Arg621 serve to stabilize the 
pyruvate enolate (Duangpan et al., 2010; Xiang & Tong, 2008; Yu et al., 2009) (Figure 1-
10). Furthermore, there is ample kinetic evidence suggesting that the spatially distinct 
reactions in the BC and CT domains are remarkably well coordinated (Zeczycki et al., 
2011). However, the molecular basis for this coordination remains largely unknown. The 
inability to recognize the necessary molecular mechanisms required for catalysis in PC 
stems, in large part, from an absence of directly comparable structures and complex 
enzyme kinetics associated with multifunctional enzymes. As discussed in chapter 3, the 
difficulties associated with studying the role of biotin and the kinetic contributions of the 
CT domain to the overall reaction have been reduced with a more thorough description of 
the oxamate-induced decarboxylation reaction and structure-based protein engineering. 
Recently, I reported structures of RePC suggesting that BCCP-biotin is precluded 
from the BC domain active site following carboxylation (Lietzan et al., 2011). This 
protects against the abortive decarboxylation of carboxybiotin in the BC domain that 
would result in an energetically wasteful decoupling of ATP hydrolysis from pyruvate 
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carboxylation (Zeczycki et al., 2011). Whereas a mechanism to protect against abortive 
decarboxylation has been proposed for the BC domain, it is not yet clear whether a 
related mechanism exists in the CT domain. Interestingly, PC-carboxybiotin is quite 
stable in the absence of substrates, but several competitive inhibitors of pyruvate are 
sufficient to invoke the translocation and decarboxylation of N-[14C]carboxybiotin in the 
CT domain (Goodall et al., 1981). These experiments, along with kinetic data presented 
in chapter 3, imply that 1) carboxybiotin can rapidly decarboxylate in the CT domain, 
even in the absence of the bona fide acceptor substrate, and 2) that a CT domain ligand is 
required to facilitate biotin access to the CT domain active site. It is clear from structural 
studies (Xiang & Tong, 2008) and kinetic isotope effects (Attwood et al., 1986) that PC 
catalyzes biotin decarboxylation in the CT domain without direct transfer of the carboxyl 
group from biotin to pyruvate. However, existing structural models are unable to explain 
how the CT domain ligand facilitates biotin access and decarboxylation.  
The present chapter describes a series of directly comparable structures and 
accompanying kinetic studies that reveal a substrate-induced biotin binding pocket in the 
CT domain of RePC. The active site of the CT domain undergoes a conformational 
change upon pyruvate binding. This conformational rearrangement, which is stabilized by 
the interaction of conserved Asp590 and Tyr628 in RePC, results in formation of the 
biotin-binding pocket. Due to the conserved nature of both Asp590 and Tyr628 and 
similar active site architecture in homologous biotin-dependent enzymes, I hypothesize 
that the structural mechanism described here for PC is applicable to the broader family of 
biotin-dependent enzymes.   
4.2 Results 
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4.2.1 Active Site Remodeling in the Carboxyltransferase Domain During Substrate 
Binding 
 
 
 
A small number of PC structures have been reported (Lietzan et al., 2011; St. Maurice et 
al., 2007; Xiang & Tong, 2008; Yu et al., 2009), but direct comparisons between these 
structures have been complicated by differences in the source organism and in the set of 
bound ligands. To date, there are no directly comparable structures of the CT domain of 
PC in the presence and absence of pyruvate. After screening several engineered 
constructs of RePC, it was determined that removing both the BC and BCCP domains 
(ΔBCΔBCCP RePC) rendered the enzyme more amenable to crystallization. The relative 
ease of crystallization afforded a unique opportunity to directly investigate the structural 
perturbations accompanying substrate binding in the CT domain of PC. Consequently, 
ΔBCΔBCCP RePC was crystallized with and without the bona fide substrate, pyruvate. 
The protein crystallized in the space group P212121 under all co-crystallization conditions 
reported in this dissertation. The unit cell contains four monomers of ΔBCΔBCCP RePC, 
arranged as a dimer of dimers. In all structures, one homodimer is comprised of chains A 
and C, while the second homodimer is comprised of chains B and D. All four monomers 
of ΔBCΔBCCP RePC include a pyruvate molecule bound in the active site when co-
crystallized with pyruvate. Representative electron density for chain A is presented in 
Figure 4-1A. 
The CT domain architecture consists of a canonical α8β8 TIM barrel fold with a 
large C-terminal funnel, comprised of nine α-helices, that leads into the active site at the 
mouth of the barrel. The active site is centered on a structurally conserved Lewis acid 
metal. Mutation of several conserved, metal-coordinating residues results in a loss of 
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enzymatic activity in PC (Yong-Biao et al., 2004). PC enzymes from vertebrates 
predominantly bind Mn2+, while yeast and bacteria prefer Zn2+ (Attwood, 1995). 
However, X-ray fluorescence analysis of the ΔBCΔBCCP RePC crystals indicates the 
presence of both Mn2+ and Zn2+ (Figure 4-2), suggesting that RePC may be partially 
indiscriminate in its metal ion preference. Given that this may be an artifact of expression  
 
Figure 4-1. Substrate binding leads to active site remodeling in the carboxyltransferase 
(CT) domain of RePC.  
 
A. Stereo view of representative electron density for the active site of ΔBCΔBCCP RePC co-
crystallized with pyruvate. The 2Fo-Fc electron density map is contoured to 1.0 σ and is 
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represented as a grey mesh. The Fo-Fc omit density map is contoured to 3.0 σ and is represented 
as a green mesh. The representative electron density is for monomer A. Electron density is not 
averaged. The modeled atoms correspond to the final submitted coordinates. B. Stereo view of 
the active site from the CT domain upon pyruvate binding. The positioning of the orange loop is 
from the X-ray crystal structure devoid of pyruvate. Pyruvate is colored green and the residues 
labeled in red were selected for mutagenesis and kinetic analysis. The multiple conformations for 
Arg621 were modeled from RePC wild-type (pdb i.d. 2QF7). C. Structural alignment of the 
pyruvate-bound ΔBCΔBCCP RePC with the HsPC crystal structure (pdb i.d. 3BG3; monomer B; 
root-mean-square (r.m.s.) deviation = 1.3 Å) reveals the expected positioning of biotin in the CT 
domain active site of RePC. In the closed conformation, Asp590 and Tyr628 form a surface to 
assist with biotin insertion into the active site. 
 
 
 
 
Figure 4-2. X-ray fluorescence spectrum for Zn, Mn, and Fe in the crystals of ΔBCΔBCCP 
RePC.  
 
X-ray fluorescence spectra for (A) Zn, (B) Mn, and (C) Fe were collected on a Bruker-AXS 
XFlash 1001 SSD at the APS beamline 21-ID-D. 
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and purification from a heterologous host, further analyses of RePC purified from source 
are needed to unequivocally establish the physiological metal preference.  
The structures in the presence and absence of pyruvate enable, for the first time, 
an analysis of conformational changes that accompany substrate binding in the CT 
domain of PC. The most pronounced difference between the structures determined in the 
presence and absence of pyruvate lies within a flexible loop (Arg621 − Asn630), which 
forms a portion of the CT domain active site. In the absence of substrate, the loop 
occupies an open conformation. The side chain of Tyr628 is oriented away from the 
metal center and the guanidinium group of Arg621 is disordered (Figure 4-1B; orange). 
This disordered side-chain is consistent with multiple conformations observed for Arg621 
in the higher resolution (2.0 Å) apo structure of RePC (St. Maurice et al., 2007). When 
pyruvate is bound, the active site loop adopts a closed conformation over the pyruvate 
binding site (Figure 4-1B; cyan). The loop movement coincides with the formation of a 
salt bridge between the carboxyl moiety of pyruvate and the guanidinium group of 
Arg621. Mutation of the equivalent residue to Arg621 in Staphylococcus aureus PC 
(SaPC) resulted in a nearly complete loss of PC enzyme activity, indicating an important 
role for this residue in catalysis (Yu et al., 2009). The guanidinium group of Arg621 is 
within hydrogen bonding distance to the backbone carbonyl oxygen of Val626 and 
Gly627 on the active site loop. These interactions are likely to stabilize the closed 
conformation of the loop. In the closed conformation, the tyrosyl moiety of Tyr628 
rotates inward towards the active site, bringing it within hydrogen bonding distance of the 
carboxyl group from Asp590 that is located opposite the active site cleft. The positioning 
of Asp590 appears to be aided by the guanidinium side-chain of Arg594, which is located 
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within 2.5 Å of the carboxyl group of Asp590. Based on an overlay with the X-ray crystal 
structure of pyruvate-bound Homo sapiens PC (HsPC), tethered biotin binds in the active 
site with its thiophene ring positioned directly above the aromatic ring of Tyr628 (Figure 
4-1C).  
4.2.2 Steady State Kinetic Analysis of Asp590 and Tyr628 Mutations 
 
 
 
Structures of the RePC CT domain suggest an important contribution from Asp590 and 
Tyr628 to catalysis. Both amino acid residues are conserved in all PC enzymes and in the 
CT domain of the homologous biotin-dependent enzymes, oxaloacetate decarboxylase 
complex (ODC) and transcarboxylase (Figure 4-3). Furthermore, these two amino acids 
are not conserved in the DRE-TIM metallolyase superfamily suggesting that these 
residues may play a specific role in the biotin-dependence of the reaction. Members of 
the DRE-TIM metallolyase superfamily share a TIM-barrel fold, a D-R-E active site 
motif, rely on a divalent cation for activity and are hypothesized to stabilize an enolate 
intermediate using the conserved arginine in the DRE motif (Casey, Hicks, Johnson, 
Babbitt, & Frantom, 2014; Gerlt & Babbitt, 2001).   
To determine the role of Asp590 and Tyr628 in the carboxylation of pyruvate, 
Y628F, Y628A and D590A mutations were generated in RePC by site-directed 
mutagenesis and the modified enzymes were assessed for their catalytic activity. The Km 
for pyruvate, kcat and kcat/Km were determined for wild-type and the mutant forms of 
RePC. For the overall reaction, starting from HCO3-, MgATP, and pyruvate, all three 
mutations resulted in a pronounced effect on the Km for pyruvate, kcat and kcat/Km for 
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Figure 4-3. Amino acid conservation between pyruvate carboxylase, 5S subunit of 
transcarboxylase and the oxaloacetate decarboxylase complex.  
 
Both Asp590 (green) and Tyr628 (red) from RePC are strictly conserved in the biotin-dependent 
enzymes, the oxaloacetate decarboxylase complex and transcarboxylase. 
 
 
  
pyruvate carboxylation (Table 4-1). Removing the hydroxyl moiety from Tyr628 
(Y628F) resulted in a 7-fold reduction in kcat while the Y628A mutation resulted in a 780-
fold reduction in kcat. The Tyr628 mutations also resulted in a sizable increase in the Km 
for pyruvate, which contributed to the ~80-fold and ~20 000-fold decrease in catalytic 
efficiency for Y628F and Y628A, respectively. Mutating Asp590 to Ala resulted in a 6-
fold increase in Km for pyruvate, and a 350-fold decrease in kcat/Km         
Although these mutations are located within the CT domain and disrupt the ability 
of the enzyme to carboxylate pyruvate, previous studies suggest that mutations in the CT 
domain can influence the rate of reactions in the neighboring BC domain (Zeczycki et al., 
2009). To evaluate the effects of these mutations on the BC domain activity, the specific 
activities for the phosphorylation of MgADP using carbamoyl phosphate as the 
phosphoryl donor were determined (Table 4-2). All mutations resulted in only a minor 
reduction in the ability of the BC domain to phosphorylate MgADP at saturating 
substrate concentrations. 
The preceding results indicate that the catalytic role of both Asp590 and Tyr628 is 
exclusive to the CT domain reaction. To date, kinetic investigations of PC have 
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demonstrated a significant effect of free biotin in the BC domain reaction (Adina-Zada et 
al., 2012; Zeczycki et al., 2011; Zeczycki et al., 2011) and only recent kinetic data clearly 
demonstrate a biotin-dependence in the CT domain reaction (Chapter 3). To further 
investigate the role of Asp590 and Tyr628 in the CT domain reaction, the biotin-
dependent and biotin-independent rates of oxaloacetate decarboxylation in the wild-type 
and mutant forms of  
 
Table 4-1: Catalytic Activities of Full-length RePC Mutants Compared to wild-type for the 
Pyruvate Carboxylation Reactiona 
 
 kcat (min-1)b % wild-type 
kcat 
Km pyruvate 
(mM) 
kcat/Km  (min-1 
mM-1) 
% wild-type       
kcat/ Km 
wild-type 2960 ± 50 (100) 0.29 ± 0.02 10200 ± 720 (100) 
Y628F 443 ± 7 15 3.52 ± 0.2 126 ± 7 1 
Y628A 3.81 ± 0.08 0.1 7.71 ± 0.5 0.5 ± 0.03 0.005 
D590A 53.5 ± 0.7 2 1.86 ± 0.09 29 ± 1  0.3 
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 25 °C, 25 mM NaHCO3-, 7 mM MgCl2, 2.5 
mM MgATP, 0.25 mM acetyl CoA, pyruvate (0 − 50 mM). bErrors reported are the standard 
errors from the non-linear regression fit of the data to the Michaelis-Menten equation.  
 
 
 
Table 4-2: Catalytic Activities of Full-length RePC Mutants Compared to wild-type for the 
ADP Phosphorylation Using Carbamoyl Phosphate Reactiona  
 
 kcat (min-1)b % wild-type 
wild-type 11.5 ± 0.3 (100) 
Y628F 9.5 ± 0.1 83 
Y628A 8.8 ± 0.2 77 
D590A 8.2 ± 0.06 71 
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 25 °C, 7 mM MgCl2, 3.5 mM MgADP, 0.25 
mM acetyl CoA, 20 mM carbamoyl phosphate. bSpecific activities were determined in triplicate 
and the error reported is the standard deviation of the three determinations.  
 
 
 
ΔBCΔBCCP RePC were measured. The biotin-dependent decarboxylation of 
oxaloacetate involves a carboxyl transfer from oxaloacetate to biotin, thus forming 
carboxybiotin (Attwood et al., 1986; Zeczycki et al., 2009). However, PC also catalyzes 
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the decarboxylation of oxaloacetate in the absence of biotin (Attwood & Cleland, 1986b; 
Duangpan et al., 2010). As described in chapter 3, the truncation of the BC and BCCP 
domains from RePC generates a unique and simplified system to investigate the effect of 
free biotin on the rate of oxaloacetate decarboxylation. 
At 1 mM oxaloacetate, each ΔBCΔBCCP RePC mutation had a modest effect on 
the biotin-independent rate of oxaloacetate decarboxylation (Table 4-3). The Y628A 
ΔBCΔBCCP RePC mutation represented the largest difference relative to wild-type. The 
biotin-dependent decarboxylation of oxaloacetate was measured by supplementing the 
reaction with biocytin and biotin. The wild-type ΔBCΔBCCP RePC rate of oxaloacetate 
decarboxylation increased by 5.6-fold and 1.9-fold in the presence of 5 mM biocytin and 
5 mM biotin, respectively (Table 4-3). Notably, this biocytin-dependent rate 
enhancement is completely lost in the Tyr628 and Asp590 mutations of ΔBCΔBCCP 
RePC. Only the D590A ΔBCΔBCCP RePC exhibited a rate enhancement (3.1-fold) in the 
presence of 5 mM biotin, likely because the mutation eliminated the charge repulsion 
between Asp590 and the carboxylate moiety of free biotin. These results unequivocally 
demonstrate that Asp590 and Tyr628 are required to accommodate the binding of biotin 
in the CT domain active site.   
Oxaloacetate decarboxylation was also assayed for the wild-type and mutant 
forms of full-length RePC in the presence and absence of oxamate (Table 4-4). Oxamate, 
a structural analog of pyruvate, serves as a carboxyl acceptor from carboxybiotin in the 
CT domain; in the presence of oxamate, the decarboxylation of oxaloacetate proceeds 
through a double-displacement reaction mechanism with biotin acting to shuttle CO2 
from oxaloacetate to oxamate (Marlier et al., 2013). Wild-type RePC exhibits a kcat of 
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1.23 min-1 and 1.29 min-1 for the decarboxylation of oxaloacetate when assayed at 1 mM 
and 0.2 mM oxaloacetate, respectively. At higher concentrations of oxaloacetate, the 
reaction is subject to substrate inhibition in the presence of oxamate. Therefore, the 
oxamate-induced decarboxylation of oxaloacetate was measured at 0.2 mM oxaloacetate. 
In the presence of 0.5 mM oxamate, the rate of oxaloacetate 
Table 4-3: Biotin and Biocytin-dependent Oxaloacetate Decarboxylation Activities for Site-
directed Mutants of ΔBCΔBCCP RePC Compared to wild-type ΔBCΔBCCP RePCa  
 
 1 mM 
oxaloacetate 
(+) 5 mM biotin (+) 5 mM biocytin 
 kcat (min-1)b kcat (min-1) kcat(+ biotin)/ 
kcat(- biotin) 
kcat (min-1) kcat(+ 
biocytin)/  
kcat(- biocytin) 
wild-type CT 0.46 ± 0.007 0.88 ± 0.01 1.9 2.56 ± 0.006 5.6 
Y628F 0.38 ± 0.002 0.43 ± 0.01 1.1 0.41 ± 0.007 1.1 
Y628A 0.33 ± 0.03 0.35 ± 0.006 1.1 0.36 ± 0.006 1.1 
D590A 0.38 ± 0.01 1.16 ± 0.01 3.1 0.40 ± 0.006 1.1 
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 30 °C, 1 mM oxaloacetate, 0.24 mM NADH. 
bSpecific activities were determined in triplicate and the error reported is the standard deviation of 
the three determinations.  
 
 
 
Table 4-4: Catalytic Activities of Site-directed Mutants of Full-length RePC Compared to 
wild-type for the Oxamate-induced Decarboxylation of Oxaloacetatea 
 
 1 mM 
oxaloacetate 
0.2 mM 
oxaloacetate 
0.2 mM oxaloacetate  
+ 0.5 mM oxamate 
 kcat (min-1)b kcat (min-1) kcat (min-1) kcat (+ oxamate)/ 
kcat (- oxamate) 
wild-type 1.23 ± 0.006 1.29 ± 0.02 3.81 ± 0.2 3.0 
Y628F 0.97 ± 0.05 0.87 ± 0.006 0.99 ± 0.03 1.1 
Y628A 0.79 ± 0.04 0.50 ± 0.01 0.49 ± 0 1.0 
D590A 0.92 ± 0.02 0.85 ± 0.006 0.91 ± 0.02 1.1 
aReaction conditions: 100 mM Tris-HCl (pH 7.8), 30 °C, 0.2 and 1 mM oxaloacetate, 0.5 mM 
oxamate, 0.25 mM acetyl-CoA. bSpecific activities were determined in triplicate and the error 
reported is the standard deviation of the three determinations. 
 
 
 
decarboxylation is enhanced 3-fold for wild-type RePC. However, this rate enhancement 
is lost in the Tyr628 and Asp590 mutants. These results provide additional evidence that 
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Tyr628 and Asp590 are critical for the biotin dependence of RePC. The combined kinetic 
data is fully consistent with the proposed model: substrate binding in the CT domain 
initiates the closure of the active site loop (Arg621 − Asn630), which is necessary for the 
formation of the biotin binding pocket through the conserved interaction between Tyr628 
and Asp590. To ensure that the observed changes in steady state kinetics are the direct 
result of the mutations and not the absence of biotin, all forms of RePC utilized in these 
kinetic investigations were assayed for biotinylation and were found to be > 95% 
biotinylated, as shown by SDS-PAGE analysis of an avidin-gel shift assay (Figure 4-4).  
 
 
Figure 4-4. Avidin-gel shift assay for protein biotinylation of RePC and mutant forms.  
 
Purified RePC wild-type, Y628A RePC, Y628F RePC, and D590A RePC were all assayed for 
biotinylation via the avidin-gel shift assay. The proteins were resolved on an 8% SDS-PAGE gel.   
 
 
 
4.2.3 The X-ray Crystal Structure of Y628A ΔBCΔBCCP RePC 
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In order to further evaluate the role of Tyr628 in catalysis, the Y628A ΔBCΔBCCP RePC 
mutant was crystallized in the presence of pyruvate. The Y628A mutant has exactly the 
same overall conformation as the wild-type ΔBCΔBCCP RePC. Structural superposition 
of the Cα atoms from the Y628A ΔBCΔBCCP RePC dimer with the dimers of 
ΔBCΔBCCP RePC co-crystallized in the presence and absence of pyruvate yields an 
r.m.s. deviation of 0.2 and 0.3 Å, respectively. 
 Of the four monomers in the asymmetric unit, only one member of each 
homodimer pair (monomer A of CT dimer 1 and monomer B of CT dimer 2) had 
pyruvate bound in the active site. Neither pyruvate nor the guanidinium portion of 
Arg621 could be resolved in the active site of monomers C and D. The active sites from 
monomers A and B are equivalent to the active site for ΔBCΔBCCP RePC co-crystallized 
with pyruvate and the binding orientation of pyruvate in the active site from monomers A 
and B is unperturbed relative to the wild-type enzyme (Figure 4-5). The salt bridge 
interaction between the carboxyl moiety of pyruvate and the guanidinium side chain of 
Arg621 is retained, despite the loop being 2 Å further displaced from the metal center. 
However, the positioning of the loop resembles the open conformation observed for 
ΔBCΔBCCP RePC in the absence of pyruvate. The structure of Y628A ΔBCΔBCCP 
RePC further supports a role for Tyr628 in stabilizing the closed conformation of the 
active site. 
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Figure 4-5. The interaction between Arg621 and pyruvate is unperturbed in the Y628A 
ΔBCΔBCCP RePC crystal structure.  
 
Stereo view of the simulated annealing omit map contoured at 3.0 σ for Arg621 and pyruvate 
(rose). The positioning of pyruvate and the loop when the active site is in the closed conformation 
is represented in cyan. 
 
 
   
4.3 Discussion 
 
 
 
4.3.1 Conformational Remodeling of the Active Site Enhances Catalytic Efficiency in 
Biotin-dependent Enzymes that Bind Pyruvate 
 
 
 
Taken together, the structures presented in this chapter suggest that the CT domain active 
site receives carboxybiotin only after pyruvate is bound, when the active site loop has 
been remodeled into the closed conformation. These structural insights trace a direct 
connection between pyruvate binding and the subsequent formation of the biotin-binding 
site in the CT domain and serves to significantly advance the description of how PC and 
related biotin-dependent enzymes affect the control and coordination of biotin-dependent 
catalysis between remote active sites. 
Substrate analogs that contain both the carboxyl and oxo groups of pyruvate, such 
as 3-fluoropyruvate, 3-hydroxypyruvate, oxamate, and glyoxylate, are inhibitors of the 
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CT domain reaction of PC (reviewed in Zeczycki, Maurice, & Attwood, 2010). Further, 
these compounds are sufficient to invoke the translocation and spontaneous 
decarboxylation of N-[14C]carboxybiotin in the CT domain of PC from sheep liver 
(Goodall et al., 1981). However, propionate, lactate and acetaldehyde, which lack either 
the carboxyl or oxo groups, do not invoke decarboxylation of N-[14C]carboxybiotin 
(Goodall et al., 1981). The conformational remodeling observed in our structures 
indicates that pyruvate binding leads directly to carboxybiotin insertion in the active site 
of the CT domain and explains why only close analogs of pyruvate are able to invoke 
carboxybiotin decarboxylation. X-ray crystal structures of ΔBCΔBCCP RePC co-
crystallized with oxamate, oxalate, 3-bromopyruvate or 3-hydroxypyruvate all occupy the 
binding site for pyruvate and promote the closed conformation of the CT domain 
(Chapter 5). 
The conformational remodeling observed for the ΔBCΔBCCP RePC structures in 
the presence and absence of pyruvate is consistent with previous reported structures of 
PC. In the structure of SaPC co-crystallized with pyruvate (pdb i.d. 3BG5), all four CT 
domain active sites of the tetramer have pyruvate bound and exhibit a closed 
conformation. Further, the BCCP domain is observed interacting with one of the four CT 
domains with biotin extending into the active site (Xiang & Tong, 2008). In the only 
apparent contradiction of my hypothesis, the structure of T906A SaPC (SaPC Thr906 is 
equivalent to RePC Thr882; pdb i.d. 3HBL) reveals biotin extending into the active site in 
the absence of pyruvate (Yu et al., 2009). Based on this observation, the authors suggest 
that pyruvate binding is not needed to facilitate BCCP-biotin docking in the active site. 
However, a lobe of well-defined positive electron density occupies the binding site for 
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pyruvate in the T906A SaPC structure and locks the guanidinium side-chain of Arg644 
(equivalent to RePC Arg621) into a fixed conformation, suggesting that T906A SaPC is 
not a true apo structure (Figure 4-6). The unidentified molecule occupying this lobe of 
electron density promotes the closed conformation, thereby accommodating BCCP-biotin 
insertion into the active site of the CT domain, consistent with the proposed model. 
Consequently, all reported structures of PC that reveal tethered biotin in the active site 
also have a ligand occupying the pyruvate binding site, consistent with my hypothesis. 
 
 
 
 
Figure 4-6. An unidentified molecule corresponding to a lobe of electron density is 
occupying the pyruvate binding site and promoting the closed conformation in the X-ray 
crystal structure of T906A S. aureus PC (pdb i.d. 3HBL). 
 
The Fo-Fc omit density map is contoured at 3.0 σ, showing a distinct lobe of electron density 
(green) in the pyruvate binding site. The lobe of electron density corresponds to an unidentified 
molecule that is promoting the hydrogen bonding interaction of Tyr651 with Asp613 (cyan; 
closed conformation) allowing biotin (grey) to dock into the active site. 
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Substrate-induced conformational remodeling also occurs in the α subunit of the 
ODC. Structural superposition of the Cα atoms of the CT-CT dimer from ΔBCΔBCCP 
RePC with the CT-CT dimer of ODC from Vibrio cholerae (pdb i.d. 2NX9; VcODC) 
reveals a nearly identical active site architecture and dimer interface, with a r.m.s. 
deviation of 2.2 Å (Figure 4-7). The X-ray crystal structure of the CT domain from 
 
 
 
 
 
Figure 4-7. Structural alignment between the CT domain dimer of RePC with the CT 
domain dimer of the α  subunit of VcODC.  
 
The r.m.s. deviation for alignment of the Cα atoms of the CT-CT dimer from RePC with the CT-
CT dimer from the α subunit of VcODC (pdb i.d. 2NX9) is 2.2 Å. The CT domains are colored 
green and cyan for RePC and rose for VcODC. The allosteric domains of RePC, which are not 
present in the α subunit of VcODC, are colored blue and orange. 
 
 
 
VcODC was determined in the absence of substrate and the active site displays an open 
conformation (Studer et al., 2007). Red Edge Excitation Shift and FTIR data on VcODC 
demonstrates that ligand binding restricts the tryptophan microenvironment and promotes 
structural changes in the CT domain (Granjon et al., 2010). This suggests that structural 
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rearrangements accompany substrate binding in the CT domain of homologous biotin-
dependent enzymes.   
4.3.2 The Aromatic Ring of Tyr628 Contributes to Biotin Binding in the Active Site 
 
 
 
The structure of Y628A ΔBCΔBCCP RePC further supports a role for Tyr628 in 
stabilizing the closed conformation of the active site. Upon substrate binding, Tyr628 is 
repositioned such that the hydroxyl moiety is within hydrogen bonding distance of 
Asp590 (see above). In the Y628A mutation, the interaction with Asp590 is destroyed 
and the active site binds pyruvate but remains in the open conformation. The biotin-
binding pocket cannot form in the open conformation and carboxybiotin insertion is 
prevented. The Y628A structure, therefore, is fully consistent with the kinetic data 
showing that this mutant is not activated by biocytin, biotin or BCCP-biotin (Tables 4-3 
and 4-4).  
My kinetic analyses reveal a clear discrepancy between the Y628F and Y628A 
mutants of RePC. The Y628F RePC mutant is capable of carboxylating pyruvate 250-fold 
more efficiently than the Y628A RePC mutant, suggesting that the aromatic portion of 
Tyr628 plays a specific role in catalysis. When biotin is bound in the active site of PC, 
the sulfur atom of the thiophene ring is positioned over the aromatic π-electron cloud of 
Tyr628 (Xiang & Tong, 2008). There exists clear structural evidence for the preferential 
localization of divalent sulfur (-CH2-S-CH3) at the edge and slightly above the plane of 
aromatic rings, both in protein stabilization and protein-ligand complexes (Maveyraud et 
al., 1996; Reid, Lindley, & Thornton, 1985). A single sulfur-aromatic interaction is 
estimated to contribute 1-2 kcal/mole in stabilization energy (Zauhar, Colbert, Morgan, & 
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Welsh, 2000). Given that there are few specific interactions serving to facilitate biotin 
binding in the CT domain active site (Xiang & Tong, 2008), the sulfur/π interaction 
between biotin and Tyr628 is expected to contribute to carboxybiotin binding in the 
active site. 
In summary, I report structural and kinetic evidence in this chapter for a substrate-
induced biotin-binding pocket in the CT domain of PC. All biotin-dependent enzymes 
must coordinate two, independent reactions in physically separate active sites. The 
translocation of tethered-biotin links these activities. Evidence is emerging that the 
individual active sites are structured to control biotin access, thereby avoiding abortive 
decarboxylation and ensuring efficient coupling between the BC and CT domain 
reactions. According to my model, biotin is unable to bind in the CT domain in the 
absence of a carboxyl group acceptor. In this way, PC has evolved a mechanism to avoid 
the energetically wasteful decoupling of ATP hydrolysis in the BC domain from pyruvate 
carboxylation in the CT domain, at physiological substrate concentrations. Based on 
sequence conservation and similar structural and biophysical evidence in ODC and  
transcarboxylase, I expect that this general mechanism is applicable to all members of the 
biotin-dependent enzyme family that contain oxaloacetate decarboxylase activity. 
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CHAPTER 5: INSIGHTS INTO THE CARBOXYLTRANSFERASE REACTION 
OF PYRUVATE CARBOXYLASE FROM THE STRUCTURES OF BOUND 
PRODUCT AND INTERMEDIATE ANALOGS 
 
 
 
5.1 Introduction 
 
 
 
Chapter 3 further elaborated on the role of biotin in the carboxyl transfer reaction 
whereas chapter 4 introduced two conserved amino acid residues (Asp590 and Tyr628 in 
RePC) that are necessary to form the biotin binding pocket in the active site of the CT 
domain during catalysis. While both of these chapters describe the mechanistic role biotin 
plays in the CT domain reaction, neither adequately acknowledge the chemistry that 
occurs to the reaction substrate pyruvate during catalysis. 
Recent X-ray crystal structures of PC have shown pyruvate bound in the active 
site (Xiang & Tong, 2008; Yu et al., 2013) but, surprisingly, pyruvate does not coordinate 
the active site metal through a bidentate interaction. This unexpected pyruvate binding 
pose raises questions about the role of the metal ion in the carboxyltransferase reaction. A 
structure of the product, oxaloacetate, bound in the active site would further clarify the 
position of reactants relative to the active site metal ion. However, attempts at 
determining a structure of PC with bound oxaloacetate have not been successful, largely 
due to the relatively rapid rate of spontaneous oxaloacetate decarboxylation (Xiang & 
Tong, 2008).  
Here I report three X-ray crystal structures of the CT domain from RePC with 
bound analogs of the reaction intermediate and product (Figure 5-1). The structure with 
oxalate, a stereoelectronic mimic of the reaction intermediate, enolpyruvate, provides 
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insights into how the metal center participates in the reaction mechanism. Additionally, 
the structures of the CT domain with the product analogs, 3-hydroxypyruvate and 3-
bromopyruvate, bound in the active site further assist in detailing the reaction mechanism 
for the CT domain. Taken together with previously reported studies, these structures 
contribute new details to the mechanistic description of the PC catalyzed reaction. 
 
 
 
 
 
Figure 5-1. Structures of the reaction substrate (pyruvate), reaction intermediate 
(enolpyruvate), reaction product (oxaloacetate), reaction intermediate analog (oxalate), and 
two reaction product analogs (3-hydroxypyruvate and 3-bromopyruvate). 
 
 
 
 
5.2 Results and Discussion 
 
 
 
5.2.1 Structure of the CT Domain from RePC with Bound Oxalate, a Structural Analog of 
the Enolpyruvate Reaction Intermediate. 
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The carboxyl transfer reaction in the CT domain of PC is proposed to proceed through a 
stabilized enolpyruvate intermediate (Zeczycki et al., 2009). In the active site, 
carboxybiotin decarboxylates to release CO2. The resulting biotin enolate abstracts a 
proton from a nearby conserved threonine (Thr882 in RePC), which, in a concerted step, 
abstracts a proton from pyruvate to form the enolpyruvate intermediate. The enolpyruvate 
then attacks the liberated CO2 to form oxaloacetate (Zeczyki, St. Maurice et al. 2009). 
The enolpyruvate is typically depicted as being stabilized through bidentate coordination 
to the Lewis acid metal at the center of the active site and mutations to residues 
coordinating this metal ion lead to a complete loss of enzymatic activity in PC (Yong-
Biao et al., 2004). However, to date, none of the crystal structures of PC co-crystallized 
with pyruvate show the substrate chelating the divalent active site metal through a 
bidentate interaction (Lietzan et al., 2011; St. Maurice et al., 2007; Xiang & Tong, 2008; 
Yu et al., 2009). Instead, pyruvate is always oriented with just the carbonyl oxygen 
oriented toward the metal center and, furthermore, a water molecule is often observed to 
be bridging this interaction.  
Oxalate is the most potent inhibitor reported for PC. It is non-competitive with 
respect to pyruvate with a reported Ki value of 70 µM (Ruiz-Amil, De Torrontegui, 
Palacian, Catalina, & Losada, 1965), 50-130 µM (McClure, Lardy, Wagner, & Cleland, 
1971), and 12 µM (Scrutton et al., 1969) for PC enzymes from yeast, rat liver, and 
chicken liver, respectively. Oxalate is competitive with respect to oxaloacetate and has a 
dissociation constant of 8.9 µM for the metal center of chicken liver PC (Mildvan et al., 
1966). At neutrality, the two carboxylates of oxalate are deprotonated (pKa1=1.19; 
pKa2=4.22) (Riemenschneider & Tanifuji, 2000). In this ionization state, oxalate is a very 
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strong chelator of metal ions and shares structural and chemical properties with the 
enolpyruvate intermediate. Typically, enzymes that catalyze reactions proceeding through 
an enolpyruvate intermediate, such as pyruvate kinase and phosphoenolpyruvate 
caboxykinase, reveal oxalate bound as a bidentate ligand in the crystal structures  
(Cotelesage, Prasad, Zeikus, Laivenieks, & Delbaere, 2005; Larsen, Benning, Rayment, 
& Reed, 1998; Tari, Matte, Pugazhenthi, Goldie, & Delbaere, 1996).  
A truncated construct of RePC was generated that lacked both the BC and BCCP 
domains and included only the allosteric and CT domains of the enzyme (ΔBCΔBCCP 
RePC; Chapters 3 and 4). Using isothermal titration calorimetry (ITC), the KD values for 
pyruvate and oxalate with ΔBCΔBCCP RePC were determined to be ~ 2 mM and 0.13 
mM, respectively (KD determinations for pyruvate and oxalate using ITC were conducted 
by Dr. Verna Frasca at GE Healthcare Life Sciences). These data indicate that oxalate 
binds the active site with a 15-fold greater affinity than the bona fide substrate, pyruvate. 
To gain further insights into the catalytic mechanism in the CT domain of PC, this 
construct was co-crystallized with oxalate in order to probe the binding orientation of an 
enolpyruvate intermediate analog in the active site of the CT domain.  
As previously reported, ΔBCΔBCCP RePC crystallizes in the P212121 space group 
and the asymmetric unit is composed of four monomers in a dimer of dimers arrangement 
(Chapters 3 and 4). For all structures reported here, all monomers within each 
asymmetric unit are near identical to one another with the highest r.m.s. deviation for all 
atoms being 0.3 Å. The CT domain architecture consists of a canonical α8β8 TIM barrel 
fold with the active site centered on the structurally conserved Lewis acid metal, which is 
either Mn2+ or Zn2+ (Chapter 4).  
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Surprisingly, oxalate does not interact with the active site in a bidentate 
coordination state (Figure 5-2A). Instead, oxalate is positioned in the active site similarly 
to both pyruvate (green; pdb i.d. 4JX5) and oxamate (yellow; pdb i.d. 4LOC) (Figure 5-
2B). The planes of the carboxyl moieties for oxalate are staggered such that one carboxyl 
moiety forms a salt bridge with the guanidinium side-chain of Arg621 and the other 
maintains hydrogen bond interactions with Arg548 (3.1 Å) and Gln552 (3.3 Å), two 
residues that are essential for RePC catalysis (Duangpan et al., 2010). The substrates, 
pyruvate and oxamate, also interact with Arg621, Arg548 and Gln552, but they adopt a 
planar conformation in the active site of RePC (Chapter 3; pdb i.d. 4LOC). Because the 
planes of the oxalate carboxyl moieties are staggered, the carboxyl moiety closest to the 
metal center is positioned near to Thr882, the residue responsible for transferring a proton 
to the enolpyruvate intermediate in the oxaloacetate decarboxylation reaction. Further, 
oxalate does not directly interact with the active site metal. The distance between the 
metal ion and oxalate is 4.5 Å, with a bridging water molecule located 2.3 Å away from 
the metal (Figure 5-2A). The binding of oxalate promotes closure of the active site 
through an interaction between the hydroxyl moiety of Tyr628 and the side chain of 
Asp590, an interaction that results in formation of the biotin binding pocket in the CT 
domain active site (Chapter 4).  
 
	   117	  
 
 
Figure 5-2: ΔBCΔBCCP RePC with oxalate bound in the active site.  
 
A. Stereo view of representative electron density for the active site of ΔBCΔBCCP RePC co-
crystallized with oxalate. The 2Fo-Fc electron density map is contoured at 1.0 σ and is represented 
as a grey mesh. The Fo-Fc omit density map is contoured at 3.0 σ and is represented as a green 
mesh. B. Structural overlay of ΔBCΔBCCP RePC with oxalate (cyan; monomer A) against the 
structures of ΔBCΔBCCP RePC with pyruvate (green; pdb i.d. 4JX5 - monomer A) and oxamate 
(yellow; pdb i.d. 4LOC - monomer A). The rms deviation of the structure with oxalate against the 
structures with pyruvate and oxamate is 0.17 and 0.20 Å, respectively. 
 
 
 
The structure of ΔBCΔBCCP RePC with oxalate bound in the active site further 
clarifies the chemical mechanism in the CT domain of PC. Oxalate does not form a 
bidentate interaction with the metal ion located at the center of the active site, despite 
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being an excellent metal chelator. The binding mode for oxalate strongly suggests that the 
enolpyruvate intermediate formed during catalysis is not primarily stabilized through a 
bidentate interaction with the metal center. Instead, the developing negative charge in the 
enolpyruvate intermediate is stabilized through a salt bridge interaction with the 
guanidinium of Arg621 and interactions with Arg548, Gln552, and the metal. Mutating 
Arg548 and Gln552 in RePC results in the complete loss of pyruvate carboxylation 
activity, further supporting a role for these amino acids in catalysis (Duangpan et al., 
2010). Notably, the glutamine/arginine pair (Arg548/Gln552) is conserved in the broader 
DRE-TIM metalloenzyme family that catalyzes carbon-carbon bond cleavage on 
substrates that proceed through stabilization of an enolate intermediate (Forouhar et al., 
2006). The binding mode observed for pyruvate and oxalate permits rotation about the 
C1-C2 bond to allow C3 to be properly positioned for proton transfer between from C3 to 
the hydroxyl moiety of Thr882. The carbanion at C3 is also expected to be properly 
oriented to attack the liberated CO2 from biotin in order to form oxaloacetate. 
Interestingly, the only available structures of a homologous enzyme with bound products 
and substrates are from the 5S subunit of transcarboxylase, which also revealed that the 
substrates and products do not directly interact with the active site metal ion (Hall et al., 
2004). 
5.2.2 Structures of the CT Domain from RePC with the Bound Product Analogs 3-
hydroxypyruvate and 3-bromopyruvate. 
 
 
 
To date, attempts at capturing structures of oxaloacetate, the reaction product, in the 
active site of PC have been unsuccessful (Xiang & Tong, 2008). Both co-crystallization 
and soaking attempts with oxaloacetate have resulted in electron density corresponding to 
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pyruvate in the active site ((Xiang & Tong, 2008); Chapters 3 and 4). Capturing 
structures of oxaloacetate in the active site is complicated by the ability of the CT domain 
to catalyze the decarboxylation of oxaloacetate at a reduced rate (Chapters 3 and 4). In 
order to gain insights into how the reaction product oxaloacetate is positioned in the 
active site, apo crystals of ΔBCΔBCCP RePC were soaked with 3-hydroxypyruvate and 
3-bromopyruvate, structural mimics of oxaloacetate and inhibitors of the carboxyl 
transfer reaction. 
3-hydroxypyruvate, which is a non-competitive inhibitor with respect to MgATP 
(Ki = 5.5 mM), HCO3- (Ki = 7.1 mM), and pyruvate (Ki = 5.4 mM) for the pyruvate 
carboxylation reaction from Thiobacillus novellus PC (Charles & Willer, 1984; Charles, 
Willer, & Scharer, 1984), binds in the active site of ΔBCΔBCCP RePC in a similar 
orientation to pyruvate. Like pyruvate, the carboxyl moiety of 3-hydroxypyruvate forms a 
salt bridge interaction with the guanidinium moiety of Arg621, while the C2 carbonyl 
oxygen is within hydrogen bonding distance to the side chains of Arg548 and Gln552 
(Figure 3A). Interestingly, the hydroxyl moiety at C3 of 3-hydroxypyruvate is positioned 
in close proximity to the side chain of Thr882. The position occupied by the hydroxyl 
moiety is likely to represent the position at which enolpyruvate is carboxylated during the 
reaction. Like pyruvate, oxamate, and oxalate (Xiang & Tong, 2008); pdb i.d. 4LOC), 3-
hydroxypyruvate is not a bidentate ligand and the binding of 3-hydroxpyruvate promotes 
the closed conformation of the active site. 
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Figure 5-3: ΔBCΔBCCP RePC with 3-hydroxypyruvate and 3-bromopyruvate bound in the 
active site. 
  
Representative omit maps for (A) 3-hydroxypyruvate (3PY; purple) and (B) 3-bromopyruvate 
(BPV; grey) in the active site of ΔBCΔBCCP RePC. The electron density maps are contoured at 
3.0 σ. 
 
 
 
Halogenating the C3 position of pyruvate results in effective, specific inhibitors of 
PC (reviewed in Zeczycki et al., 2010). For instance, fluoropyruvate is a non-competitive 
inhibitor with respect to pyruvate (Ki = 0.17 mM) for the pyruvate carboxylation reaction 
(Scrutton et al., 1969), with pulse NMR data suggesting that it prevents pyruvate 
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coordination in the active site (Mildvan et al., 1966). Further, 10 mM fluoropyruvate and 
chloropyruvate inhibit gluconeogenesis by 85% and >95%, respectively, in the rat liver 
by modulating PC activity (Doedens & Ashmore, 1972). Given that halogenated 
derivatives of pyruvate are more potent inhibitors of PC compared to 3-hydroxypyruvate, 
we determined the structure of ΔBCΔBCCP RePC with 3-bromopyruvate.   
3-bromopyruvate binds in the active site of ΔBCΔBCCP RePC in a similar 
manner to 3-hydroxypyruvate (Figure 5-3B). Again, the carboxyl moiety of 3-
bromopyruvate forms a salt bridge interaction with the guanidinium moiety of Arg621, 
and the bromine atom is positioned towards the side-chain of Thr882, much like the C3 
hydroxyl moiety of 3-hydroxypyruvate. However, a second, weaker binding orientation 
for 3-brompyruvate is also observed in the electron density. The second orientation, 
which is modeled at 0.2 occupancy, results in the bromine atom being positioned 2.3 Å 
away from the active site metal. Normally, the active site metal is octahedrally 
coordinated by the side chains of Asp549, His747, His749, carbamylated Lys718 and a 
water molecule. In this second binding mode, 3-bromopyruvate displaces the water 
molecule and directly interacts with the metal center. Halocarbon compounds are capable 
of forming a wide array of specific molecular interactions with proteins, making them 
ideal for pharmaceutical development (reviewed in Bissantz, Kuhn, & Stahl, 2010). This 
interaction may explain the enhanced potency of halogenated pyruvate derivatives for 
PC.  
3-bromopyruvate has been described as an anti-cancer agent with a wide range of 
possible targets required for energy metabolism in tumor cells (reviewed in Shoshan, 
2012). Most recently, 3-bromopyruvate has also been described as a novel antifungal 
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agent against human pathogens such as Cryptococcus neoformans (Dylag et al., 2013). 
While it is recognized that 3-bromopyruvate exerts its effects on cellular metabolism by 
targeting multiple metabolic pathways, to my knowledge PC is not recognized as a target 
for 3-bromopyruvate. Based on the current findings, PC inhibition must be considered 
when interpreting the mechanism of cellular inhibition for 3-bromopyruvate and other 
halogenated derivatives of pyruvate. 
5.3 Conclusion 
 
 
 
In summary, I report three X-ray crystal structures of the RePC CT domain with the 
bound inhibitors oxalate, 3-hydroxypyruvate, and 3-bromopyruvate. These structures 
offer new insights into the carboxyl transfer reaction mechanism in pyruvate carboxylase. 
Oxalate, which may be considered an analog of the enolpyruvate reaction intermediate, 
does not form a bidentate interaction with the active site metal, contrary to what has long 
been assumed for intermediate stabilization in PC. Instead the active site is structured to 
stabilize the developing negative charge of the enolpyruvate intermediate through a 
positively charged pocket that includes interactions with Arg621, Arg548, Gln552 and 
the active site metal. Further, 3-hydroxypyruvate, a mimic of the reaction product 
oxaloacetate, is positioned in the active site such that the C3 hydroxyl moiety faces the 
side chain of Thr882. This positioning further supports the conclusion that the substrate 
maintains its orientation in the active site as catalysis proceeds. Much like 3-
hydroxypyruvate, 3-bromopyruvate positions the bromine atom in close proximity to 
Thr882. However, a second binding mode is suggested in the electron density whereby 
the bromine atom is oriented toward the active site metal. This altered positioning relative 
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to the active site metal may explain the increased inhibition potency of halogenated 
pyruvate derivatives for PC and demonstrates that PC may factor into the anti-tumor and 
anti-fungal mechanism of 3-bromopyruvate.  
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CHAPTER 6: SYMMETRY OF THE PYRUVATE CARBOXYLASE ENZYME 
FROM RHIZOBIUM ETLI 
 
 
 
6.1 Introduction 
 
 
 
In eukaryotes and most bacteria, the active PC enzyme is comprised of four identical 
polypeptide chains (~120 – 130 kDa) that associate together into a homotetramer (α4). 
Early electron micrographs of various PC enzymes suggested that the α4 form possesses 
either a tetrahedral or rhombic geometry with the tetramer containing two pairs of 
subunits located orthogonally to one another on two different planes (Mayer et al., 1980; 
Osmani et al., 1984). 
The first X-ray crystal structure of a complete biotin-dependent enzyme was 
reported for the α4-type PC from Rhizobium etli (St. Maurice et al., 2007). The R. etli PC 
structure was closely followed by the report of the holoenzyme structure of PC from S. 
aureus (Xiang & Tong, 2008). Together, these X-ray analyses unveiled the quaternary 
arrangement of PC and revealed the relative disposition of the individual catalytic 
domains. The monomers of the α4 PC tetramer are arranged on two distinct layers, 
running perpendicularly between the two layers and oriented antiparallel to each other on 
opposite sides of the tetramer (Figure 1-6). Minimal direct contacts are observed between 
monomers located on the same face. The tetramer is held together at the corners by BC-
BC and CT-CT dimerization interfaces. From the arrangement of the catalytic domains 
and analysis of mixed hybrid tetramers, it was determined that BCCP-biotin physically 
moves by ~50-70 Å from the BC domain on one polypeptide chain to the 
carboxyltransferase domain on a neighboring polypeptide chain (Figure 1-6). This 
	   125	  
intermolecular transfer mechanism for catalysis was confirmed by additional structures 
that captured the BCCP domain physically interacting with the carboxyltransferase 
domain of a neighboring polypeptide chain (Lasso et al., 2010; Xiang & Tong, 2008; Yu 
et al., 2009). These data served to explain the long-standing observation that PC does not 
exhibit pyruvate carboxylation activity in its dimeric or monomeric states (Attwood et al., 
1993; Attwood & Geeves, 2002; Khew-Goodall et al., 1991). 
However, despite ~50% sequence identity between SaPC and RePC, there have 
been striking differences in the overall arrangement of the tetramers: the opposing faces 
of the enzyme are highly asymmetrical in RePC (Lietzan et al., 2011; St. Maurice et al., 
2007), while they are nearly symmetrical in SaPC (Xiang & Tong, 2008; Yu et al., 2009; 
Yu et al., 2013). This difference in the enzyme symmetry results in a dramatic difference 
in the intermolecular contacts that stabilize the tetramer: the SaPC tetramer is stabilized 
by interface contacts between allosteric domains, while no such contacts are present in 
the RePC tetramer. The basis for the striking deviation in quaternary structure between 
RePC and SaPC remains unclear.  
In this chapter, I report biochemical and structural evidence suggesting that RePC 
may adopt a wider array of structural conformations than previously recognized. 
Understanding the various structural conformations that PC experiences during catalysis 
will offer a more complete description of how specific structural conformations coorelate 
with catalytic turnover and will eventually lead to a complete description of how each 
active site effectively coordinates the intermolecular transfer mechanism for maximum 
efficiency. The studies presented in this chapter, combined with recent cryoelectron 
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microscopy studies of SaPC (Lasso et al., 2014), have assisted in precipitating an initial 
model concerning the tetrameric arrangement of PC during catalysis. 
 
 
 
6.2 Results and Discussion 
 
 
 
6.2.1 Structural Studies of the CT Domain from RePC 
 
 
 
To investigate the contribution of individual domains to the asymmetrical arrangement of 
RePC, I removed the biotin carboxylase and biotin carboxyl carrier protein domains from 
RePC. The resulting recombinant protein (ΔBCΔBCCP RePC) retains both the allosteric 
and CT domains of RePC and is amenable to crystallization. The X-ray crystal structures 
of truncated RePC in the presence and absence of substrates and substrate analogs have 
been described in chapters 3-5. The protein crystallized in the space group P212121 under 
all co-crystallization conditions indicating that all structures reported in this dissertation 
have similar quaternary features regardless of bound ligand. The unit cell contains four 
monomers of ΔBCΔBCCP RePC, arranged as a dimer of dimers. Analysis of the dimer 
interfaces using the PISA service from the European Bioinformatics Institute (Krissinel 
& Henrick, 2007) reveals that the CT-CT dimer interface is thermodynamically stable, 
with each monomer contributing ~1400 Å2 of buried surface area. The predicted dimer 
stability is consistent with size exclusion gel filtration chromatography that demonstrates 
ΔBC RePC exists in solution as a dimer (Figure 6-1). The ΔBC RePC construct elutes at a 
single peak with a molecular weight corresponding to a dimer in the presence and 
absence of the allosteric activator, acetyl CoA (Figure 6-1). This suggests that, contrary  
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Figure 6-1. Size exclusion chromatography of wild-type and BC domain deletion RePC 
(ΔBC RePC) 
 
Representative chromatograms for wild-type RePC (wt RePC; long dashed line) and the BC 
domain deletion of RePC (ΔBC). The elution profile of ΔBC RePC is unaffected by the presence 
(short dashed line) or absence (solid line) of acetyl CoA. Inset: standard curve (open circles) and 
predicted Kav for the ΔBC monomer, dimer, and tetramer (open squares). The measured Kav for 
wild-type and ΔBC is indicated (closed circles), corresponding to a dimer for ΔBC RePC (MW = 
150 kDa) and a tetramer for wild-type RePC (MW = 500 kDa). 
 
 
 
to what was previously observed for SaPC, the central allosteric domain of RePC does 
not contribute significantly to tetramerization. Structural superposition of the Cα atoms 
of the CT-CT dimer from ΔBCΔBCCP RePC with wild-type, full length RePC reveals a 
nearly identical interface, with a r.m.s. deviation of 0.3 Å.  
Surprisingly, two ΔBCΔBCCP RePC dimers interact in the crystal via their 
allosteric domains to form a symmetrical tetramer reminiscent of SaPC (Figure 6-2). The 
contacts between these opposing allosteric domains are minimal, contributing only ~320  
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Figure 6-2. The structure of the BC and BCCP domain truncation of RePC (ΔBCΔBCCP 
RePC) reveals a symmetrical tetramer.  
 
The green and cyan domains represent the carboxyl transferase (CT) domain, while the blue and 
magenta domains represent the allosteric/ pyruvate carboxylase tetramerization (PT) domains. 
The green and blue domains are located on the top face of the tetramer whereas the pink and cyan 
domains are on the bottom face. A. Structural alignment between the chain A and C homodimer 
of ΔBCΔBCCP RePC and the chain A and D homodimer of ΔBC human pyruvate carboxylase 
(brown- colored, semi-transparent ribbons; pdb i.d. 3BG3). B. Structural alignment between the 
chain A and C homodimer of ΔBCΔBCCP RePC and the chain A and D homodimer of the 
allosteric+CT domains of the full length S. aureus PC enzyme tetramer (yellow-colored, semi-
transparent ribbons; pdb i.d. 3BG5). C. Structural alignment between the chain A and C 
homodimer of the ΔBCΔBCCP RePC and the chain A and B homodimer of the allosteric+CT 
domains of the full length RePC enzyme tetramer (rose-colored, semi-transparent ribbons; pdb 
i.d. 2QF7). 
 
 
 
Å2 of buried surface area to the tetramer. The most prominent contact is a parallel π-
stacking interaction between the phenyl groups of equivalent Phe1051 residues. This 
same interaction has been shown to be essential for tetramerization in both H. sapiens PC 
(HsPC) and SaPC (Xiang & Tong, 2008), but it does not contribute to the tetramerization 
of wild-type RePC in solution. This conclusion stems from the size exclusion gel 
filtration chromatography experiment whereby the ΔBC RePC construct retains the 
Phe1051 residue, but is not able to tetramerize in solution (Figure 6-1). Similar size 
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exclusion gel filtration chromatography experiments conducted on a BC domain 
truncation of HsPC revealed that it tetramerizes in solution whereas the F1077A and 
F1077E (equivalent to Phe1051 in RePC) mutants exist as dimers (Xiang & Tong, 2008). 
Interestingly, the symmetrical arrangement of the ΔBCΔBCCP RePC tetramer is in good 
agreement with what has been observed in both SaPC and in a BC domain truncation of 
HsPC (Figure 6-2A & B) but is in sharp contrast with the asymmetrical tetramer of full-
length RePC (Figure 6-2C). Because the CT-CT dimer structure is identical between the 
truncated and full-length RePC, the asymmetry observed in full-length RePC is likely to 
originate in the BC domain. Of the two catalytic domains, the BC domain occupies a 
much greater range of conformations, while the CT domain remains static in all X-ray 
crystal structures of PC (St. Maurice et al., 2007; Xiang & Tong, 2008; Yu et al., 2009). 
6.2.2 A Model to Explain the Changes in Quaternary Structure of PC During Catalysis 
 
 
 
The surprising finding that RePC crystallizes as a symmetrical tetramer in the absence of 
the BC and BCCP domains demonstrate that RePC may access a wider range of 
conformations than previously recognized. Since the ΔBCΔBCCP RePC construct 
crystallizes as a symmetrical tetramer with the CT domain dimer unaltered, it suggests 
that the BC domain dimer plays an important role in altering the tetrameric arrangement 
of the enzyme. The BC domain, which possesses greater rotational flexibility compared 
to the CT domain, rotates 6 to 20 degrees depending on the placement of the BCCP 
domain or presence of CoA (Lasso et al., 2014; Xiang & Tong, 2008; Yu et al., 2009; Yu 
et al., 2013). Recent cryo-electron microscopy studies have recently demonstrated that 
the SaPC tetramer can also exist in an asymmetrical state, a conformation not previously 
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recognized in the reported X-ray crystal structures of SaPC (Lasso et al., 2014; Xiang & 
Tong, 2008; Yu et al., 2009).  
With the knowledge of the studies presented in this chapter, Lasso et al (2014) 
proposed a model that suggests the PC tetramer transitions between asymmetrical and 
symmetrical tetramer conformations, depending on how the BCCP domain is positioned 
during the catalytic cycle (Figure 6-3). The model proposed by Lasso et al (2014) is 
described as follows. The layers, or faces, of the PC tetramer alternate between an active 
and a quiescent state. That is, when one layer of the tetramer is active, the other layer is 
not. In order to simplify the model presented in Figure 6-3, the top layer is depicted as 
being active while the bottom layer is inactive or quiescent. To initiate catalysis, the 
BCCP domain must dock in the BC domain active site located on the same monomer in 
order for the biotin cofactor to be carboxylated through the bicarbonate-dependent 
cleavage of ATP (Figure 6-3A). At the same time, the inactive layer (bottom) positions 
its BCCP domain to interact with the exo binding site located on the top layer. At this 
stage of the catalytic cycle, the tetramer is in an asymmetric arrangement, as observed in 
the X-ray crystal structures of full length RePC. In this conformation, the allosteric 
domains on the top layer are separated by a great distance while the allosteric domains on 
the bottom layer are close enough to exhibit slight contacts. The BC domains located on 
the top layer are also rotated slightly towards the opposing CT domains. Once pyruvate 
binds in the CT domain active site and forms the biotin binding pocket (Chapter 4), 
BCCP-carboxybiotin can physically dock into the CT domain active site. At this stage of 
the catalytic cycle, the allosteric domains on the top layer reposition towards the center of 
the tetramer to allow the BCCP domains to reach the opposing CT domains. At the same 
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time, the BCCP domains located on the bottom layer dissociate from the exo binding site 
resulting in increased flexibility. The resulting tetrameric arrangement appears 
symmetrical, as observed in the X-ray crystal structures of SaPC. 
 
 
 
 
Figure 6-3. Proposed model explaining the different tetrameric states of PC during 
catalysis.  
 
A. When the BCCP domain is bound in the BC domain on the top layer (Purple and Tan; red – 
BCCP), the allosteric domains located on the bottom layer (Green and Blue) maintain contacts 
across the tetramer. Further, the BCCP domains on the bottom layer are interacting with the exo 
binding site located on the top layer. This conformation appears asymmetrical. B. As the BCCP 
translocates to the CT domain on the top layer, the distance between the allosteric domains 
located on the bottom layer increases resulting in a symmetrical tetramer. This figure was adapted 
from Lasso et al., 2014.  
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CHAPTER 7: CONCLUSIONS 
 
 
 
Enzymes involved in regulating or sustaining central metabolic pathways such as the 
TCA cycle are often observed to be compromised during various disease states and PC is 
not an exception. PC, a multifunctional biotin-dependent enzyme, catalyzes the 
bicarbonate- and MgATP-dependent carboxylation of pyruvate to oxaloacetate, an 
important anaplerotic reaction in central metabolism. PC activity is aberrant in multiple 
disease states such as type II diabetes and tumor growth, making the need to understand 
the fundamental catalytic and regulatory mechanisms of this enzyme incredibly important 
(see section 1.2.1).  
In order to carboxylate pyruvate, PC utilizes two spatially distinct active sites 
with one located in the BC domain and the other in the CT domain. The coordination 
between these two domains must be precise such that ATP cleavage is not uncoupled 
from oxaloacetate formation (Zeczycki et al., 2011). The recent X-ray crystal structures 
of PC from R. etli  (St. Maurice et al., 2007) and S. aureus (Xiang & Tong, 2008; Yu et 
al., 2009; Yu, Chou, Choi, & Tong, 2013) have lead to a surge of structure-guided 
mutagenic studies and kinetic analyses of each individual active site. These studies have 
undoubtedly advanced the description of the chemical mechanisms associated with each 
active site, but many mechanistic features, especially in the CT domain, remain unknown. 
This dissertation describes the reaction mechanism for the CT domain of PC, with an 
emphasis on the role of biotin in the reaction. The conclusions from this work provide a 
thorough description of how biotin affects the active site chemistry and how pyruvate 
binding in the CT domain active site accommodates biotin binding. 
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7.1 Further Development of an In Vitro Enzyme Assay System to Dissect the Role of 
Biotin in the Isolated CT Domain Reaction 
 
 
 
The overall PC-catalyzed reaction thermodynamically favors the carboxylation of 
pyruvate. However, the enzyme also maintains the ability to catalyze the decarboxylation 
of oxaloacetate in the absence of other substrates. In this respect, PC also serves as a 
paradigm for two other biotin dependent enzymes that catalyze the decarboxylation of 
oxaloacetate: the oxaloacetate decarboxylase complex and transcarboxylase (Section 1.1). 
Thus, studies of oxaloacetate decarboxylation in PC are generally applicable to a range of 
biotin-dependent enzymes.  
While not physiologically relevant, the addition of oxamate has been shown to 
enhance the enzyme-catalyzed rate of oxaloacetate decarboxylation in PC by nearly 10-
fold (Attwood & Cleland, 1986). This reaction, which is predicted to be confined to the 
CT domain, has enabled many isolated kinetic studies on the CT domain (Attwood, 
Tipton, & Cleland, 1986; Duangpan et al., 2010; Zeczycki et al., 2009). Until recently, 
however, the mechanism by which oxamate accelerates the decarboxylation of 
oxaloacetate in PC was unknown. Marlier et al. partially resolved this issue by providing 
13C NMR evidence that oxamate serves as an alternate substrate in the CT domain 
reaction (Marlier, Cleland, & Zeczycki, 2013). However, the initial velocity patterns were 
inconsistent with a simple ping-pong mechanism, leaving several aspects of the oxamate 
stimulation mechanism unresolved. 
Chapter 3 describes the X-ray crystal structure of the CT domain of RePC with 
oxamate bound in the active site. This structure revealed that oxamate is positioned in the 
active site similarly to pyruvate further supporting the notion that oxamate serves as a 
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carboxyl group acceptor in the oxamate-stimulated oxaloacetate decarboxylation reaction 
(Figure 3-4).  
Further, the kinetic data presented in Figure 3-5 suggest that, in the absence of a 
BC domain, the oxamate-stimulated decarboxylation of oxaloacetate proceeds through a 
simple ping-pong bi bi mechanism with double competitive substrate inhibition. That is, a 
carboxyl group is transferred from oxaloacetate to biotin and then from carboxybiotin to 
oxamate with both oxaloacetate and oxamate serving as competitive inhibitors to the 
overall reaction. 
While similar kinetic studies with the wild-type RePC enzyme predicted a ping-
pong type mechanism, these results were inconclusive due to the presence of two kinetic 
pathways (Marlier et al., 2013). In one kinetic pathway, the carboxyl group is transferred 
from the carboxybiotin intermediate to oxamate forming the carbamylated oxamate 
product. In the second kinetic pathway, which is more prominent at low concentrations of 
oxamate, carboxybiotin decarboxylates either in the CT or BC domain without 
transferring CO2 to an acceptor substrate, making this route unproductive. Because the 
biotin binding pocket does not form unless the pyruvate binding site is occupied (Chapter 
4), it appears unlikely that the CT domain active site would accommodate carboxybiotin 
binding in the absence of pyruvate or a pyruvate analog, and more probable that the 
unproductive decarboxylation of carboxybiotin is the result of it translocating to the BC 
domain. Because of the uncertainty associated with the reaction pathway, a simpler 
system was developed in chapter 3 to truly confine the reaction to the CT domain active 
site. The development of a simplified in vitro enzyme assay provided the means to dissect 
the role of biotin in the substrate induced biotin binding pocket of the CT domain 
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(Chapter 4) and has the potential to be utilized when screening specific inhibitors of the 
CT domain reaction (see section 7.4). 
7.2 An Updated Reaction Mechanism for the Carboxyl Transfer Reaction in the 
Carboxyltransferase Domain of Pyruvate Carboxylase    
 
 
 
The work presented in this dissertation has advanced the mechanistic description of the 
carboxyl transfer reaction catalyzed by PC and therefore will be highlighted in this 
section by a thorough summary of the reaction mechanism. To initiate the overall 
reaction, biotin is carboxylated in the BC domain by the bicarbonate-dependent cleavage 
of MgATP. The newly formed carboxybiotin, which is physically tethered to the C-
terminal portion of the BCCP domain, must physically translocate ~60 Å to the CT 
domain (Lasso et al., 2010; St. Maurice et al., 2007; Xiang & Tong, 2008). While the 
exact molecular mechanism that induces BCCP domain translocation between the two 
active sites remains unknown, it is recognized that the translocation of BCCP-
carboxybiotin away from the BC domain and to the CT domain is dependent upon the 
active site of the CT domain being occupied (Easterbrook-Smith, Hudson, Goss, Keech, 
& Wallace, 1976; Goodall, Baldwin, Wallace, & Keech, 1981).  
Once the BCCP domain has translocated away from the BC domain, it interacts 
with the α-helix-rich C-terminal extension of the CT domain (Xiang & Tong, 2008). The 
interaction between the BCCP and CT domains induces a slight structural perturbation in 
α-helix 10 leading into the active site (Xiang & Tong, 2008). Kinetic data presented in 
chapter 3 demonstrates that enzyme activity cannot be rescued in the presence of the 
BCCP domain devoid of tethered biotin with free biocytin. It is therefore concluded that 
either a tethered biotin cofactor is required to properly anchor the BCCP domain in the 
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CT domain or that the BCCP-CT domain interaction is necessary to properly position 
carboxybiotin in the active site. It is not possible to distinguish between these possibilities 
with the data presented in this dissertation. Nevertheless, the positioning of the BCCP 
domain over the CT domain appears to guide carboxybiotin into the funnel leading to the 
active site. This funnel exhibits a largely positive surface charge that may assist in 
shuttling the negatively charged carboxybiotin into the active site (Figures 3-7 and 3-8). 
 In order for carboxybiotin to physically enter the active site, a CT domain ligand 
must be bound (Goodall et al., 1981). The X-ray crystal structures of the CT domain from 
RePC presented in chapter 4 helps clarify this observation by describing a substrate-
induced biotin binding pocket in the CT domain active site. In the absence of substrate, 
the CT domain active site is in an open conformation with a conserved tyrosine (Tyr628 
in RePC), which resides immediately outside the active site, oriented away from the 
Lewis acid metal center (Figure 4-1). The conformational change required for biotin 
binding is the result of a flexible active site loop (Arg621-Asn630 in RePC) altering its 
conformation in the presence and absence of the substrate pyruvate (Figure 4-1). The 
conformational change observed for the loop coincides with the formation of a salt bridge 
between the carboxyl moiety of pyruvate and the guanidinium group of a conserved 
arginine (Arg621 in RePC; Figure 4-1). Arg621 is required for oxaloacetate 
decarboxylation activity in RePC (Chapter 3) and for pyruvate carboxylation activity in 
SaPC (Yu et al., 2009) making it essential for catalysis in the CT domain.  
Further, the carbonyl oxygen of pyruvate is also positioned within hydrogen 
bonding distance of both Arg548 and Gln552, two additional amino acids conserved in 
all PC enzymes. Both of these residues are required for catalysis and structurally 
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contribute to the proper positioning of the planar molecule in the active site (Duangpan et 
al., 2010). The carbonyl oxygen of pyruvate is also observed interacting with the Lewis 
acid metal in X-ray crystal structures of PC from H. sapiens and S. aureus (Xiang & 
Tong, 2008; Yu et al., 2009), but in structures of RePC, a water molecule has been 
observed bridging the metal with the carbonyl oxygen of pyruvate.  
As pyruvate is binding and stabilizing the active site loop, a hydrogen bonding 
interaction between Tyr628 of the loop and Asp590 located opposite the active site cleft 
is forming (Figures 4-1 and 7-1B). This interaction helps stabilize the closed 
conformation and is essential for creating a pocket for biotin binding in the active site 
(Chapter 4). Substituting tyrosine to an alanine nearly eliminates pyruvate carboxylation 
activity whereas removing the hydroxyl group from the tyrosine reduces it by 7-fold 
(Chapter 4). Furthermore, removing Tyr628 does not interfere with the ability of the 
active site to bind pyruvate (Chapter 4). These kinetic data suggest that the aromatic ring 
of the tyrosine may contribute to carboxybiotin binding in the active site thus explaining 
why the closed conformation is preferred for biotin binding.  
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Figure 7-1: An updated proposed mechanism for pyruvate carboxylation in the 
carboxyltransferase domain of pyruvate carboxylase 
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Once carboxybiotin reaches the entrance of the active site, it passes over Tyr628 and 
settles in a pocket with the 1’-N positioned ~8.8 Å from the Lewis acid metal. At this 
point, carboxybiotin undergoes decarboxylation to generate a biotin enolate intermediate 
and the release of free CO2 into the active site (Figure 7-1C). The negative charge that 
develops on the ureido oxygen of biotin during decarboxylation is stabilized by hydrogen 
bonds at tetrahedral angles originating from an active site triad (backbone amide of 
Lys886, Ser885 and Gln844; (Zeczycki et al., 2009)). It is hypothesized that rotation of 
the carboxyl group out of the plane with the urea ring of biotin assists in facilitating the 
decarboxylation of carboxybiotin once bound in the active site (Thatcher, Poirier, & 
Kluger, 1986). Recent quantum-mechanics/molecular-mechanics calculations predict that 
the covalent bond between the 1’-N of biotin and the carbon of CO2 in carboxybiotin is 
gradually weakened by an increase in bond length until CO2 is released and the enolbiotin 
intermediate is formed (Sheng & Liu, 2014). Once free CO2 is released into the active 
site, it must be contained such that it does not dissipate. Stabilizing the librated CO2 in 
the active site is predicted to occur through its interaction with the main chain amide of 
Thr882 (Sheng & Liu, 2014).  
Immediately following the formation of the biotin enolate intermediate and 
through a concerted proton transfer, a conserved threonine (Thr882) protonates the 1’-N 
of the biotin enolate intermediate while simultaneously abstracting a proton from the 
methyl group of pyruvate (Figure 7D; (Zeczycki et al., 2009)). Initial proposals of the 
reaction mechanism positioned pyruvate in the active site such that it forms a bidentate 
interaction with the Lewis acid metal. This interaction serves to lower the pKa of the 
methyl group for proton abstraction. However, the structure of RePC with oxalate bound 
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does not reveal oxalate, an intermediate analog, forming a bidentate interaction with the 
Lewis acid metal (Chapter 5). This strongly suggests that the enolpyruvate intermediate 
formed during catalysis is not primarily stabilized through an interaction with the metal 
center. Instead, the developing negative charge in the enolpyruvate intermediate is 
stabilized through a salt bridge interaction with the guanidinium of Arg621 and 
interactions with Arg548, Gln552 and the metal. The binding orientation of oxalate also 
suggests that a rotation about the C1-C2 bond occurs to allow C3 to be properly 
positioned for the proton transfer between C3 and the hydroxyl moiety of Thr882 (Figure 
5-2).  
Finally, the nucleophilic enolpyruvate attacks the liberated CO2 to form 
oxaloacetate (Figure 7-1E). This step proceeds with retention of the stereochemical 
configuration of the carbon undergoing carboxylation (Cheung, Fung, & Walsh, 1975; 
Rose, 1970). This finding is further supported by the structure of RePC with 3-
hydroxypyruvate bound (Chapter 5). The hydroxyl moiety at C3 of 3-hydroxypyruvate is 
positioned in close proximity to the side chain of Thr882 (Figure 5-3A). The position 
occupied by the hydroxyl moiety likely represents the position at which enolpyruvate is 
carboxylated during the reaction thus allowing the stereochemical configuration to be 
retained. Oxaloacetate and tethered biotin exit the active site and the enzyme is prepared 
for another catalytic cycle.       
7.3 Hypotheses for the Coordination of Catalysis Between the Biotin Carboxylase and 
Carboxyltransferase Domains in Pyruvate Carboxylase  
 
 
 
Prior to these studies, and even after them, the biggest uncertainty that remains is the 
precise mechanism underlying how PC coordinates catalysis between the BC and CT 
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domains. It is universally accepted that the enzyme couples the carboxylation of pyruvate 
to the cleavage of MgATP making the overall reaction thermodynamically favorable, and 
that PC accomplishes pyruvate carboxylation through an intermolecular mechanism 
involving the translocation of BCCP-carboxybiotin between active sites located on two 
separate monomers. However, employing a mechanism that consumes ATP in order to 
activate bicarbonate and carboxylate biotin comes with the unique risk of wasting energy 
if biotin decarboxylates without the production of oxaloacetate. Such an event would 
disrupt central metabolism and be potentially fatal to the cell. Therefore understanding 
the regulation needed for the BCCP domain to translocate between active sites has 
become the focus of current PC research.  
 There are currently two prominent hypotheses to explain how the BCCP domain 
translocates between active sites. The first assumes that the translocation activity for the 
BCCP domain occurs via dynamic equilibrium. That is the BCCP domain translocates 
between the two protein domains, randomly surveying each active site. The half-life of 
[14C]-carboxybiotin complex isolated from chicken liver PC is > 300 minutes at 0°C 
indicating that tethering CO2 to the 1’-N position of biotin stabilizes the carboxybiotin 
complex considerably providing ample time for BCCP domain translocation (Attwood & 
Wallace, 1986). Further, the X-ray crystal structure of T882A RePC revealed electron 
density for tethered biotin in the BC domain (Lietzan et al., 2011). This structure 
identified the direction from which tethered biotin accesses the BC domain but tethered 
biotin is not positioned within the BC domain active site. Instead, a shallow ledge formed 
by the interaction between Glu248 and Arg353 precludes biotin access to the active site, 
thus protecting it from returning to the active site to be nonproductively decarboxylated  
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(Lietzan et al., 2011). Mutating Glu248 and Arg353 resulted in a substantial loss of 
pyruvate carboxylation activity with the mutations exerting much less of an effect on the 
rate of MgADP phosphorylation with carbamoyl phosphate in the BC domain. This is 
consistent with increased biotin access to the BC domain active site resulting from a 
disruption of the interaction between Glu248 and Arg353. These findings, which ensure 
carboxybiotin is not prematurely decarboxylated prior to pyruvate carboxylation, support 
a mechanism for BCCP-carboxybiotin translocation that occurs by dynamic equilibrium. 
 However, indirect kinetic data strongly support a mechanism where BCCP-
carboxybiotin translocates away from the BC domain and towards the CT domain when 
signaled. For example, the rates of [14C]-carboxybiotin decarboxylation were measured in 
the presence of structural and inhibitory analogs of pyruvate (Goodall et al., 1981). The 
rates were found to be linearly dependent on the concentration of several CT domain 
analogs including fluoropyruvate, 2-oxobutyrate, 3-hydroxypyruvate, and glyoxylate 
(Goodall et al., 1981). Such translocation effects were not observed for substrate analogs 
lacking an oxo or carboxyl moiety further suggesting that when a ligand binds in the CT 
domain active site, it initiates a signaling mechanism.  
These translocation effects have only been observed when the CT domain is 
occupied and the BCCP domain is biotinylated. When the site of biotinylation is mutated 
in the full length RePC enzyme and assayed for MgATP cleavage in the presence of 
varying levels of oxamate, no impact is observed on the rate of MgATP cleavage in the 
BC domain (Zeczycki et al., 2009). Likewise, the bicarbonate-dependent ATPase activity 
in the BC domain is partially inhibited in the presence of oxamate when the proton 
shuttling threonine located in the CT domain is replaced with an alanine (Zeczycki et al., 
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2009) further supporting the notion that the CT domain must be occupied and the BCCP 
domain must be biotinylated. 
However, in chapter 3, I showed that removing the BC domain from RePC 
reduces the rate of oxaloacetate decarboxylation to 40% that of full length RePC, 
irrespective of whether the enzyme is biotinylated. The reduced activity observed in 
RePC enzymes lacking a BC domain suggests that either the BC domain itself or enzyme 
tetramerization influences the biotin-independent CT domain activity, revealing that the 
BC domain does influence CT domain activity. For the first time, the studies presented in 
chapter 3 offer direct evidence for communication between the BC and CT domains in 
PC, even in the absence of a biotin cofactor. 
 Further, as pyruvate concentrations approach the KM value for PC, the coupling 
between MgATP cleavage and subsequent oxaloacetate formation is nearly unified, 
further suggesting that substrate occupancy of the CT domain plays a role in 
carboxybiotin-BCCP translocation. When pyruvate concentrations are at subsaturating 
levels, MgATP is cleaved and carboxybiotin is decarboxylated without oxaloacetate 
formation. Such a result indirectly suggests the possibility of a communication 
mechanism between the CT domain dimer pair during pyruvate binding. As pyruvate 
binds in the active site of the CT domain, it may signal the closure of the other active site 
located on the other face of the CT domain dimer pair. In this way, carboxybiotin could 
be primed to translocate away from the BC domain on one layer of the tetramer, and the 
binding of pyruvate on the bottom layer CT domain may promote the closure of the CT 
domain primed to accept the carboxybiotin (Figure 6-3), thus explaining the 
nonproductive decarboxylation of carboxybiotin a subsaturating levels of pyruvate. 
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Regardless, the KM value of pyruvate for PC does not vary greatly between species 
(RePC: 0.29 mM (Chapter 4); HsPC: 0.23 mM (Jitrapakdee, Walker, & Wallace, 1999); 
rat liver PC: 0.20 mM (McClure, Lardy, Wagner, & Cleland, 1971); chicken liver PC: 
0.19 mM (Utter & Keech, 1963)) and, while intracellular concentrations of pyruvate are 
difficult to estimate, it is reported that cells can maintain concentrations close to 10 mM 
depending on cellular activity (Tsau, Guffanti, & Montville, 1992; Yang, Bennett, & San, 
2001). These data suggest that the CT domain active site is frequently occupied with 
pyruvate, making the uncoupling of MgATP cleavage with oxaloacetate formation 
unlikely under physiological conditions.  
Unfortunately, no unrecognized structural perturbations were observed at the CT 
domain dimer interface with substrate binding in any of the reported X-ray crystal 
structures within this dissertation. However, all crystals were grown in concentrations of 
pyruvate or structural analogs of pyruvate that greatly exceeded the KM or Ki values, 
making any minor structural changes that occur at subsaturating levels impossible to 
observe. Hence it remains unclear whether the CT domain dimer interface is capable of 
signaling pyruvate binding between active sites. It is therefore recommended that future 
structural studies of PC focus on titrating pyruvate concentrations during crystal growth 
with the goal of trapping any potential structural changes that may occur as the result of 
pyruvate binding. 
In the end, the recurrent question that remains is: what is the exact molecular 
mechanism that induces the translocation of carboxybiotin to the CT domain upon 
pyruvate binding? While the exact details cannot be currently described, studies 
presented in this dissertation and recent structural cryo-electron microscopy studies of 
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SaPC (Lasso et al., 2014) have permitted the development of an initial model for BCCP 
domain translocation during catalysis (Section 6.2.2).  
The tetrameric arrangement for all currently reported X-ray crystal structures of 
RePC is asymmetrical (Lietzan & St. Maurice, 2013; St. Maurice et al., 2007) whereas 
SaPC is symmetrical (Xiang & Tong, 2008; Yu et al., 2009; Yu et al., 2013). This lead to 
the hypothesis that the differences in symmetry observed between the RePC and SaPC 
enzymes were species specific. However, the removal of the BC domain from RePC 
facilitates the formation of a symmetrical tetramer (Figure 6-2), suggesting that the 
overall tetramer conformation is not species specific, but instead is the direct result of the 
BC domain dimer positioning. The inability to recognize various tetrameric states in the 
full length RePC enzyme may be the result of crystallization conditions and the contacts 
formed between tetramers during crystal packing, thus stabilizing one tetrameric 
conformation over another. To date, none of the reported structures of the full length 
RePC enzyme have been co-crystallized in the presence of pyruvate. If the CT domain 
does signal the translocation of the BCCP domain, then a high priority should be to 
determine the structure of the full length RePC enzyme with pyruvate bound in the active 
site of the CT domain. Occupying the pyruvate binding site in the active site of the CT 
domain may trap the enzyme in a symmetrical state, thus supporting the role of the CT 
domain in signaling the translocation of the BCCP domain during catalysis.   
Collectively, the data presented in this dissertation supplied Lasso et al. (2014) the 
foundation to propose a model to explain the changes in quaternary structure of PC 
during catalysis (Section 6.2.2). While this model explains most of the current data with 
regards to overall quaternary structure and BCCP translocation activity, it fails to 
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recognize that eukaryotic PC enzymes do not contain an exo binding site. The exo 
binding site in the Lasso et al. (2014) model is predicted to bind tethered biotin from the 
inactive face of the tetramer, thus anchoring and constricting its movement when not 
active. This prediction has yet to be observed in any of the reported X-ray crystal 
structures of PC making this aspect of the Lasso et al. (2014) model purely speculative. 
While I agree that the exo binding site may serve to constrict BCCP domain movement 
by binding biotin, I think it is more likely that the exo binding site serves to increase the 
local concentration of free biotin. The binding of free biotin in the exo-binding site may 
promote the biotinylation of the BCCP domain by biotin protein ligase, affording a 
degree of posttranslational control to the enzyme in prokaryotes (Chapter 3). If the BCCP 
domain located on the inactive layer of the tetramer cannot reside in the exo binding site, 
as is the case in eukaryotic PC enzymes, then where does it go? Presumably it must 
occupy a site close to the BC or CT domains, but the exact positioning remains unknown. 
Therefore studies addressing the positioning of the BCCP domain during catalysis are 
paramount in order to resolve this uncertainty. Understanding the positioning of the 
BCCP domain when various substrates are bound in the active sites will provide further 
evidence to support a mechanism for BCCP domain translocation activity that is 
explained by dynamic equilibrium or through domain signaling.         
7.4 Implications for the Development of Therapeutic Agents Against Pyruvate 
Carboxylase Activity 
 
 
 
According to the American Cancer Society, approximately 580 000 Americans died as a 
result of cancer in 2013 (American Cancer Society, 2013), making it the second leading 
cause of death behind heart disease (~ 600 000 deaths; Murphy, Xu, & Kochanek, 2013). 
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Tumor cells require a constant supply of metabolites and interrupting this supply has 
been proposed as a therapeutic strategy against cancer. The recent findings that PC 
activity plays a role in malignant cancer cells has made it a potential target for the 
reduction of cancer cell growth. For example, malignant tumor cells increase their 
glycolytic activity and direct evidence indicates that human lung cancer increases both 
PC expression and activity (Fan et al., 2009). Further, PC has been shown to increase its 
activity nearly 100-fold in order to increase cellular anaplerotic activity suggesting that 
PC activity may be correlated with uncontrolled proliferation of tumor cells (Forbes, 
Meadows, Clark, & Blanch, 2006). 
 An equally concerning health issue was recently addressed by the World Health 
Organization suggesting that a post-antibiotic era may be imminent without novel 
therapeutic targets and improved efforts to reduce antibiotic resistance (Thomas, 2014). 
In 2013, the number of individuals infected with an antibiotic resistant bacteria strain was 
at least 2 000 000 (23 000 deaths) and this number is expected to increase considerably in 
the coming decades (Antibiotic resistance threats in the United States, 2013, 2013). 
Bacterial infections, which have primarily been considered as minor public health threats 
since the first discovery of penicillin, will become a serious health concern again.  
One such potentially fatal pathogenic bacterium is Listeria monocytogenes. This 
gram-positive bacterium causes listeriosis, which has a fatality rate as high as 30% 
among immuno-compromised individuals resulting in 400-500 deaths annually (Gellin & 
Broome, 1989). Interestingly, because L. monocytogenes contains an interrupted TCA 
cycle and lacks PEP carboxylase and PEP carboxykinase, it relies exclusively on PC 
activity to generate C4-dicarboxylic acids (Eisenreich, Dandekar, Heesemann, & Goebel, 
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2010). Mutating the PC gene results in a significant reduction in virulence by L. 
monocytogenes further suggesting that PC may serve as a novel antibiotic target in this 
bacterium (Schaer et al., 2010). 
 The recently reported X-ray crystal structures of PC have identified various 
potential sites that have become candidates for direct drug design. In order for a drug to 
be an effective inhibitor against enzyme activity, it must possess properties that result in 
both high affinity and selectivity for the target enzyme. The BC domain active site 
architecture is conserved for all biotin-dependent carboxylases making it a poor target in 
terms of selectivity (Section 1.2.4). The allosteric domain is another potential target site, 
but until the mechanism of allostery is further defined in PC, targeting this site may prove 
to be futile. The remaining potential target site is the active site of the CT domain. This 
active site, which has been thoroughly described throughout this dissertation, contains the 
specificity needed to target PC enzyme activity.  
First, the CT domain active site binds both pyruvate and tethered biotin. A 
structural analog of pyruvate alone will not specifically target PC as many central 
metabolic enzymes such as pyruvate dehydrogenase, pyruvate kinase and lactate 
dehydrogenase also bind pyruvate. However, if, through fragment based drug design, the 
biotin and pyruvate binding pockets are targeted together, then the prospect of designing 
a specific inhibitor against PC enzyme activity becomes achievable. Fragment based drug 
design involves screening numerous small molecules with moderate binding affinities 
with the goal of potentially tethering a couple small molecules together to create a ligand 
with a low binding affinity (Martell, Brooks, Wang, & Wilcoxen, 2013).       
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Secondly, an inhibitor designed to target the active site of the CT domain may 
also promote the closed conformation and increase its capacity to disrupt cellular 
metabolism. It is well documented that PC can nonproductively cleave ATP without the 
carboxylation of pyruvate. An inhibitor that promotes the closed conformation of the CT 
domain active site may induce the translocation and subsequent decarboxylation of 
carboxybiotin without the production of oxaloacetate. Such a mechanism could prove 
highly detrimental to cellular metabolism, as cellular ATP stores would inevitably 
become depleted. 
While the proposition of developing an inhibitor against the CT domain activity 
of PC is spectacular, it does present with a few practical limitations. The most significant 
problem is cross reactivity between, for example, PC from H. sapiens and PC from L. 
monocytogenes. The active site architecture and catalytic features are predicted to be 
conserved between all species specific PC enzymes making it difficult to target the 
activity of one without disrupting another. However, many antibiotic therapies are the 
result of administering multiple drugs together making their bactericidal or bacteriostatic 
affects on the bacterial cell synergistic. For example, the penicillin family of antibiotics is 
a group of broad-spectrum antibiotics that are highly effective against gram positive 
bacteria such as L. monocytogenes. The mechanism of action for penicillin is to inhibit 
transpeptidases and activate autolysins that destroy cell walls, making the bacterial cell 
porous. An inhibitor against the CT domain activity of PC would most likely be 
negatively charged in order to bind in the positively charged active site with high affinity 
and, as a result, be hydrophilic in nature. Eukaryotic cell membranes do not readily take 
up highly charged, hydrophilic therapeutic molecules. Therefore an inhibitor of the CT 
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domain could be parenterally co-administered with penicillin such that the resulting 
porous bacterial cell wall allows the charged inhibitor to move into the bacterial cell 
without penetrating the host’s cells and disrupting its PC activity. 
Equally important, cancer cells utilize an altered metabolism compared to healthy 
cells whereby aerobic glycolysis with reduced mitochondrial oxidative phosphorylation 
for glucose metabolism results in unsually high levels of lactate in the presence of oxygen 
(Warburg, 1956; Kim & Dang, 2006; Chen, Lu, Garcia-Prieto, & Huang, 2007). This 
increase in aerobic glycolysis activity, which ensures that cancer cells can maintain 
adequate ATP levels and sustain cellular proliferation in a hypoxic environment, is 
known as the Warburg effect (Warburg, 1956; Fantin, St. Pierre, & Leder, 2006). The 
increased levels of lactate in the cytosol of cancer cells causes lactic acidosis which has 
been related to cancer cell proliferation, metastasis and inhibition of the immune response 
against cancer cells (Walenta & Mueller-Klieser, 2004; Quennet et al., 2006). Therefore 
oxamate, an anolog of pyruvate and competitive inhibitor of lactate dehydrogenase, has 
been moderately successful at reducing cancer cell proliferation both in vitro and in vivo 
(Li et al., 2013). Oxamate is a metabolic intermediate in allantoin degradation (purine 
degradation) in Streptococcus allantoicus (Bojanowski et al., 1964) and E. coli K-12 
(Cusa et al., 1999). In chapter 3, I clearly demonstrated that oxamate serves as an 
alternate substrate for pyruvate carboxylase in the CT domain. However, the role that 
oxamate has on PC activity and the effect of producing a carbamylated oxamate 
derivative has on cellular health has not been clearly examined. It appears likely that 
oxamate may not only disrupt cellular metabolism by serving as a potent inhibitor of 
lactate dehydrogenase, but also by disrupting the carboxylation of pyruvate by PC. Future 
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cancer therapeutic studies involving the inhibition of glycolysis by inhibiting lactate 
dehydrogenase with oxamate should also consider the role oxamate plays on pyruvate 
carboxylase activity.  
Lastly, coupled enzyme assays are not particularly efficient when screening large 
libraries of small molecules for the inhibition of enzyme activity. This is due mainly to 
the uncertainty of whether the small molecule is targeting the activity for the coupling 
enzyme or the targeted enzyme. However, the development of a simplified in vitro 
enzyme assay system using the ΔBC RePC construct could prove to be a useful secondary 
or counter screen once a subset of molecules have been identified using other methods 
(Chapter 3). This simplified system maintains the general properties required for the CT 
domain reaction such as pyruvate and biotin binding without the added complexities 
associated with the BC domain. Therefore when screening potential ligands, a direct 
change in enzyme activity will most likely be due to the inhibition of the CT domain 
reaction.    
 Collectively this work has extended the reaction mechanism for the CT domain by 
primarily showing that the active site must undergo a conformational change upon 
substrate binding in order to accommodate carboxybiotin insertion. While the discoveries 
presented here do not completely unveil the exact molecular mechanism associated with 
how PC is able to effectively coordinate catalysis between its two spatially distinct active 
sites, it does contribute to its description. Further studies should be directed towards 
elucidating the mechanism by which the BCCP domain is signaled to translocate away 
from the BC domain and towards the CT domain. Such knowledge may contribute to the 
development of therapeutics against PC activity. 
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APPENDIX A: INSIGHTS INTO ALLOSTERIC REGULATION OF PYRUVATE 
CARBOXYLASE FROM THE KINETICS AND STRUCTURE OF THE 
ASPERGILLUS NIDULANS ENZYME 
 
 
 
A.1 Experimental Procedures 
 
 
 
A.1.1 Subcloning of pyc from Aspergillus nidulans 
 
 
  
The subcloning of the pyc gene from Aspergillus nidulans into the pET-17b vector for 
recombinant protein expression was completed in the lab of Dr. Sarawut Jitrapakdee 
(Department of Biochemistry - Mahidol University, Bangkok, Thailand). 
During protein crystallization trials (see Protein Crystallization), it was discovered 
the holoenzyme of AnPC does not yield crystals capable of diffracting X-rays to a 
resolution suitable for structure determination. After aligning the protein sequence of 
AnPC against other species-specific PC enzymes, it was realized AnPC contains a N-
terminal sequence (42 amino acid) leading into the BC domain, which is conserved only 
in PC from Aspergillus niger. In an attempt to enhance crystal lattice packing and X-ray 
diffraction quality, the N-terminal portion of AnPC (ΔN-AnPC) was removed by deleting 
a 126-nucleotide sequence using a single cloning step as previously described (Makarova, 
Kamberov, & Margolis, 2000)with the AnPC pET-17b vector as the cloning template. 
The primers used for cloning ΔN-AnPC are as follows: (forward) 5’-CCA CCA CCA 
TCA TCA CCA CCA CCA CAT GCA GTT CCA GAA GAT CCT CGT CG-3’ and 
(reverse) 5’-CGA CGA GGA TCT TCT GGA ACT GCA TGT GGT GGT GGT GAT 
GAT GGT GGT GG-3’. 
	   171	  
A.1.2 Protein Expression and Purification 
 
 
  
AnPC and ΔN-AnPC were expressed and purified in a similar manner. AnPC in a pET-
17b-(His)9 plasmid was co-expressed in E. coli BL21Star(DE3) with E. coli biotin protein 
ligase A (BirA) on vector pCY216. AnPC was expressed in M9 minimal media 
containing 200 mg/L ampicillin and 30 mg/L chloramphenicol. Cultures were grown at 
37°C to an Optical Density (600 nm) of 0.8 – 0.9 and immediately supplemented with D-
biotin and MnCl2 to a final concentration of 4 mg/L and 80 µM, respectively. The cells 
were placed on ice for ~ 10 minutes and then were induced with IPTG and L-arabinose to 
1 mM and 25 mM, respectively. Following induction, cultures were grown at 16°C for 48 
hours prior to harvesting.    
 The AnPC proteins were purified to homogeneity using Ni2+-affinity and anion 
exchange chromatography. Harvested cells were re-suspended in “Buffer A” containing 
20 mM Tris-HCl (pH 7.5), 5 mM imidazole, 200 mM NaCl, 10 mM MgCl2, 0.5 mM 
EGTA, 6 mM 2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 µM 
pepstatin A, 5 µM E-64, and 200 µg/mL lyzozyme. Cells were disrupted by sonication 
and the cell lysate was cleared by centrifugation at 10°C prior to loading onto a 10 mL 
Ni2+-NTA Profinity resin column (Bio-Rad Life Sciences; Hercules, CA). The protein 
was eluted from the column in Buffer A, with a gradient from 20 mM to 250 mM 
imidazole. Purified protein samples were pooled and dialyzed overnight in “Buffer B” 
containing 20 mM triethanolamine (pH 8.0), 50 mM NaCl, 3 mM MgCl2, 1 mM EGTA, 
and 2 mM DTT at 4°C. Protein was loaded on a 10 mL volume of Q-sepharose Fast Flow 
resin (GE Healthcare) and was subsequently eluted form the resin in Buffer B using a 
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linear gradient from 50 mM to 1 M NaCl. Fractions were pooled and dialyzed against a 
storage buffer consisting of 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 5% 
(v/v) glycerol and 2 mM DTT. An Amicon stirred cell with a 100 000 molecular weight 
cutoff filter was used to concentrate the AnPC preparations to a range of 10 – 15 mg/mL. 
Concentrated protein was flash frozen in liquid nitrogen and stored at -80°C. AnPC and 
ΔN-AnPC protein concentration were determined spectrophotometrically using the 
calculated molar extinction coefficient of 94 660 M-1cm-1 and 93 920 M-1cm-1, 
respectively at 280 nm (Gasteiger et al., 2005).   
A.1.3 Reductive Alkylation of ΔN-AnPC 
 
 
  
ΔN-AnPC crystallizes in the space group P4 with unit cell dimensions of a=b=331 Å, 
c=202 Å and α=β=γ=90°. Due to the high solvent content (77% assuming 2 tetramers of 
ΔN-AnPC in the asymmetric unit), poor diffraction resolution (~7 Å), increased 
susceptibility to radiation damage, and a lack of diffraction improvement using various 
dehydration techniques, an alternate crystal form was required for structure 
determination. Primary amines of ΔN-AnPC were therefore reductive methylated using 
borane dimethylamine and formaldehyde as previously described (Rayment, 1997). Prior 
to reductive methylation, protein was purified as described in Protein Expression and 
Purification with the Tris-HCl and Trienthanolamine buffers of the protocol being 
replaced with HEPES. The reductive methylation reaction proceeded for 24 hours at 4°C 
and was quenched with excess glycine for 1 hour. The purified methylated protein was 
dialyzed against 10 mM HEPES (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 2 mM DTT, and 
5% (v/v) glycerol, concentrated to ~ 13 mg/mL and flash frozen in liquid nitrogen for 
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storage at -80°C.   
A.1.4 Protein Crystallization 
 
 
 
 Reductive methylated ΔN-AnPC (rmΔN-AnPC) was crystallized using the batch 
crystallization method under oil. A protein solution consisting of 11.5 mg/mL rmΔN-
AnPC, 15 mM pyruvate and 5 mM AMP-PNP was mixed at a 1:1 ratio with a precipitant 
solution comprised of 9.2% (w/v) PEG 8000, 80 mM BisTris (pH 6.0), and 390 mM 
tetramethylammonium chloride (TMACl). A seed stock was created using the seed bead 
kit from Hampton Research (Aliso Viego, CA). Briefly, a single rmΔN-AnPC crystal was 
pulverized in 500 µL of precipitant solution and 0.5 µL of the seed solution was added to 
the crystallization drop immediately following mixing. The drop was covered with 
paraffin oil and cuboid shaped crystals (300 µm × 250 µm × 200 µm) formed within 2-3 
weeks (Figure A1). After 2-3 months, the crystals equilibrated for 5-10 minutes in a 
synthetic mother liquor consisting of 10% (w/v) PEG 8000, 70 mM BisTris (pH 6.0), 220 
mM TMACl, 5% (v/v) glycerol, 15 mM pyruvate and 2.5 mM AMP-PNP. Crystals were 
subsequently transferred to a cryoprotectant consisting of 26% (w/v) PEG 8000, 70 mM 
BisTris (pH 6.0), 220 mM TMACl, 14% (v/v) glycerol, 15 mM pyruvate, and 2.5 mM 
AMP-PNP and flash cooled in liquid nitrogen.      
A.1.5 Data Collection and Structure Determination 
 
 
  
X-ray diffraction data were collected at the Advanced Photon Source (APS), beamline 
LS-CAT 21-ID-D on a Rayonix MarMosaic 300 CCD detector. The X-ray wavelength  
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Figure A1. Protein crystal of rmΔN-AnPC in a cryo-loop at beamline APS 21-ID-D. 
 
 
 
was tuned to 0.976 Å. Diffraction images were processed with the HKL2000 suite 
(Otwinowski & Minor, 1997). The structure was solved by molecular replacement using 
the program Phaser (McCoy et al., 2007). To obtain a molecular replacement solution, 
four biotin carboxylase (BC) domains (residues 36-489) and four pyruvate 
tetramerization + caroxyltransferase (PT+CT) domains (residues 495-1091) from wild-
type SaPC enzyme (pdb i.d. 3BG5) were used as the search models. Following molecular 
replacement, translation/liberation/screw (TLS) refinements were performed using 
REFMAC (Murshudov, Vagin, & Dodson, 1997; Winn, Isupov, & Murshudov, 2001; 
Winn, Murshudov, & Papiz, 2003). Each domain was treated as a rigid TLS group. All 
BC and CT domains in the asymmetric unit were restrained using non-crystallographic 
symmetry during the entire refinement process. The program AutoBuild assisted with 
building amino acid side chains prior to several rounds of manual building with COOT 
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(Adams et al., 2010; Emsley & Cowtan, 2004; Terwilliger et al., 2008). Data collection 
and processing statistics are summarized in Table A1. 
A.1.6 Enzyme Assays. 
 
 
  
The reaction conditions for the assays performed in order to evaluate various properties 
of AnPC wt or ΔN-AnPC are included for each figure or table of data. 
A.2 Results 
 
 
 
Table A1. Data Collection and Refinement Statistics 
 
 ΔN-AnPC 
PDB ID code Xtal286 
Space Group P21 
Cell Dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
89, 208, 158 
90, 104.3, 90 
Resolution range, Å 50.0–2.95 (3.00 - 2.95)a 
Redundancy 3.8 (3.8) 
Completeness (%) 98.6 (97.0) 
Unique Reflections 113 780 
Rmerge (%) 6.2 (46.5) 
Average I/s 25.9 (2.9) 
Refinement: TBD 
Resolution range, Å - 
Rcryst - 
Rfree - 
No. protein atoms - 
No. water molecules - 
Wilson B-value (Å2) 82.1 
Average total  
B-factors 
(BTLS+Bresidual) (Å2) 
 
Protein TBD 
Chain A - 
Chain B - 
Chain C - 
Chain D - 
Ligands TBD 
Solvent TBD 
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Ramachandran (%) TBD 
Most favored - 
Additionally 
allowed - 
Generously 
allowed - 
Disallowed - 
r.m.s. deviations  
Bond lengths (Å)  TBD 
Bond angles (°) TBD 
a Values in parentheses are for the 
highest resolution bin. 	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Figure A2. Acetyl coenzyme A does not activate the pyruvate carboxylation reaction 
for A. nidulans PC wt or ΔN-AnPC. 
  
Reaction conditions:  
AnPC wt conditions () - 100 mM HEPES (pH 7.5), 100 mM KCl, 5 mM pyruvate, 2 
mM MgATP, 20 mM KHCO3, 2.5 mM MgCl2, 0−0.5 mM acetyl coenzyme A, 0.15 mM 
NADH, 5 µg AnPC wt, 10 U malate dehydrogenase, 25°C, 1 mL reaction volume 
ΔN-AnPC wt conditions () - 100 mM HEPES (pH 7.5), 100 mM KCl, 10 mM pyruvate, 
2.5 mM MgATP, 20 mM NaHCO3, 5.5 MgCl2, 0−0.5 mM acetyl coenzyme A, 0.15 mM 
NADH, 1-5 µg ΔN-AnPC wt, 10 U malate dehydrogenase, 25°C, 1 mL reaction volume  
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Acetyl-CoA, 
mM 
Ki for L-aspartate, 
mM 
Hill Coefficient kcat maximum, 
min-1 
kcat minimum, 
min-1 
0 1.6 ± 0.05 2.1 ± 0.1 1981 ± 25 138 ± 37 
0.02 3.9 ± 0.1 2.9 ± 0.3 2655 ± 64 195 ± 64 
0.05 8.1 ± 0.2 2.7 ± 0.2 2842 ± 41 36 ± 52 
0.1 14.4 ± 0.2 3.0 ± 0.1 2898 ± 33 110 ± 46 
Reaction conditions: 100 mM HEPES (pH 7.5), 100 mM KCl, 10 mM pyruvate, 2.5 mM 
MgATP, 20 mM NaHCO3, 5.5 mM MgCl2, 0−60 mM L-aspartate, 0.15 mM NADH, 5 µg 
AnPC wt, 10 U malate dehydrogenase, 25°C, 1 mL reaction volume  
 
Data were fit to:  
 
 
 
 
Figure A3. Ki determination for L-aspartate at various concentrations of acetyl 
coenzyme A for the pyruvate carboxylation reaction of PC from A. nidulans 
 
 
! 
Activity = kcat max" kcat min
1+ [I]Kih
+ kcat min
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Table A2. The oxamate-induced decarboxylation of oxaloacetate reaction is 
activated by acetyl coenzyme A, but not inhibited by L-aspartate, in PC from A. 
nidulans 
 
 Specific Activity (nmol/mg•min) 
A. nidulans PC wt 4.6 ± 0.4 
AnPC wt + 10 mM L-aspartate 5.5 ± 0.2 
AnPC wt + 0.25 mM acetyl coenzyme A 60.4 ± 1.2 
Reaction conditions: 100 mM HEPES (pH 7.5), 100 mM KCl, 1 mM oxamate, 1 mM 
oxaloacetate, 0.15 mM NADH, 500−750 µg AnPC wt, 10 U lactate dehydrogenase, 25°C, 
3 mL reaction volume 	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L-aspartate, 
mM 
KA for acetyl-
CoA, µM 
Hill coefficient kcat maximum, 
min-1 
kcat minimum, 
min-1 
0 4.5 ± 0.1 2.3 ± 0.1 7.4 ± 0.06 0.6 ± 0.1 
1 20.9 ± 0.5 3.1 ± 0.2 8.0 ± 0.1 0.4 ± 0.1 
5 130 ± 3.2 2.6 ± 0.2 6.5 ± 0.09 0.3 ± 0.07 
10 223 ± 4.3 3.0 ± 0.2 8.5 ± 0.1 0.4 ± 0.09 
Reaction conditions: 100 mM HEPES (pH 7.5), 100 mM KCl, 1 mM oxamate, 1 mM 
oxaloacetate, 0−1.2 mM acetyl coenzyme A, 0.15 mM NADH, 700 µg AnPC wt, 10 U 
lactate dehydrogenase, 25°C, 3 mL reaction volume 
 
Data were fit to: 
 
 
 
 
 
Figure A4. L-aspartate increases the KA for acetyl coenzyme A in the oxamate-
induced decarboxylation of oxaloacetate reaction for A. nidulans PC  
! 
v =
kcat max+ kcat min• [A]
h
KAh
1+ [A]
h
KAh
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Table A3. Specific activities for the phosphorylation of ADP using carbamoyl 
phosphate reaction in PC from A. nidulans 
 
 Specific Activity (nmol/mg•min) 
A. nidulans PC wt 27.4 ± 0.8 
AnPC wt + 20 mM L-aspartate 16.8 ± 0.3 
AnPC wt + 0.25 mM acetyl-CoA 28.1 ± 0.2 
Reaction conditions: 100 mM HEPES (pH 7.5), 100 mM KCl, 3 mM MgADP, 20 mM 
carbamoyl phosphate, 3 mM MgCl2, 0.2 mM glucose, 0.24 mM NADP, 250 µg AnPC wt, 
5 U glucose-6-phosphate dehydrogenase, 1 U hexokinase, 25°C, 1 mL reaction volume  
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Acetyl-CoA, 
mM 
Ki for L-aspartate, 
mM 
Hill coefficient kcat maximum, 
min-1 
kcat minimum, 
min-1 
0 3.9 ± 0.3 1.3 ± 0.1 4.5 ± 0.06 1.9 ± 0.05 
0.03 12.6 ± 0.9 1.6 ± 0.1 4.7 ± 0.08 1.7 ± 0.05 
0.1 34.4 ± 1.8 1.3 ± 0.1 4.8 ± 0.04 1.5 ± 0.08 
Reaction conditions: 100 mM HEPES (pH 7.5), 100 mM KCl, 3 mM MgADP, 20 mM 
carbamoyl phosphate, 3 mM MgCl2, 0.2 mM glucose, 0−250 mM L-aspartate, 0.24 mM 
NADP, 250 µg AnPC wt, 5 U glucose-6-phosphate dehydrogenase, 1 U hexokinase, 
25°C, 1 mL reaction volume 
 
Data were fit to: 
 
 
 
 
Figure A5. Acetyl coenzyme A increases the Ki for L-aspartate in the 
phosphorylation of ADP using carbamoyl phosphate reaction in PC from A. 
nidulans ! 
Activity = kcat max" kcat min
1+ [I]Kih
+ kcat min
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